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Abstract
This thesis has focussed on the expression of the different insulin like growth factor-I 
(IGF-I) isoforms (IGF-IEa, IGF-IEb and MGF) in human skeletal muscle, with 
specific reference to exercise and the ageing process. To enable this, a method of real 
time quantitative PCR was developed for the accurate detection and quantification of 
these splice variants. Studies were performed both in our laboratory and at the 
Copenhagen Muscle Research Centre, Denmark.
The acute response of IGF-IEa and MGF to a single bout of high resistance exercise 
was studied in young (n=8, age 29.5±1.5 years) and old (n=7, age 74.4±1.8 years) 
subjects. At rest there were no significant differences between resting levels of either 
isoform between the young and old subjects. The study showed that when measured 
2Vz hours after the end of the exercise bout, the mechano-sensitive isoform, MGF, 
was significantly upregulated in the young but not the old subjects (P<0.05). No 
change was observed after exercise in the IGF-IEa isoform in either age group 
suggesting that the isoforms were differentially regulated. Furthermore, in situ 
hybridisation using oligo probes specific for MGF mRNA confirmed its localisation 
within the muscle fibres. No significant correlation was observed between the change 
in MGF expression and the muscle myosin heavy chain isoform composition was 
observed.
A second study in young (n=10, age 20-27 years) and old subjects (n=10, age 67-75 
years) evaluated the effects of a single bout of prolonged (1 hour) eccentric muscle 
damaging cycling exercise. In this study, and in contrary to the weightlifting study, a 
significant increase was observed in MGF mRNA levels in both the young and old 
subjects after the end of the exercise challenge (P<0.05), whereas levels of IGF-IEa 
again showed no significant increase. Thus suggesting that older muscle might 
require some myofibrillar disruption and/or sarcolemmal damage caused by eccentric 
exercise as a prerequisite for stimulating MGF expression.
The effects of a period of resistance training in older people (n=19, age 70-82 years) 
performed over 12 weeks revealed a significant increase in the mRNA of both MGF 
and IGF-IEa and also the third isoform detected, IGF-IEb (P<0.05). In addition, the 
role that growth hormone (GH) might play in regulating the IGF-I spice variants in 
muscle with training was also investigated in this study. Recombinant GH 
administered to subjects without exercise, favoured expression of the IGF-IEa 
isoform. When resistance training was combined with GH administration, enhanced 
levels of MGF were observed but not IGF-IEa. This suggests that GH administration 
may lead to an overall upregulation of the primary IGF-I transcript, which is spliced 
towards MGF when mechanical activity in the form of resistance training is imposed.
The results of the work in this thesis have shown that it possible to detect and 
quantify IGF-I mRNA transcripts in human skeletal muscle, even those expressed at 
low levels. It has also shown that there may be differential regulation of the different 
isoforms in young and old muscle in response to exercise, which would support the 
idea that these isoforms of IGF-I have different physiological actions.
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General Introduction
Muscle is a remarkably plastic tissue, altering its size and phenotype in response to 
challenges that may be placed upon it. It is able to respond to functional overload by 
increasing its size (hypertrophy). In contrast, removal of load caused by micro­
gravity or joint immobilisation causes it to decrease its size (atrophy). Whilst the 
mechanisms which govern these different responses are still not fully understood, a 
number of key factors in the regulation of muscle mass have been identified. In 
addition, one of the most striking features of the ageing process is the loss of muscle 
mass, which has more recently been termed ‘sarcopenia’. This loss of muscle mass 
determines to a large extent the loss of muscle strength and power that occurs with 
age. Such functional changes have important implications on the quality of life of the 
older person, in that it decreases their ability to perform simple everyday tasks as 
well as impairing its role as a dynamic metabolic store, endogenous store of heat and 
a form of protective padding (reviewed by Harridge and Young, 1998).
There is some evidence to suggest an age-related decline in the rates of muscle 
protein synthesis (Welle et al. 1993; Yarasheski et al. 1993; Welle et al. 1995; 
Balagopal et al. 1997; Hasten et al. 2000). Amino acids and proteins are the primary 
substrates for skeletal muscle mass maintenance. An increase in muscle mass will 
inevitably lead to a net gain in protein, whereas a decrease in muscle mass, a net loss. 
There is a fine balance between the factors that regulate protein synthesis and those 
that regulate protein breakdown. Hormones and growth factors that encode for 
proteins such as testosterone and IGF-I act to stimulate, while myostatin works as a 
negative regulator of protein synthesis. On the other side of the equation, calpain and 
proteosomes appear to function by regulating protein degradation. The complex
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nature of these interactions are not yet fully understood but the work in this thesis has 
focussed on the expression of genes that regulate muscle protein synthesis.
It has long been accepted that strength and progressive resistance training leads to 
gains in muscle mass and strength in young individuals. Moreover, the 
responsiveness of aged muscle to strength training has also been confirmed by a 
considerable number of longitudinal studies (Frontera et al. 1988; Brown et al. 1990; 
Skelton et al. 1995; Welle et al. 1996; Harridge et al. 1998) in which elderly people 
have performed similar progressive resistance regimes as young people. Training 
studies in older people have also shown an increase in the rates of muscle protein 
synthesis (Yarasheski et al. 1993). However, the precise underlying mechanisms 
which trigger this increase have yet to be determined.
It is becoming increasingly more apparent that local growth factors produced by the 
muscle may play an important role in the adaptation of muscle to overload. In 
particular, the role of IGF-I as a positive regulator of muscle mass has been 
highlighted by a number of animal and cell culture studies. For example, genetic 
manipulation of IGF-I in animal muscle has shown that it has considerable anabolic 
effects in both young and old muscles (Barton Davis et al. 1998; Musaro et al. 2001). 
However, recent work has shown that the involvement of IGF-I is more complex 
than initially envisaged, with the individual splice variants of the IGF-I gene having 
been shown to have quite independent roles. In vivo animal studies (Yang et al. 
1996; McKoy et al. 1999; Hill and Goldspink, 2003) and in vitro (Yang and 
Goldspink, 2003) experiments have suggested that the main isoform produced by the 
liver, IGF-IEa, and the locally produced activity sensitive, mechano growth factor
11
(MGF), are both positive regulators of muscle growth. In contrast to these animal and 
cell culture studies, there is little information concerning the role of these IGF-I 
splice variants in human skeletal muscle. This thesis is therefore concerned with the 
role that these different isoforms may play in the regulation of muscle mass with 
exercise, with specific relevance to old age.
Aims
The specific aims of this thesis are:
1) To develop a quantitative PCR technique to measure IGF-I isoforms in 
human skeletal muscle.
2) To study the acute effects of a single bout of high resistance exercise on the 
expression of different isoforms of IGF-I in the muscle of young and old 
individuals.
3) To investigate the acute effects of a prolonged bout of eccentric exercise on 
the different isoforms of IGF-I in the muscle of young and old individuals.
4) To determine the effects of a period of resistance training on IGF-I mRNA 
expression in the muscles of elderly individuals and the role that GH may 
play in modifying this response.
12
Chapter 1
Introduction and Review of the Literature
13
Muscle loss with age
The ageing process is associated with a number of physiological changes. One of the 
most striking of these is the loss of muscle mass (sarcopenia) (reviewed by Harridge et 
al 1998). This loss of muscle mass is in part responsible for the decline in muscle 
function as we get older. This includes its mechanical function (i.e. generating force, 
power, or braking movement), its role as a dynamic metabolic store and generator of 
heat (Griffiths et al 2001). In addition, the decline in muscle mass also accounts for a 
significant proportion of the decline observed in maximal aerobic power with increasing 
age (Flegg and Lakatta, 1988). As physical function declines with age, simple daily 
tasks such as rising from a chair unaided or climbing stairs become increasingly more 
difficult, and eventually impossible to perform. This has important consequences for 
older people whose quality of life is reduced through a loss of independence and 
increased reliance upon others and also for the strain put upon health and social services 
charged with the care of an increasingly ageing population. The mechanisms by which 
muscle is lost with age and what possibilities there might be for restoring muscle mass 
and function in later life, are still not fully understood. However, interventions that 
augment muscle mass can help older men and women maintain or regain their ability to 
perform daily functional activities and live independently (reviewed by Harridge and 
Young, 1998).
Why is muscle lost with increasing age?
Sarcopenia is likely to be caused by a combination of several inter-related factors. At 
an anatomical level, it is clear that the loss of muscle with age reflects a reduction in 
the actual number of muscle fibres (Lexell et al. 1988). There is also 
electromyographical evidence to suggest that there is a reduction in the number of
14
functioning motor units as a consequence of the ageing process. Remaining / 
surviving motor units are larger in size, due to the re-innervation of abandoned and 
dying muscle fibres through a process of collateral nerve sprouting (Brown, 1972; 
Campbell et al. 1973; Sica et al. 1976). Thereby implying that part of the fibre 
population undergoes a denervation and re-innervation process with increasing age 
(Lexell et al. 1998). There are also a number of structural and compositional 
differences that are characteristic of ageing muscle such as an increase in the amount 
of connective tissue and intra-muscular fat (Frontera et al. 1991). These 
compositional changes can, in part, be explained by some fibres losing their capacity 
to be reinnervated. Having become permanently denervated, these fibres are 
eventually lost and replaced by fat and fibrous tissue. These changes in aged muscle 
reduce the contractile tissue volume available for locomotive and metabolic 
functions and act, presumably, as a friction brake to slow contractile velocity (Bross 
etal. 1999).
Histological analysis of aged muscle has shown a change from the traditional mosaic 
arrangement of type 1 and type 2 fibres into one in which fibres of the same type are 
‘grouped’ together (Nygaard and Sanchez, 1982; Lexell et al. 1986; Lexell and 
Downham, 1991). It is thought that this grouping together in clusters of certain fibre 
types can be largely attributed to the age-related process of denervation and partial 
reinnervation mentioned earlier. Cross sectional analysis of muscle has shown that 
the characteristic angular shape of individual muscle fibres also changes with age. In 
the very elderly, many fibres appear flattened, crushed or even banana-shaped, with 
this shape change being more pronounced in the type 2 fibres (reviewed by 
Andersen, 2003). Lower proportions of the fast contracting myosin heavy chain
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(MyHC) isoforms have also been reported in the vastus lateralis of aged muscle, 
which is in part due to an atrophy of the faster type 2 fibres (Klitgaard et al. 1990). 
This preferential atrophy of the fast twitch, type 2 fibres could be in part explained 
by their reduced reinnervation capacity compared with type I fibres (Tseng et al. 
1995). Furthermore, an increase in the number of muscle fibres that express more 
than one MyHC isoform appears to be a characteristic of the ageing process 
(reviewed by Andersen, 2003).
Approximately 20% of muscle weight is protein (Tzankoff and Norris, 1977) 
therefore, changes in muscle mass will probably be associated with alterations in 
muscle protein turnover (which includes muscle protein synthesis and breakdown) 
(Brozek, 1952; Proctor et al. 1998). With age, there is suggested to be a general 
decline in whole body protein synthesis. However, it is now generally agreed that 
when normalised to fat free mass (FFM), there is very little difference, if any at all, 
in whole body protein turnover rates between young and old individuals (Fukagawa 
et al. 1988; 1989; Welle et al. 1993; Yarasheski et al. 1993; Welle et al. 1994; 
Benedek et al. 1995; Millward et al. 1997; Hasten et al. 2000; Volpi et al. 2001). 
Contrary to this, Balagopal et al (1997) reported an age-related decline of 20% in 
whole body protein turnover rates in elderly subjects, even after correcting for FFM. 
One limitation of whole body measurements is that they are susceptible to influence 
from dietary intake. The results of the aforementioned study could therefore, in part, 
be explained by the 5-day weight maintaining diet that was given to the elderly 
subjects prior to measurements being made. The protein requirements for elderly 
people have been suggested to be higher than those for young individuals 
(Pannemans et al. 1998). However, the question of protein requirements for elderly
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people remains a difficult one. Work by Millward (in press) and co workers have 
shown that elderly people probably have no greater absolute need for protein, but 
that food with a high protein:energy ratio, rather than an increase in absolute protein 
requirements per day would be beneficial. Limiting the protein intake in these 
elderly subjects may have had the effect of further reducing whole body protein 
synthesis, particularly in the study by Balagopal et al. However, this was not the case 
in other studies of this kind where no effect of age on whole body protein synthesis 
was reported, even where controlled diet plans were used, albeit that they were for 3 
and not 5 days (Welle et al. 1993; Yarasheski et al. 1993; Welle et al. 1994; Hasten 
et al. 2000). Muscle contributes less than 30% to whole body protein turnover. 
Therefore small changes in muscle protein synthesis or breakdown are difficult to 
detect using measurements of whole body protein turnover (Bross et al. 1999). Many 
studies have therefore measured muscle protein rates directly to determine the effects 
of aging on skeletal muscle and the results of these studies have been summarised in 
Table 1.1. Indeed, a number of authors have suggested that the basal rates of mixed 
muscle protein synthesis are lower in elderly people when compared with younger 
individuals (Welle et al. 1993; Yarasheski et al. 1993; Welle et al. 1995; Balagopal 
et al. 1997; Hasten et al. 2000). However, there is also conflicting evidence in the 
literature to suggest that basal rates of muscle protein synthesis are unaffected by age 
(Volpi et al. 1999; 2001). These discrepancies in basal muscle protein synthesis rates 
with age are further highlighted in some studies that report different rates of 
synthesis in the different muscle fractions. For example, although Balagopal et al 
(1997) report similar rates of synthesis in the sarcoplasmic muscle fraction between 
young and old subjects, they also report lower rates of MyHC and mixed muscle 
protein synthesis in elderly when compared with young individuals. This was also
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the case in the study by Hasten et al (2000), where rates of MyHC synthesis were 
lower in the elderly subjects but rates of mixed muscle protein synthesis were no 
different to the young. It is also possible that some workers controlling the diet and 
activity of the subjects whereas others (Volpi et al. 1999; 2001) allowing subjects to 
continue with their usual routine prior to making the measurements, may have caused 
some of these discrepancies in the results. As mentioned earlier on in this section, 
protein turnover includes both muscle protein synthesis and its breakdown. In order 
to determine protein turnover requires the measurement of both. Different groups 
using different methods to measure these parameters may have also caused the 
discrepancies in results. In the main, the studies reported above (Welle et al. 1993; 
Yarasheski et al. 1993; Welle et al. 1995; Hasten et al. 2000) used a non specific and 
relatively insensitive technique to measure protein breakdown, which involved 
measuring whole body 3-methylhistidine excretion. Work by Volpi and co workers 
however used a more direct approach, the AV balance method. This method relies on 
the measurement of phenylalanine enrichments and concentrations in the femoral 
artery and vein to estimate muscle protein synthesis, breakdown and net balance. 
Whether muscle protein synthesis rates are reduced with age is still the matter of 
much debate and much needs to be done to improve and standardise methods for 
reliable and consistent results.
The reasons why muscle fibres are lost, fast fibres atrophy and protein synthesis rates 
may be reduced in old age are not fully understood and remain the important 
questions concerning the aetiology of sarcopenia. Much work has focussed on the 
relationship between the age-related decline in levels of the growth hormone/insulin
18
like growth factor-I (GH/IGF-I) axis and muscle loss with age. This work has been 
evaluated in the next section.
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Author Muscle fraction Tracer used Conditions Male, Female 
Young; Middle aged; Old
Conclusion
Volpi e ta l (2001) Mixed 300 min 
L-[ring2H5] Phe
Regular diet 
Usual routine
All male No difference
Volpi et al (1999) Mixed 480 min 
L-[ring2H5] Phe
Regular diet 
Usual routine
3,4; 2,6 No difference
Hasten et al (2000) Actin 840 min
L-[1-13C] leucine
3 days meat free 
controlled protein
4,3; 3,4 Insignificant rise
Hasten et al (2000) Mixed 840 min
L-[1-13C] leucine
3 days meat free 
controlled protein
4,3; 3,4 No difference
Balagopal et al (1997) Sarcoplasmic 600 min
L-[1-13C] leucine
5 days weight 
maintaining diet
4,4; 4,4; 4,4 No difference
Yarasheski et al (1993) Mixed 840 min
L-[1-13C] leucine
3 days meat free 
controlled protein
4,2; 2,4 Lower in elderly
Welle et al (1993) Myofibrillar 480 min
L-[1-13C] leucine
3 days controlled 
meat free diet + activity
All male Lower in elderly
Welle et al (1995) Myofibrillar 480 min
L-[1-13C] leucine
3 days controlled 
meat free diet + activity
5,4; 5,4 Lower in elderly
Hasten et al (2000) Myosin heavy chain 840 min
L-[1-13C] leucine
3 days m eat free 
controlled protein
4,3; 3,4 Lower in elderly
Balagopal et al (1997) Myosin heavy chain 600 min
L-[1-13C] leucine
5 days weight 
maintaining diet
4,4; 4,4; 4,4 Lower in middle aged and 
elderly
Balagopal et al (1997) Mixed 600 min
L-[1-13C] leucine
5 days weight 
maintaining diet
4,4; 4,4; 4,4 Lower in middle aged and 
elderly. No diff middle aged to 
elderly
Rooyackers et al (1996) Mixed 240 min
L-[1-13C] leucine
5 days weight 
maintaining diet
6,6; 7,7; 7,9 Lower in middle aged and 
elderly. No diff middle aged to 
elderly
Table 1.1 Basal muscle protein synthesis in young and elderly people. (Adapted from Dorrens and Rennie, 2003).
Growth hormone/IGF-I axis
Growth hormone (GH) is secreted from somatotroph cells located within the anterior 
pituitary gland in a pulsatile manner, with one of its main actions being synthesis of the 
anabolic peptide insulin like growth factor-I by the liver. The GH/IGF-I axis plays an 
essential role in postnatal growth and development. Levels of these hormones reach their 
peak during adolescence and are maintained at somewhat lower levels during adulthood. 
However, with increasing age there is a further decline in the circulating levels of GH 
and IGF-I. (Rudman et al. 1981; Corpas et al. 1993; Lamberts et al. 1997; Morley, 
1995). The relationship between the age-related decline in the GH/IGF-I axis and loss of 
muscle mass and strength has been extensively studied. In young adults who were 
growth hormone deficient, the administration of recombinant GH (rhGH) was shown to 
have positive effects on muscle mass and function (Cuneo et al. 1991). Another study 
where GH deficient adults were treated with GH for an extended period of time 
concluded that there was not only increased muscle strength but also decreased body fat 
(Beshyah et al. 1995). This lead to the belief that older individuals with decreased levels 
of circulating GH and IGF-I would also benefit from rhGH therapy. However, studies 
which have combined GH administration and resistance training in both young 
(Yarasheski et al. 1992) and older men (Yarasheski et al. 1995) have shown that the 
rates of protein synthesis are no greater when resistance training is combined with GH 
than when resistance training is performed alone. Furthermore, in older people the 
changes in muscle mass and function have also been reported to be similar between both 
groups (Lange et al. 2002). The roles of circulating GH and IGF-I, particularly with 
regards to muscle adaptation in later life are still unclear. In support of an argument that 
systemic growth factors may be of relatively minor importance in muscle hypertrophy, is 
one study which showed that the overloaded muscles in hypophysectomized rats were
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still able to hypertrophy despite significantly reduced systemic IGF-I levels (Adams and 
Haddad, 1996). These findings, coupled together with the simple observation that it is 
only challenged muscles which hypertrophy and not all the muscles of the body, 
highlights the importance of a ‘local’ system of muscle adaptation.
The somatomedin hypothesis
The original somatomedin hypothesis originated in the 1950’s in early efforts to 
understand how somatic growth was regulated by factors secreted by the pituitary. It 
was determined that pituitary-derived GH did not act directly on its target tissues to 
promote growth, and that there were intermediary substances involved (Daughday 
and Reeder, 1966). The term ‘somatomedin’ was later adopted to reflect the growth 
promoting actions of these substances (Daughday et al. 1972), and some two decades 
later, IGF-I (and IGF-II) were characterised, with IGF-I being the somatomedin 
regulated by GH (Rinderknecht and Humble, 1978; Klapper et al. 1983). Both 
substances were termed ‘insulin-like’ due to their ability to stimulate glucose uptake 
into fat cells and muscle. The original hypothesis became the widely accepted model 
of IGF action: namely, that the effect of GH on longitudinal body growth was 
mediated in an endocrine fashion, solely by liver-derived IGF-I. This hypothesis was 
later revised in the 1980’s when D’Ercole and co workers discovered that extra- 
hepatic tissues also expressed IGF-I, thus suggesting that IGF-I also had an 
autocrine/paracrine effect (D’Ercole et al. 1984). In 1985, an alternative view was 
proposed by Green and co-workers known as the ‘dual effector hypothesis’ (Green et 
al. 1985). This hypothesis suggested that GH had direct effects on peripheral tissues 
not mediated by IGF-I and that GH stimulated local IGF-I production for 
autocrine/paracrine action. However, current evidence suggests that the situation is
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more complex than any of these early hypotheses envisioned. It is now clear that GH, 
in addition to stimulating hepatic IGF-I synthesis, stimulates the formation of a 
ternary IGF binding complex, including IGFBP-3 and the acid labile subunit (ALS), 
which stabilises IGF-I in the serum. Furthermore, the results of recent gene deletion 
experiments using the Cre-loxP model of gene deletion have questioned the role of 
liver IGF-I and the bound form of circulating IGF-I in controlling postnatal growth 
and development (Sjogren et al. 1999; Yakar et al. 1999). This homologous 
recombination system creates a liver specific deletion of the IGF-I gene and allows 
normal expression of this gene in other non-hepatic tissues, such as heart, muscle, 
fat, spleen and kidney. When testing the effect of this liver specific gene deletion of 
IGF-I on growth and development in these animals, it was found that circulating 
IGF-I levels were markedly reduced at six weeks of age compared with wild type 
animals. However measurements of body weight made from 3 to 6 weeks, body 
length and individual organ weights at 6 weeks were no different between the 
knockout animals and their wild type littermates. Thus, postnatal growth and 
development was considered normal without the contribution of liver derived IGF-I 
(Sjogren et al. 1999) and emphasising the role of the local IGF-I system in this 
process. A schematic representation of the somatomedin hypothesis is shown in 
Figure 1.1.
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Figure 1.1 Schematic representation of the somatomedin hypothesis. (A) The original 
hypothesis proposed that the effect of GH on longitudinal body growth was mediated 
exclusively by IGF-I (originally termed somatomedin). (B) The revised hypothesis proposed 
that IGF-I was also expressed by most extra-hepatic tissues, thus suggesting a possible 
autocrine/paracrine role for IGF-I as well as endocrine. (C) Current evidence has shown that 
liver-derived IGF-I and the bound form are not essential for postnatal growth and 
development. Abbreviations: ALS (acid labile subunit), GH (growth hormone), IGF-I 
(insulin-like growth factor-I), IGFBP-3 (insulin-like growth factor binding protein-3). 
(Adapted from LeRoith et al. 2001).
24
GH and the GH receptor
GH belongs to a large family of peptides (Miller and Eberhardt, 1983) and is known 
to exert its effects by binding to the growth hormone receptor (GHR) (Bazan, 1989; 
1990; Cosman et al. 1990). It circulates in a complex with its binding protein, growth 
hormone binding protein (GHBP). Upon binding to the hepatic GHR, GH induces 
the expression of IGF-I. As the liver has the highest expression of the GHR, it 
accordingly expresses a large fraction of circulatory/serum IGF-I. However, it is also 
known that other tissues including bone, muscle and the kidney also express the 
GHR and may therefore contribute to the levels of serum IGF-I. Circulating IGF-I 
inhibits GH secretion, providing a negative feedback loop on the actions of GH in 
peripheral tissues. Two hypothalamic factors, GH releasing hormone (GHRH) and 
the inhibitory hormone, somatostatin (SS), are known to act together to regulate GH 
secretion from pituitary somatotrophs. More recently, another GH-secretory factor 
that is derived from a peripheral organ has been isolated. Ghrelin, a 28-residue 
peptide, is expressed at high levels in endocrine cells of the stomach (Kojima et al. 
1999). GH secretion is therefore likely to be controlled by a combination of 
hypothalamic and peripheral signals.
GHR signal transduction pathways
The actions of GH are mediated by its binding to the transmembrane GHR. As with 
most cytokine receptors, the GHR utilises the JAK-STAT signal transduction 
pathway. The activated GHR associates with JAK2 (Janus kinase 2). JAK2 is a 
tyrosine kinase, which upon activation by GH phosphorylates STATs 1, 5a, and 5b 
(signal transducers and activators of transcription) on tyrosines. Upon 
phosphorylation by GHR and JAK2, the STAT proteins translocate to the nucleus
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where they bind to specific DNA sequences and activate gene transcription. 
Activation of the GHR also induces tyrosine phosphorylation of the insulin receptor 
substrate (IRS) proteins IRS-1 and IRS-2. These behave as docking proteins to direct 
signals from the IGF and insulin receptors to various downstream signalling 
pathways. Activation of the insulin like growth factor-I receptor (IGF-IR) also 
stimulates the phosphorylation of these IRS proteins, thus providing for cross talk 
between GH and IGF-I at the level of signal transduction (Reviewed by Le Roith et 
al. 2001). IGF-IR signal transduction pathways are discussed in detail later on in this 
chapter.
GH stimulation has been shown to regulate the gene expression of IGF-I and many 
of the IGF binding proteins (IGFBPs). However, it is still not clear precisely how GH 
regulates IGF-I gene expression and whether the alternative promoters PI and P2 on 
the IGF-I gene are differentially activated. The data on GH control of IGF-I 
promoters has only been generated by studies on hypophysectomized rats and was 
investigated in relation to GH control of hepatic tissue (Adamo et al. 1991). Mittanak 
et al (1997) showed that GH activates both PI and P2 equally. However, there is also 
evidence from studies on the ovine IGF-I gene to suggest that only transcripts 
initiating at P2 are GH sensitive (Lyall, 1996). In addition, there is evidence of 
constitutive activation of the P2 (the minor promoter) in non-hepatic tissue, which 
was unaffected by GH activity (Le Stunff et al. 1994), suggesting that there may be 
alternative regulatory elements within the promoter regions of the IGF-I gene, which 
allow for GH-independent, tissue specific expression.
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The insulin like growth factor system
The insulin like growth factors (IGF-I and IGF-II) belong to a family of polypeptides 
with marked structural similarities to insulin and possess both anabolic and 
mitogenic properties both in vivo and in vitro (Blundel et al. 1983; Rinderknecht and 
Humble, 1978a; b). The IGF system is comprised of the ligands: IGF-I, IGF-II and 
insulin, six well characterised binding proteins, and cell surface receptors that 
mediate the actions of these ligands (IGF-IR, insulin receptor and the IGF-H 
mannose-6-phosphate [M-6-P] receptor). The work in this thesis focuses on IGF-I. 
The following sections will therefore describe this particular system in detail.
IGF-I gene structure
In both human beings and rats, the IGF-I gene spans more than 70 kilobases and 
consists of six exons and at least five introns (Rotwein et al. 1986; Shimatsu and 
Rotwein, 1987; Rotwein, 1991). Two promoters, one adjacent to exon 1 and the other 
to exon 2 govern gene transcription. Both promoters lack a “TATAA” box, a 
“CCAAT” box and other typical proximal control elements, yet neither resemble a 
GC-rich “housekeeping” promoter (Adamo et al. 1991; Jansen et al. 1991; Hall et al. 
1992). Exons 1 and 2 are alternative leader exons derived from different transcription 
start sites, and encode part of the signal peptide (Jansen et al. 1983; Tobin et al. 
1990). The resulting variant mRNA transcripts with different 5’ untranslated regions 
(UTR) have been classified as Type/Class 1 (exon 1-3) and Type/Class 2 (exon 2-3) 
(for schematic representation of the IGF-I gene see Figure 1.2). These 5’UTR 
mRNA variants are differentially regulated during development in a tissue specific 
manner (Lowe et al. 1988). Class 1 mRNA transcripts have been shown to be 
expressed in rat liver and a wide range of non-hepatic tissues both in prenatal and
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postnatal animals (Hoyt et al. 1988; Adamo et al. 1989). In contrast, Class 2 mRNA 
transcripts were undetectable or barely detectable in non-hepatic tissues (Hoyt et al., 
1988; Adamo et al, 1991), suggesting that the basal promoter associated with exon 1 
is active in a wide range of tissues.
In addition to transcription from two promoters, IGF-I is regulated by post- 
transcriptional events, which yield several mature mRNA transcripts. In all of these 
variants exons 3 and 4, which encode the mature 70 amino acid peptide are constant 
(Bell et al. 1986; Gilmour, 1994) whereas, exons 5 and 6 are subject to a complex 
alternative splicing pattern. This is a complex mechanism by which exons are 
arranged in different combinations from pre-mRNA. It is an important and common 
process for generating protein diversity and regulating gene expression in higher 
eukaryotes (Chew, 1997).
IGF-I primary structure
The primary structure of IGF-I is similar to that of pro-insulin as it comprises an 
amino terminal B region and an A region that is separated by a short connecting C 
domain. Unlike pro-insulin however it also has a D region extension peptide and an 
E peptide at its carboxyl terminus (Lowe, 1985). The different E peptides are cleaved 
from the pre-pro-IGF-I to yield a single mature IGF-I peptide consisting of the B, C, 
A, and D domains (Kim et al. 1991; Jansen et al. 1991).
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IGF-I isoform Names used in the literature
IGF-IEa L.IGF-I m-IGF-11
IGF-IEb
IGF-IEc IGF-IEb (rats)3, MGF1
Table 1.2 The different names used to describe the IGF-I isoforms in the literature. 
1 Yang et al. 1996,2 Musaro et al. 2001,3 Rotwein, 1987.
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Figure 1.2. Schematic representations of the human IGF-I gene and its splice variants. 
Exons are shown as ‘boxes’, introns as ‘lines’. The arrows under exons 1 and 2 indicate 
multiple transcription start sites. Promoter elements 5’ to exons 1 and 2 are shown as PI and 
P2 respectively. Polyadenylation signals are shown by the letter ‘A’. Splicing patterns are 
shown by ‘broken lines’. The protein-coding potential of the exons is indicated underneath 
the IGF-I gene. Exon 1 or 2 is spliced to exon 3 to give rise to either class 1 or class 2 
mRNA transcripts.
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551 610
CCCAGCGCCACACCGACATGCCCAAGACCCAGAAG/TATCAGCCCCCATCTACCAACAAGA Hum Ec  
CCCAGCGCCACACTGACATGCCCAAGACTCAGAAG/TCCCAGCCCCTATCGACACACAAGA r a t  Eb 
CCCAGCGCCACACCGACATGCCCAAGACCCAGAAG/TATCAGCCCCCATCTACCAACAAGA Hum Eb 
* * * * * * * * * * * * *  * * * * * * * * * * * * * *  * * * * * * *  * * * * * * *  * * *  **  * * * * * *
611 651
ACACGAAG TCTCAGAGAAGGAAAG/GAAGTACATT TGAAGAACGCAAGTAGA Hum Ec
AAAGGAAGCTGCAAAGGAGAAGGAAAG/GAAGTACACT TGAAGAACACAAGTAGA r a t  Eb
ACACGAAG TCTCAGAGAAGGAAAG/GTTGGCCAAAGACACATCCAGGAGGGGAACAGA Hum Eb
*  *  * * * *  * * * * * * * * * * *  *  *  * *  *  ★ *  *  *  * ★ ★
668 700
GGGAGTGCAGGAAACAAGAACTA  Hum E c
GGAAGTGCAGGAAACAAGACCTACAGAATGTAG r a t  Eb
AGGAGGGGACAGAAGCAAGTCTGCAGATCAGAG Hum Eb
*  * *  *  *  * *  *
Figure 1.3. Human exon 4-5 (Eb) and exon 4-5-6 (Ec) cDNA sequences aligned with rat 
exon 4-5-6 (Eb) cDNA. Homology to human Ec is denoted by the ‘asterisks’ under the 
sequence, exon boundaries are marked by the ‘broken lines’ and in-frame stop codons are 
underlined in human Ec and rat Eb. The numbering refers to the human Eb sequence cloned 
by Rotwein (1986). Taken from Chew et al (1995).
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IGF-I mRNAs that encode different E peptides
Alternative splicing of exons 5 and 6 of the IGF-I gene results in IGF-I mRNAs 
encoding different E peptides. Exon 4 usually splices to exon 6 (Jansen et al. 1983), 
but can also splices to exon 5, representing 1-10% of IGF-I transcripts (Rotwein, 
1986). A minor isoform results from splicing of exons 4 and 5, and from an 
alternative 5’ splice site in exon 5 to exon 6 (Chew et al. 1995). A schematic 
representation of the human IGF-I gene and the splicing pattern of its splice variants 
is shown in Figure 1.2. 3’ alternative splicing of the primary IGF-I gene generates 
six different IGF-I mRNAs in humans: Class 1 or 2 IGF-IEa, IGF-IEb and IGF-IEc, 
and these are indicated on the figure.
In the rat, the splicing pattern of exon 5 is different from that in the human as exon 4- 
6 or exon 4-5-6 splicing occurs (Roberts et al. 1987; Shimatsu and Rotwein, 1987), 
and exon 5 is a cassette exon of 52 base pairs (bp), rather than a terminal exon as it is 
in humans. This therefore generates 4 different IGF-I mRNAs: either Class 1 or 
Class 2 IGF-IEa and IGF-IEb. The nomenclature is highly confusing and it should be 
noted that the human IGF-IEc isoform corresponds to the rat IGF-IEb isoform. This 
confusion in the nomenclature has been further compounded by different groups 
further re-naming the isoforms. Table 1.2 shows the different names used for each of 
the IGF-I isoforms in the literature. Comparison between the human and rat cDNA 
and deduced peptide sequences suggests that the exon 4-5-6 splice variants in both 
species are equivalent (Roberts et al. 1987; Shimatsu and Rotwein, 1987). The 
deduced E-peptide sequences of the rat and human 4-5-6 mRNAs have been shown 
to share 73% homology and this has been shown in Figure 1.3. It has been suggested 
that the rat hepatic exon 4-5-6 mRNA variant may generate circulating and GH-
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responsive IGF-I (Lowe et al. 1988; Lund, 1994). It is therefore likely that the human 
eion 4-5-6 splice may also play a role in generating circulating IGF-I (Chew et al.
1995).
The role of £  peptides
As previously mentioned, IGF-I cDNAs predict at least four different mRNA species 
(six in humans) and at least two different IGF-I translational products (Daughaday 
and Rotwein, 1989). These different IGF-I precursors or pro hormones: proIGF-IA 
and proIGF-IB have identical initial sequences, which are encoded by exon 4 but 
different carboxyl-terminal extensions. Therefore IGF-I is synthesised as precursor 
molecules that are post-translationally processed to a biologically active mature 
peptide. It is believed that transcripts encoding proIGF-IA are more abundantly 
expressed than those encoding proIGF-IB (Nagaoka et al. 1991). The physiological 
rcles of these precursors and those of the cleaved E peptides (Ea and Eb) are 
essentially unknown. However, the significant sequence homology for IGF-I during 
evolution would suggest that these E peptides or pro hormones may have important 
biological functions independent of that of IGF-I (Wilson et al. 2001). An amino acid 
sequence within the E domain of proIGF-IB was shown to have mitogenic activity in 
normal and malignant bronchial epithelial cells (Siegfried et al. 1992). More 
recently, work by Tian et al (1999) demonstrated that recombinant E-peptides, 
corresponding to sequences in the carboxy terminal of proIGF-IA from rainbow 
trout, possessed mitogenic activity in heterologous systems. In addition, Yang and 
Goldspink (2002) reported that the IGF-IEc peptide had a different role to that of 
mature IGF-I in myoblast proliferation and differentiation. This work and later work 
by Hill and Goldspink (2003), suggests that the IGF-IEc peptide is involved in the 
activation of satellite cells. Studies of this kind would therefore suggest that the
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different E peptides o f  IGF-I have distinct biological roles, independent to that o f 
IGF-I.
IGF-I receptor
The cellular effects o f IGF-I are mediated by its cell surface receptor, the IGF-IR 
(Figure 1.4). The IGF-IR is a heterotetrameric glycoprotein composed o f two extra 
cellular a- subunits and two transmembrane /3-subunits. The IGF-IR is similar in 
structure to the insulin receptor and both receptors share >50% amino acid identity. 
The a- subunits contain the ligand binding region o f the receptor, while the /3- 
subunits are composed o f a short extracellular domain, a membrane spanning 
segment and a large cytoplasmic region containing a tyrosine kinase domain and 
sites o f  tyrosine and serine phosphorylation (Reviewed by Stewart and Rotwein,
1996).
cl a
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Figure 1.4. IGF-IR. Functional domains within the a  and /3 chains are labelled and disulfide 
bonds responsible for maintaining receptor heterotetramer are indicated by the ‘s-s’. 
(Adapted from Stewart and Rotwein, 1996).
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Ligand binding to the receptor results in a conformational change whereby the a  and 
/3-subunits are drawn together. This then leads to receptor autophosphorylation in the 
tyrosine kinase domain. This tyrosine phosphorylation is an essential activating step 
for receptor function.
It is known that the biological activity of a hormone or growth factor does not simply 
reflect the level of hormone or growth factor, but also depends on the concentration 
of the receptor and the affinity of its interaction. There is evidence that there is an 
impairment of both IGF-IR density and signalling in aged skeletal muscle 
(Renganathan et al. 1997). However, IGF-IR number, binding capacity and affinity 
were shown to increase in the soleus muscle of old mice after physical exercise 
(Willis et al. 1998), suggesting that old animals retain plasticity for IGF-IR.
IGF-IR signal transduction pathways
This intrinsic tyrosine kinase activity of the IGF-IR mediates the different biological 
actions of IGF-I by phosphorylating endogenous cellular substrates. Many of the 
substrates that have been identified are also phosphoproteins, with insulin receptor 
substrate-I (IRS-I) being the most well characterised. IRS-I behaves as a multi-site 
‘docking’ protein, which upon phosphorylation associates with other intracellular 
proteins with src homology 2 (SH2) domains (LeRoith et al. 1995). Different 
proteins containing SH2 binding domains bind to IR-S such as Grb2 Nek (adaptor 
proteins), c-Crk (a Grb2 and Nek homolog), Syp a protein tyrosine phosphatase (SH- 
PTP2) and the p85 subunit of phosphatidyl-inositol- 3 kinase (PI3-kinase). The 
recruitment of Grb-2 through IRS-1 leads to the activation of the ras mitogen- 
activated protein (MAP) kinase pathway. Activation of PI3-kinase leads to activation
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of the enzyme p70 S6 kinase, which may be involved in mitogenesis (LeRoith et al.
1995). Other proteins activated by phosphorylation include extracellular signal 
related kinases 1 and 2 (ERK-1 and ERK-2).
IGF binding proteins
Over 97% of IGFs are bound to members of a family of six proteins, the IGF binding 
proteins (IGFBPs 1-6), which bind IGF-I and IGF-II with an affinity equal to or 
greater than that of the IGF-I receptors (Jones and Clemmons, 1995). These IGFBPs 
are modulators of IGF action and essentially serve to: transport IGFs from the 
circulation to peripheral tissues, maintain a reservoir of IGFs in the circulation, 
potentiate or inhibit IGF action and mediate IGF-independent biological effects 
(Reviewed by Stewart and Rotwein, 1996). The actions of the individual binding 
proteins is summarised in Table 1.3.
IGFBPs are highly conserved cysteine proteins that vary in length from 216 to 289 
amino acids. Structurally, IGFBPs have a conserved N-terminal domain involved in 
IGF binding, and a carboxyl terminal, that is important for protein-protein or protein- 
extracellular matrix (ECM) interactions (Hwa et al. 1999). The central portion of 
earii binding protein is unique and commonly subject to proteolysis. Although IGF-I 
is bought to bind largely around the highly conserved cysteine residues, the carboxyl 
teminal does play a role in ligand recognition, as cleavage of the domain greatly 
reduces the binding affinity for IGF-I (Reviewed by Rosenfield et al. 2000).
Inthe circulation, over 90% of IGF-I is found as heterotrimeric complex bound to the 
m«st abundant binding protein, IGFBP-3, and the acid labile subunit (ALS). ALS, as
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the name suggests, loses its ability to form ternary complexes and is irreversibly 
destroyed under acidic conditions (pH<4.5). Its main physiological role is thought to 
be to extend the half lives of IGFs from 10 minutes, when in the free form, and 30-90 
minutes when in binary complexes, to more than 12 hours when bound in ternary 
complexes. Another role of ALS is the prevention of the non-specific metabolic 
effects of the IGFs, such as causing severe hypoglycaemia (reviewed by Biosclair et 
al. 2001). Other IGFBPs found in the bloodstream include IGFBP-1, IGFBP-2 and 
IGFBP-4, but are present at much lower concentrations. IGFBP-4, IGFBP-5 and 
IGFBP-6 are expressed in many muscle cell lines and have also been reported to be 
present in muscle tissue in vivo (Ewton and Florini, 1995; Bayol et al. 2000). There 
is some evidence to suggest that alterations in IGFBP expression, namely IGFBP-4 
and IGFBP-5 occur in unloaded or overloaded soleus muscle, and that this may play 
a role in skeletal muscle adaptation to changes in loading (Bonaventure et al. 1999).
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IGFBP Potential functions Cell surface/ 
matrix 
binding
Modification 
by proteolysis
IGFBP-1 Minor serum carrier; 
potentiates/inhibits IGF action
Yes No
IGFBP-2 Minor serum carrier; 
potentiates/inhibits IGF action
No Yes
IGFBP-3 Major serum carrier; 
potentiates/inhibits IGF action: 
IGF-independent modulator of cell 
proliferation
Yes Yes
IGFBP-4 Inhibits IGF action No Yes
IGFBP-5 Potentiates/inhibits IGF action Yes Yes
IGFBP-6 Potentiates/inhibits IGF action No Possibly
Table 1.3. Actions of the individual IGFBPs. (Adapted from Stewart and Rotwein, 1996).
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Autocrine/paracrine IGF-I
As previously mentioned, almost all tissues express IGF-I, including skeletal muscle. 
It is also clear that GH induces IGF-I expression in many of these tissues and that 
IGF-I can have GH independent actions. For example, GH has not been shown to 
affect prenatal development, as GH and GHR null mice appear no different from 
thdr wild type littermates at birth. Contrastingly, Igf-1 null mice are smaller 
compared with their wild type when they are bom, and most die early in the neonatal 
stages. Those that survive are severely retarded and also infertile (Liu et al. 1993).
Postnatally, the role and regulation of autocrine/paracrine IGF-I is largely determined 
by tissue type. A number of factors influence the heterogeneity of the tissue/cellular 
re^onse: the tissue type, the state of differentiation of the cell, the number and 
activity of cell surface receptors, the cellular microenvironment and the method of 
delvery of IGF-I. IGF-I has been demonstrated to stimulate the proliferation and 
differentiation of myoblasts (Florini et al. 1986), osteoblasts and adipocytes (Smith 
etil. 1988).
Local IGF-I production is believed to be important in the regulation of growth and 
differentiation following changes in the local environmental. The stimulation of IGF- 
I p*oduction in muscle in response to overload has been the topic of much recent 
research. Given the widespread action of local IGF-I in a number of tissues, it is 
bexmd the scope of this literature review to detail all of these. The following 
sections will therefore focus on evaluating its role in skeletal muscle growth, with 
specific reference to age.
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Muscle hypertrophy
Hypertrophy is the increase in muscle size. It has long been accepted that mechanical 
stress can have an effect on muscle mass. There are a number of ways of overloading 
animal muscles to produce a hypertrophic response, some of which are discussed briefly 
in the next section of this chapter. In man however, this is most easily achieved through 
high resistance or strength training. By definition, strength training involves 
progressively overloading the neuromuscular system using near maximal muscle 
contractions against high resistance, where loads near to their 1 repetition maximum (1- 
RM) are lifted (Porter et al. 1995). Body builders in contrast tend to lift less heavy loads 
to achieve definition, so that muscles can be visually separated from each other. This is 
achieved using ‘split’ system exercise programmes, i.e. a few selected muscles or 
muscle groups are exercised in each exercise session (Tesch, 1994). It is clear that as 
hypertrophy is limited to the muscle exercised and not to all muscles, there are ‘local’ 
factors regulating this process. It is now believed that IGF-I plays a key role in the 
hypertrophic adaptation of muscle to exercise.
Muscle IGF-I and hypertrophy
The anabolic effects of IGF-I have been clearly demonstrated by numerous in vitro 
studies, where it has been shown that IGF-I acts to increase the diameter of 
myotubes, suppress protein degradation, increase amino acid uptake and stimulate 
protein synthesis (Florini, 1987; Vandenburgh et al. 1991; Florini et al. 1996; 
Semsarian et al. 1999; Rommel et al. 2001; Bodine et al. 2001).
In vivo studies, employing models known to result in muscle hypertrophy have 
reported that IGF-I expression in the muscle increases early on in the process of
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hypertrophy. Studies utilising the model of stretch-induced hypertrophy of the 
muscle have reported an increased expression of muscle IGF-I mRNA (Schlechter et 
al. 1986; Czerwinski et al. 1994). A study by DeVol et al (1990) demonstrated that 
there was a three-fold increase in IGF-I mRNA levels in the soleus and plantaris 
muscles in 11-12 week old female rats following tenotomy-induced hypertrophy. 
This particular study employed hypophysectomized rats, which further suggests that 
the observed increase in IGF-I mRNA expression was GH independent. Later studies 
utilising a similar model of functional overload in both normal and 
hypophysectomized rats found that both mRNA and protein levels of IGF-I were 
increased in muscle, prior to the attainment of significant hypertrophy, and remained 
elevated for up to 28 days during the hypertrophy process (Adams and Haddad,
1996). Furthermore, when investigating the time course of changes in markers of 
myogenesis following increased loading, the myogenic processes were activated 
early on, and it was suggested that IGF-I might be modulating this response (Adams 
et al. 1999). In another study which utilised treadmill training of GH-suppressed 
rats, levels of IGF-I mRNA and protein increased by 55% and 250% respectively 
(Zanconato et al. 1994).
Few studies to date have investigated the IGF-I response to exercise and overload in 
human skeletal muscle. In a study of young military recruits, Hellsten et al (1996) 
reported an increase in IGF-I immunoreactivity after seven days of strenuous exercise. 
Later, in a study investigating IGF-I mRNA levels, Bamman et al (2001) reported a 62% 
increase in IGF-I mRNA concentration in the muscle, 48 hours after an acute bout of 
eccentric, but not concentric contractions. More recently, a study by Psilander et al 
measured mRNA levels of some of the isoforms of IGF-I after heavy resistance training
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in young subjects. In this study levels of total IGF-I (IGF-IEabc) and IGF-IEbc were 
measured before, immediately after, and 1, 2, 6, 24 and 48 hours post exercise. The 
study reported a decrease in levels of total IGF-I and no change in levels of IGF-IEbc 
mRNA after the exercise. It is difficult to determine the individual isoform response to 
training from this study, as measurements were made of the isoforms grouped together.
IGF-I stimulated hypertrophy
There is also evidence that experimental manipulations of the levels of IGF-I in 
muscle can induce muscle hypertrophy both in vitro (Vandenburgh et al. 1991) and 
in vivo (Coleman et al. 1995; Adams and McCue, 1998). For example, 
overexpression (Coleman et al. 1995) or direct infusion (Adams and McCue, 1998) 
of IGF-I in muscle results in hypertrophy, whereas inhibition of intracellular 
signalling components associated with IGF-IR activation can prevent this response 
(Bodine et al. 2001). In another study, examining the association between local IGF-I 
overexpression and atrophy induced by hind limb unloading it was concluded that 
overexpression of IGF-I in the muscles of transgenic mice, was not shown to prevent 
unloading-induced atrophy (Criswell et al. 1998).
IGF-I signalling pathways involved in skeletal muscle hypertrophy
The signalling pathways by which IGF-I promotes skeletal muscle hypertrophy 
remain unclear, with roles suggested for both the calcineurin/NFAT (nuclear factor 
of activated T cells) pathway (Musaro et al. 1999; Semsarian et al. 1999) and the 
PI3-kinase/Akt pathway (Rommel et al. 1999). These pathways have been 
summarised in Figure 1.5 below. More recently, studies investigating the 
hypertrophic response both in vitro and in vivo have reported that it is the Akt/mTOR
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pathway and not the calcineurin pathway, which is involved in promoting 
hypertrophy, by activating downstream targets such as p70 S6 kinase (Rommel et al. 
2001; Bodine et al. 2001). In addition, it was also reported that IGF-I might in fact 
act via Akt to inhibit the calcineurin/NFAT signalling pathway during this process 
(Rommel et al. 2001).
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Figure 1.5. Schematic overview of the downsteam signalling pathways of IGF-I, 
emphasising the role of the PI(3)K/Akt/mTOR pathway in skeletal muscle hypertrophy. 
Adapted from Rommel et al. 2001.
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Expression of different muscle IGF-I isoforms in response to overload
Most of the studies conducted to date have looked at the expression of total IGF-I in 
response to muscle overload. As mentioned earlier on in this chapter, IGF-I exists as 
different isoforms, which are derived from the IGF-I gene by a process of alternative 
splicing. In human beings there are three isoforms: IGF-IEa, IGF-IEb and IGF-IEc (see 
Figure 1.2). The first isoform is similar to the main isoform produced by the liver. 
Several different abbreviations exist in the literature for this isoform as shown in Table 
1.2: IGF-IEa (Rotwein et al. 1986), L.IGF-1 (Yang et al. 1996) and m.IGF-1 (Musaro et 
al. 2001). The second isoform, IGF-IEb is thought to be predominately expressed in the 
liver and its role in muscle is as yet unknown. In people, exons 5 and 6 were thought to 
be mutually exclusive however, the third isoform, IGF-IEc in human beings (IGF-IEb in 
the rat) is a splice variant resulting from a novel splice acceptor site in the intron 
preceding exon 6. This isoform contains the first 49 base pairs of exon 5 (52 base pairs 
in the rat) and exon 6 (Chew et al. 1995).
Yang et al (1996) demonstrated that following acute stretch by hind limb immobilisation 
in the extended position, rabbit EDL muscles expressed both IGF-EEa and IGF-IEb 
mRNAs. However, very little, if any IGF-IEb mRNA could be detected in the control 
muscles not subjected to stretch. This lead to the conclusion that this isoform was 
sensitive to mechanical signals or micro cellular damage. In this light, the isoform was 
re-named mechano-growth factor (MGF). To save any further confusion in the 
nomenclature of this isoform, this splice variant will subsequently be referred to as 
MGF. The notion that MGF was mechano-sensitive was supported by two further 
studies. For example, when stretch was combined with electrical stimulation of the 
tibialis anterior muscle, MGF mRNA was upregulated more so than by stretch alone
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(McKoy et al. 1999). Secondly, following stretch and immobilisation of the muscles of 
MDX mice (mice lacking the gene for dystrophin, an important cytoskeletal structural 
protein), MGF mRNA could not be detected. IGF-IEa mRNA was however present in 
detectable amounts in these animals (Goldspink et al. 1996). Furthermore, recent studies 
by Haddad and Adams (2002) have shown that MGF mRNA was significantly increased 
by at least 2-fold after a single bout of resistance type exercise in rat muscles.
MGF-stimulated hypertrophy
It has been shown that MGF is an inducer of muscle hypertrophy in experiments where a 
plasmid gene construct containing MGF cDNA (under the control of muscle regulatory 
elements) was introduced into the tibialis anterior muscle of mice by intramuscular 
injection. This resulted in 20% increase in muscle mass within two weeks, and the 
analysis showed that this was due to an increase in the size of the muscle fibres. 
(Goldspink, 2001).
IGF-I stimulated hypertrophy in aged muscle
In older animals, overexpression of the different IGF-I isoforms has been associated 
with the prevention of some of the age-related effects on skeletal muscle, namely, the 
decline in muscle mass (Barton-Davis et al. 1998; Musaro et al. 2001). For example, 
Barton-Davis and co-workers injected a recombinant adeno-associated virus (AAV) 
directing overexpression of IGF-I (Ea isoform), into the extensor digitorum longus 
(EDL) muscles of young and old mice. The construct, containing a myosin light 
chain MLC1/3 promoter resulted in an overexpression of IGF-I in the muscles, but 
did not increase circulating IGF-I levels. Four months post injection, the injected 
muscles of the younger animals were on average 15% larger and 14% stronger than
46
the non-injected muscles. In the older animals, age-related changes in muscle were 
therefore prevented and the injected muscles were 27% stronger than the non­
injected older animals. A second, more recent study also demonstrated an age-related 
improvement in muscle mass and function in transgenic animals bred to over-express 
the IGF-IEa isoform (which was termed m.IGF-I) (Musaro et al. 2001). At 6 months 
of age, the mean diameter of fibres in the transgenic animals was 32 /ml compared 
with 18 /mi in the wild type. There was however, preferential hypertrophy of the 
faster fibre types (46 fim in transgenic animals compared with 32 /xm in wild type) 
with little effect on the slow fibres (16 /xm compared with 18 /xm). This was 
attributed to the low expression of the MLC regulatory cassette (1/3 locus) in the 
slow muscle fibres. Examination of the older transgenic animals revealed that they 
were protected against the normal age-related muscle loss, whilst there was 
significantly atrophy in their wild type littermates.
Is aged muscle as sensitive to damage and overload?
The above studies give good reason to suggest that maintaining local IGF-I synthesis 
could play an important part in maintaining muscle mass in old age. Studies have shown 
that upregulation of IGF-I in response to muscle injury or mechanical damage is altered 
in older animals (Marsh et al. 1997; Owino et al. 2001). The regenerative capacity of the 
tibialis anterior muscle in young, mature and old rats were determined in the study by 
Marsh et al (1997) following an injection of the myotoxic anaesthetic, bupivacaine. In 
young animals, there appeared to be a transient surge in IGF-I mRNA levels early on in
fhthe regeneration process, which diminished by the 15 day of recovery. In contrast, 
levels of IGF-I mRNA in the mature and older animals remained elevated between 5-15 
days of recovery. Thus IGF-I mRNA expression changed from a transient surge in
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young regenerating muscles to sustained elevated levels, associated with a failure to 
complete the regeneration process in the older animals. However, this study did not 
determine the type of IGF-I involved. The recent study by Owino et al, (2001) used 
synergistic muscle tendon ablation to overload the soleus and plantaris muscles of 
young, mature and old rats, to determine if there were any age-related differences in the 
response of the different IGF-I isoforms in muscle. This study showed that as a result of 
overload MGF mRNA was 3 times higher in the young muscle as compared with mature 
muscle and 5 times higher than in the older muscles. IGF-IEa mRNA levels were also 
upregulated by the challenge, but showed no clear age-related effect. The study therefore 
suggested an age-related reduction in the ability to upregulate the MGF isoform. 
Furthermore, it was suggested that the two IGF-I isoforms were differentially regulated. 
This was based on the observation that that MGF mRNA levels significantly increased 5 
days after surgery, but no significant changes in levels of IGF-IEa mRNA were seen.
If IGF-I, more specifically the MGF isoform, were an important local repair factor, 
then these data would be in general agreement with other work that has shown an 
impairment in the response of aged skeletal muscle following overload. Three critical 
changes occur in aged muscle: muscle fibres are injured more easily (Zerba et al. 
1990), muscle fibres regenerate less successfully (Carlson and Faulkner, 1989) and 
structural and functional recovery is incomplete (Brooks and Faulkner, 1990). 
Contraction-induced injury provides a possible mechanism for the atrophic changes 
with increasing age (Faulkner et al. 1995). In two studies, isometric force was used 
to characterise force deficit after a number of high force pliometric (eccentric) 
contractions in young and old mice. Greater force deficits were observed in older 
animals when compared with young, after 10 minutes (Zerba et al. 1990) and 28
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days (Brooks and Faulkner, 1990) following contractions. A more recent study by 
Vignaud et al (2003) used a very different approach to damage the soleus muscle in 
both adult and senescent rats. The study reported incomplete regeneration of these 
muscles, 3 weeks following myotoxic injury (using snake venom) in the senescent 
rats when compared with adult.
Adaptability of aged human muscle
The adaptability of aged muscles, in particular the possibility of improving muscle 
strength and increasing muscle mass in older individuals, has been the focus of much 
work. Many studies have related low muscular strength with other conditions, such 
as increased susceptibility to falls and fractures and increasing dependence on others 
(reviewed by Porter et al. 1995). Thus, emphasising the importance of improving 
muscle mass and strength in the elderly population.
With animal studies having shown that there are age-related impairments in the 
responsiveness of muscle to damage and overload, this might suggest that older people 
may be less adaptable to strength training exercise than younger individuals. This seems 
not to be the case, as a large number of studies conducted to date have shown the 
positive effects of strength training in older individuals (Frontera et al. 1988; Brown et 
al. 1990; Charette et al. 1991; Hicks et al. 1991; Grimby et al. 1992; Nichols et al. 1993; 
Rice et al. 1993; Roman et al. 1993; Pyka et al. 1994; Skelton et al. 1995; Welle et al. 
1996; Harridge et al. 1998). With a number of studies also showing that even the 
muscles of very frail, very elderly individuals (>85 years) are able to hypertrophy in 
response to muscle strengthening exercise. (Fiatarone et al. 1990; 1994; 1999; Harridge 
et al. 1999). In general, these studies suggest that in terms of changes in the amount of
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weight that can be lifted (1-repetition maximum [1-RM]), isometric strength and muscle 
cross sectional area (CSA), older people respond to training in a similar way to young 
people.
The local IGF-I response to strength training exercise in human skeletal muscle has not 
been widely studied. In one such study investigating IGF-I peptide levels in muscle 
following 10 weeks of strength training in old men and women (aged 72 -  98 years), it 
was shown that there was a -500% increase in the levels of IGF-I immunoreactivity 
within the muscle fibres of these subjects after the training period (Fiatarone-Singh et al. 
1999). This indicates that IGF-I peptide levels in older muscles may adapt over the 
longer term to exercise training. However, the effects of exercise training on IGF-I 
peptide levels in younger individuals were not investigated in this study, to determine if 
there was an age-related difference in the muscle IGF-I response to exercise. It was also 
reported that the increase in amount of weight that could be lifted after training was 
proportional to the significant increase in IGF-I immunoreactivity in muscle after 
training. In addition, they observed increased ultrastructural damage and an increase in 
the number of fibres expressing embryonic MyHC isoforms in the post-training biopsy 
samples. This study therefore suggested that muscle damage provoked the ‘initial’ step 
in the remodelling process, which ultimately leads to muscle regeneration. Other studies 
however, have shown that what we commonly interpret as damage are in fact not the 
result of damage provoking regeneration but regeneration itself, associated with that 
invasion of myofibres by satellite cells (Yu et al. 2004).
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Mechanisms of local action
There are two likely mechanisms through which IGF-I is believed to stimulate 
muscle hypertrophy. The first is through stimulating protein synthesis and the second 
is through the activation of satellite cells (discussed in the next section). For a 
muscle to hypertrophy there must inevitably be a change in the net rate of protein 
turnover. Changes in muscle protein synthesis will particularly be effected by the 
type, duration and nature of contractile activity, but also by dietary intake (Rennie 
and Tipton, 2000). It is generally agreed that the rate of muscle protein synthesis is 
increased after resistance exercise in both young and elderly individuals. In the first 
ever reported human study, Chesley et al (1992) found a 50% increase in muscle 
protein synthesis immediately after resistance exercise. A later study by Yarasheski 
et al (1993) reported a 36% and 60% increase in the basal fractional rate of protein 
synthesis in young and old subjects, respectively, after 2 weeks of resistance training. 
This idea was further supported by more recent studies in which an increase in 
MyHC and mixed protein synthesis rates was reported following resistance exercise 
(Yarasheski et al. 1999; Hasten et al. 2000; Balagopal et al. 2001). Contrary to this, 
one such study by Welle et al (1995) reported no significant increase in myofibrillar 
protein synthesis rates in young and old subjects after 3 months of resistance 
training. There is now a large body of literature to suggest that either oral amino acid 
ingestion (Tipton et al. 1999) or intravenous infusion (Biolo et al. 1997) can alter the 
net protein balance after exercise. As detailed earlier in this chapter, binding of IGF-I 
to its cell surface receptor activates the PI(3)K/Akt/mTOR signalling pathway. This 
then triggers a cascade of downstream events attributed to PI3-kinase activity, 
including the activation of p70 S6 kinase, which phosphorylates the S6 protein 
component of ribosomes, possibly modulating the rate of translation and thereby
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protein synthesis (reviewed by Adams, 1998). Indeed, Baar and Esser (1999) showed 
a correlation between p70/S6 kinase activity and the long-term increase in muscle 
mass following training. Thus suggesting that p70 6 kinase phosphorylation may be 
a good marker for the phenotypic changes that characterise muscle hypertrophy and 
may play a role in the load induced skeletal muscle growth.
The role of satellite cells in muscle growth and repair
Satellite cells are small mononucleate precursor cells, which are typically located 
between the basal lamina and sarcolema of muscle fibres (Figure 1.6). These cells are 
believed to remain mitotically inactive but are mobilised by increased mechanical 
loading or damage, playing a role in both adaptation and repair of muscle. Satellite cells 
only account for approximately 5% of the nuclei present within muscle fibres. However, 
when activated, they have the capacity to divide extensively in order to produce 
sufficient mononuclear myoblasts to replace the damaged muscle fibres. They do this by 
fusing, either with one another or with existing but damaged muscle fibres, in order to 
repair and repopulate the traumatised muscle (reviewed by Goldring et al. 2002). These 
cells are important for postnatal growth of muscle and are an important means by which 
adult muscle mass is formed and maintained. Their number decreases gradually after 
birth and there is recent evidence from studies of human satellite cells in culture that the 
replicative potential of these cells is reduced in later life (Decary et al. 1997).
Recent studies using immunohistochemical techniques and N-CAM/Leu-19 staining 
have shown that satellite cell number (the ratio between the number of satellite cell 
nuclei and the total number of nuclei minus the myonuclei and nuclei of satellite cells) is 
increased in power-lifters when compared with untrained subjects (Kadi et al. 1999),
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and that the number of satellite cells increased in the trapezius muscle after 10 weeks of 
strength training (Kadi and Thomell, 2000). This study also showed a significant 
relationship between the CSA of the muscle after training and the increase in number of 
myonuclei in the individual muscle fibres. These data suggest that an increase in the 
number of nuclei provided by satellite cells is required to maintain the nuclear domain 
during hypertrophy.
DeVol et al (1990) suggested that during muscle growth, locally produced IGF-I had 
two distinct functions with respect to satellite cell involvement, those being stimulation 
of both proliferation and differentiation of satellite cells. This was further confirmed by 
in vitro studies demonstrating that IGF-I stimulated proliferation, differentiation and 
fusion of satellite cells into growing myotubes (Florini et al. 1991; Delany et al. 1994). 
A more recent cell culture study by Yang et al (2002) in which C2C12 cells were 
transfected with either MGF or IGF-I peptides, suggested that the MGF E-peptide was 
specifically involved in the proliferation of satellite cells, whereas mature IGF-I 
stimulated both proliferation and differentiation of these cells. The role of IGF-I in 
satellite cell activation was further supported by experiments in which direct infusion of 
IGF-I into the tibialis anterior muscle of adult rats resulted in an increased total muscle 
protein and DNA content (Rosenblatt et al. 1994; Adams and Haddad, 1996; Adams and 
McCue, 1998). Further evidence for the role of these cells in hypertrophy is provided by 
an experimental approach whereby satellite cells were prevented from proliferating 
following treatment with y-radiation. The subsequent overloading of the adult rat soleus 
muscle failed to evoke hypertrophy of the overloaded irradiated muscles (Phelan and 
Gonyae, 1997).
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Interestingly, recent work has shown that acute overexpression of IGF-I can increase the 
number of times that satellite cells can replicate, possibly explaining some of the 
positive effects this treatment has had on the age-related changes in skeletal muscle, 
which were discussed earlier in this chapter. (Chakravarthy et al. 2000a; Chakravarthy et 
al. 2000b; Chakravarthy et al. 2001). As these studies involved overexpression of the 
IGF-I gene, they give no indication about which IGF-I splice variants may be involved. 
The work of Yang and Goldspink (2002) and Hill and Goldspink (2003), suggests that 
MGF is involved with the initial activation of satellite cells. Therefore, in the present 
study it was important to study the expression of the different isoforms of IGF-I in 
human muscle in response to exercise.
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Figure 1.6 A summary of some of the molecular events involved in satellite cell activation 
during skeletal muscle regeneration. Satellite cells are activated in response to a mechanical 
signal e.g. injury, denervation, exercise or stretching. HGF is also thought to activate satellite 
cells through its receptor, c-Met, expressed in quiescent satellite cells. Activation of quiescent 
satellite cells results in the expression of the myogenic factors MyoD and/or Myf5 and the 
generation of mpc. IGF-I is thought to play a role in both mpc proliferation and in the 
differentiation of mpc into myotubes. Abbreviations: mpc: myogenic precursor cells, HGF: 
hepatocyte growth factor. (Taken from Hameed et al. 2002)
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Summary
Mechanically overloading a muscle exercise causes changes in muscle gene 
expression. This leads the muscle to hypertrophy, which involves a complex process 
cf repair and remodelling. IGF-I is believed to play an important role in these 
adaptive processes. Many studies in animal muscle have focussed on the role of this 
gowth factor in the hypertrophic response of muscle to exercise. However, there was 
Ittle knowledge about the expression of IGF-I and its splice variants in human 
skeletal muscle. The above review of the literature has focused on the current state of 
cur understanding of the structure of the mammalian IGF-I gene and its role and 
regulation in muscle growth and repair. The overall aim of the work in this thesis 
vas to study the expression of IGF-I isoforms in human skeletal muscle, and how 
tiey respond to different types of exercise. A specific focus is placed on differences 
ii their expression that might result from the ageing process.
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Chapter 2
Development of a quantitative polymerase chain reaction 
method to measure IGF-I isoforms in human skeletal 
muscle
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2.1 Introduction
Much of the initial work for this thesis has focused on the development of a 
quantitative polymerase chain reaction (PCR) method, which allows the accurate 
measurement of the different isoforms of IGF-I: IGF-IEa, IGF-IEb and MGF (IGF- 
IEc) in human skeletal muscle. This chapter outlines the developmental work and 
begins with an overview of the different methods available for measuring gene 
expression. Due to the limited tissue size available in the studies detailed in Chapters 
3-5, the most suitable and sensitive method for measuring the changes in gene 
expression was believed to be real time quantitative PCR. This is further expanded 
upon later in this chapter. The second part of this chapter (Technique Development) 
focuses on optimisation strategies employed in developing a sensitive, reliable and 
reproducible quantitative PCR assay using LightCycler technology. Many of the 
initial experiments were concerned with characterising the different isoforms of IGF- 
I in human skeletal muscle and these were carried out prior to the availability of a 
real-time quantitative PCR set-up in our laboratory. Pilot studies using conventional 
PCR methods were used to identify and characterise the different isoforms of IGF-I 
in human muscle and these are detailed in Appendix 1. These early experiments also 
investigated the option of using a ‘less invasive’ syringe needle aspiration technique 
for muscle sampling, instead of the more conventional needle biopsy technique. 
Whether this technique could be used reliably to obtain adequate muscle from the 
vastus lateralis muscle and whether the samples obtained could then subsequently be 
used for quantitative PCR was also investigated in a later pilot study, details of which 
are given in Appendix 2.
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2.2 Background
The Polymerase Chain Reaction
Emerging technology now enables the measurement of genes that are expressed at 
low copy numbers including autocrine growth factors, which may be produced by 
only a small percentage of cells within a given tissue. The polymerase chain reaction 
(PCR) was first developed in the mid-1980s as a novel method for the study and 
analysis of low abundant gene sequences from small amounts of starting material 
(Mullis and Faloona, 1987). Techniques available for detecting specific DNA 
sequences before the advent of PCR required considerable amounts of tissue, were 
time consuming and involved lengthy cloning methods. PCR offers a unique tool, 
which enables the production of large numbers of copies of specified sequences of 
DNA for analysis, without the need for cloning. The starting material for a PCR is 
DNA that contains the sequence of interest to be amplified. It is not necessary to 
isolate the sequence to be amplified, as this is defined by the specific primers used in 
the reaction. Since the introduction of PCR, the basic protocol has been further 
modified to allow for the study of messenger RNA (mRNA). Here, the starting 
material is RNA and the PCR is used in combination with reverse transcription (RT- 
PCR) to amplify specific regions of mRNA. Whether DNA or RNA, the amount of 
starting material needed to perform a PCR is very small. For RT-PCR, the mRNA is 
first converted into single stranded complementary DNA (first strand cDNA) by 
primer extension, which can be achieved by three methods: Since virtually all 
eukaryotic mRNA molecules have a run of adenine nucleotide residues called a 
poly (A) tail at their 3’ end, the first method involves using oligonucleotides 
consisting only of deoxythymidine [oligo(dT)] to prime the mRNA from the poly(A) 
tail. An alternative to this is to use random hexamers (dN)6. These are short primer
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sequences which bind at non-specific points along the RNA template. If the mRNA 
sequence to be amplified is known, short, sequence specific primers (often called 
dodecamers) can also be used for first strand cDNA synthesis. The use of 
dodecamers in this process is discussed further later on in this chapter.
Quantification of nucleic acids
There are four main methods available for quantification of nucleic acids: Northern 
blotting and in situ hybridisation (Parker and Barnes, 1999), RNase protection assays 
(RPA) (Hod, 1992; Saccomanno et al. 1992) and quantitative RT-PCR (Weiss et al. 
1992; Ferre, 1992). cDNA micro- arrays (Bucher, 1999), a fifth method, is still very 
much in its infancy due to the high cost considerations. Northern analysis provides 
information about the integrity of the RNA samples, mRNA size and the presence of 
splice variants. RPA offers the most useful tool for mapping transcript initiation and 
termination sites and intron/exon boundaries. Unlike Northern blot analysis, it is also 
able to distinguish between mRNAs of similar size and can give information about 
the primary transcript of the gene. The main advantage of these two methods are that 
their reaction kinetics are relatively easy to determine. In situ hybridisation is the 
cnly one of these methods to allow localisation of the mRNAs to specific cell types 
within a tissue. However, the main disadvantage of all three of these methods is that 
the sensitivity achieved is not sufficient for many practical applications. These 
procedures are also lengthy and labour intensive to perform, with in situ 
hybridisation being the most complex and time-consuming of the three. A further 
drawback of the Northern blotting and RPA techniques is that they usually require 
the use of radioactive substances for labelling. When autoradiography is combined 
with the used of densitometry there are problems of over saturation unless extensive
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calibration is carried out to ensure that all the measurements are made at the lower 
linear part of the curve. This reduces its sensitivity further and makes it unsuitable 
for experiments in which there may be large changes. The problems encountered 
when using optical densitometry can be overcome by using a phospho-imager, but 
these are expensive instruments. Blotting and autoradiographic methods also require 
relatively large amount of starting material, which can rule out studies where the 
sample size is limited, such as work involving human biopsy material. In contrast, 
PCR based methods for the quantification of nucleic acids are highly sensitive 
(Wang and Brown, 1999) and therefore require very tiny amounts of starting material 
(even as little as one cell). Quantitative PCR methods are highly flexible and can be 
used to compare the levels of mRNAs in different sample populations, to characterise 
patterns of mRNA expression, to differentiate between closely related mRNAs (e.g. 
splice variants of the same gene) and to analyse RNA structure. One drawback is that 
the kinetics of the PCR reaction are comparatively more complex than the more 
conventional hybridisation techniques. The conditions when using PCR as a 
quantitative method must therefore be well established for each gene of interest. 
Factors such as specificity, sensitivity and reproducibility of the PCR must therefore 
be carefully optimised in order to establish a reliable and successful quantitative 
assay. Therefore, quantitative PCR can initially be laborious to perform, but after 
careful optimisation of the PCR reaction conditions, results can be obtained in less 
than one hour.
Quantitative PCR methods
mRNA can be quantified using either semi-quantitative or quantitative methods. 
Montgomery and Dallman (1997) first described a rather laborious semi-quantitative
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RT-PCR method, which involved regular sampling of the RT-PCR reaction followed 
by dot-blot analysis. Quantitative RT-PCR methods can be categorised into non­
competitive or competitive. Non-competitive PCR involves the co-amplification of 
the target with a second RNA molecule with which it shares neither the primer 
recognition sites nor any internal sequence (standard). The PCR is run under 
conditions that allow for no competition between target and standard (Reischl and 
Kochanowski, 1999). The major disadvantage of this technique is that it compensates 
for the possibility that both the RT and PCR efficiencies are likely to be different, 
even when investigating relative changes of transcription within a sample (Ferre, 
1992). In contrast, competitive RT-PCR involves using an internal standard that is 
almost identical to the primary target. This competitor molecule shares the same 
primer recognition and internal sequences as the target and only differs from it in 
size by the inclusion or exclusion of a small number of base pairs (Gilliland et al. 
1992). Because they are virtually identical, both should be amplified with the same 
efficiency and can be distinguished by the size difference when visualising the 
products on a gel. As the name suggests, this type of PCR generates competition 
between target and competitor for reagents. A series of PCR tubes containing the 
target are spiked with serial dilutions of known copy numbers of the internal 
standard. The greater the concentration of the internal standard, the more likely it is 
that the primers will bind and amplify it, rather than the target. After gel 
electrophoresis, a comparison of the intensities of ethidium bromide stained standard 
and target amplicons allows target quantification (reviewed by Bustin 2001).
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mRNA quantification using real-time quantitative PCR
When the term quantitative PCR is used today it is highly likely that the method 
being referred to is real-time quantitative PCR. Higuchi et al (1993) documented the 
first real-time PCR method, yet this technology has only recently become 
mainstream. Real-time quantitative PCR is the detection and measurement of 
products generated during each cycle of the PCR process, which are directly 
proportional to the amount of template prior to the start of the PCR process 
(Ginzinger, 2002). To achieve this two things are necessary: a method of detecting 
the accumulation of PCR product and an instrument in which to perform the 
thermocycling that is adapted to record the results during each PCR cycle in real 
time. Real-time PCR potentially offers a highly sensitive technique for the 
quantification of mRNA. With this method only a very small number of the cycles in 
a PCR reaction contain useful information. The early cycles have undetectable 
amounts of the DNA product and late cycles (the plateau phase) are almost as 
uninformative. The quantitative information in a PCR reaction comes from those few 
cycles where the amount of DNA grows logarithmically from barely above 
background to the plateau. This is known as the log linear or exponential phase of 
the PCR and is considered the condition of constant amplification efficiency (see 
Figure 2.1). Often only 4-5 cycles out of 40 will fall in this log-linear portion of the 
curve (Rasmussen et al. 1998; Rasmussen et al. 2001). With real-time PCR it is 
possible to measure the number of cycles necessary to detect a signal (threshold 
cycle) and use this to determine the starting levels of mRNA present in the sample.
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Figure 2.1. A typical example of a PCR amplification profile illustrating the nomenclature 
typically used in real time Q-PCR experiments. The amplification profile is the plot of 
fluorescence signal vs PCR cycle number. The baseline is defined as the PCR cycles in 
which a signal is accumulating but is beneath the limits of detection of the instrument. The 
signal measured during these PCR cycles is used to plot the threshold. The threshold is 
calculated as 10 times the standard deviation of the average signal of the baseline fluorescent 
signal. A fluorescent signal that is detected above the threshold is considered a real signal 
that can be used to define the threshold cycle (Ct) for a sample. The Ct is defined as the 
fractional PCR cycle number at which the fluorescent signal is greater than the minimal 
detection level. The Ct values of different samples are then used to calculate the relative 
abundance of template for each sample. Adapted from Ginzinger (2002)
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Real-time quantitative PCR vs conventional PCR
The introduction of real-time PCR technology has markedly improved and simplified 
the quantification of nucleic acids and this technology has more recently become an 
invaluable tool for many scientists working in different disciplines. How it compares 
to conventional PCR methods is summarised in Table 2.1.
Conventional PCR Real-Time PCR
Run Time (35 cycles 
approximately
Up to 6 hours 
(including running on gel)
25-40 minutes
Set-up Time Lengthy as reagents added 
individually
Reaction-mix contains 
(Taq DNA polymerase, 
reaction buffer, dNTPs 
and SYBRGreen I dye) 
therefore saves time 
during set-up
Gel Electrophoresis Necessary to visualize PCR 
products
Not necessary 
Reaction specificity 
visible online
Quantitative Analysis Semi-quantitative analysis 
by measuring band 
intensity following gel 
electrophoresis. Problems 
with over saturation unless 
a phospho-imager is used
Accurate quantification 
of PCR products relative 
to a set of standards of 
known concentration
Contamination Risk Each reagent is added 
individually, increasing 
contamination risk
Ready to use reaction 
mix minimises risk of 
contamination during set 
up and handling
Safety Risk DNA intercalating reagent 
ethidium bromide used 
during gel electrophoresis 
(carcinogen)
None
Table 2.1 Comparison of conventional PCR with real-time PCR using LightCycler 
technology.
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Rial-time PC R  using L ightC ycler technology
Tie LightCycler (Roche Molecular Biochemicals, Manheim, Germany) is one o f the 
se/eral commercially available real-time PCR systems. It performs the PCR in small- 
vdume glass capillaries that can hold a volume of up to 20/d (Figure 2.2 inset). 
Tlese are contained within a rotor like carousel, which is heated and cooled by 
tenperature-controlled airflow. The capillaries are positioned within a rotation 
synmetric chamber to ensure homogeneous temperature distribution within all 
sanples (see Figure 2.2).
Upper unit (contains the heating coil)
Lower unit (contains the thermal 
chamber, fluorimeter, drive units, 
electronic boards and power supply)
Rotor-like carousel 
containing glass 
capillaries
Fijure 2.2. LightCycler real-time PCR instrument (Roche Molecular Biochemicals). The 
picture shows the rotor like carousel containing 32 glass capillaries. The inset shows the 
incividual glass capillaries.
The carousel is rotated past a blue light-emitting diode and fluorescence is read by 
thee photodetection diodes with different wavelength filters that allow the use o f 
sptctrally distinct fluorescent probes. The LightCycler system is compatible with
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assays based on DNA binding dyes such as SYBR green, hydrolysis and 
hybridisation probes. Details of quantification using SYBR Green I are given below. 
The probe-based assays use two sequence specific oligonucleotides labelled with two 
different fluorescent dyes. The detection is based on the generation of a fluorescent 
signal by fluorescent resonance energy transfer (FRET) when the two probes bind to 
the target sequence. The LightCycler system can carry out up to 32 reactions at one 
time and one run takes between 20 and 55 minutes to complete, depending on the 
type of chemistry employed. Fluorescent readings are taken at the end of every cycle 
of the PCR and are displayed on-screen in real-time immediately after each 
measurement, giving the user the option of extending or terminating the run if need 
be.
Quantitative PCR using a double strand DNA binding dye (SYBR green I)
SYBR green I binds in the minor groove of double stranded DNA (dsDNA) in a 
sequence independent way (Morrison et al. 1998). In its unbound state SYBR green I 
dye has relatively low fluorescence, but when it binds to DNA during elongation its 
fluorescence increases over 100-fold. As the amount of DNA increases during the 
different phases of PCR, the amount of fluorescence from the dye increases 
proportionally.
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P o ly m e r a s e
At the beginning of amplification, the reaction mixture contains 
the denatured DNA, the primers and the dye. The unbound dye 
molecules weakly fluoresce, producing a minimal background 
fluorescence signal which is subtracted during computer analysis
After annealing of the primers, a few dye molecules can bind to 
the double strand. DNA binding results in a dramatic increase of 
the SYBR Green I molecules to emit light upon excitation.
During elongation, more and more dye molecules bind to the 
newly synthesized DNA. If the reaction is monitored 
continuously, an increase in fluorescence is viewed in real time. 
Upon denaturation of the DNA for the next heating cycle, the dye 
molecules are released and the fluorescence signal falls
Figure 2.3. DNA detection using SYBR Green I dye. (Taken from LightCycler Online 
Resource Site -  Roche Diagnostics).
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Figure 2.3 summarises the events that occur during a real-time PCR reaction using 
SYBR Green I. During the denaturation step o f the PCR SYBR Green I does not bind. 
During annealing, the specific primers hybridise to the target sequence forming small 
regions of dsDNA to which the SYBR Green I binds and emits fluorescence. In the final 
step o f the PCR, elongation, the PCR primers are extended and the entire length o f the 
DNA is now double stranded. This leads to a maximum amount o f SYBR Green I dye 
being bound. When monitored in real time, the increase in fluorescent signal can be 
observed at the end o f  the elongation phase, which then falls off once the DNA is 
denatured. The excitation and emission spectra of SYBR Green I are shown in Figure 
2.4.
Figure 2.4. The excitation and emission 
spectra o f SYBR Green I dye. The 
maximum excitation of SYBR Green I 
dye occurs at 497nm. Maximal emission 
of DNA stained with SYBR Green I 
occurs at 521nm
400 450 500 550 600 650
Wavelength [nml
SYBR Green I is an easy to use and highly reliable detection method, which obviates the 
need for target-specific fluorescent probes, but the primers used for PCR solely 
determine its specificity. The main drawback in using SYBR Green I is that it binds to 
any dsDNA molecule formed during the reaction, whether this is the target o f interest or 
a non-specific product like a primer dimer. This non-specific binding o f SYBR Green I 
dye makes the quantification o f low copy numbers more difficult. Staining with SYBR 
Green I on the LightCycler system is thought to detect from approximately 1 to 109
1 '  SYBR G reen I A  A SYBR Green I 
( Excitation) \  / \  /Emission)
0.8
0.6
0.4
0.2
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copies o f a target sequence. However, there are ways o f overcoming this problem when 
using this system. The products o f a PCR reaction can be melted down by increasing the 
temperature of the sample. A melting curve is then achieved by plotting the fluorescence 
as a function o f the temperature (Ririe et al. 1997). At the melting temperature (Tm) o f 
the product, a sharp drop in the level o f fluorescence is seen (Figure 2.5). Non-specific 
products such as primer dimer tend to have much lower Tm and broader melting peaks 
than the longer specific products, which have characteristic sharp, narrow melting peaks 
(see Figure 2.5). Melting curve analysis allows the user to correct for the contribution o f 
non-specific products, thereby extending the sensitivity o f the technique to a single copy 
per reaction (Morrison et al. 1998).
120
sharp drop in 
fluorescence at Tm 
of specific product
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B
Figure 2.5. Figures A and B show typical melting curve profiles of a specific product and a 
no-template negative control. The LightCycler software presents the user with two graphs. 
Figure A shows melting curve data as Fluorescence vs Temperature and Figure B shows the 
calculated negative derivative plot of the same data. Figure B is commonly used to determine 
the specificity of the reaction. Specific products (shown in red) characteristically have sharp, 
narrow peaks whereas, non-specific amplifications such as primer dimer (shown in black), 
melt at lower temperatures and over a broader range.
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Quantification strategies 
Absolute quantification
Quantification by external standards is often referred to as ‘absolute’ quantification, 
because an actual number or concentration of the transcript can be obtained per cell, 
total RNA or unit mass of tissue. The absolute amount of target nucleic acid of 
interest is determined using external standards. These standards usually contain 
sequences that are the same as, or differ only slightly from the target sequence, and 
their primer binding sites are always identical to the target sequence. This ensures 
equivalent amplification efficiencies between standards and target molecules, which 
is essential for absolute quantification. This method requires the construction of an 
absolute standard curve (plot of Ct -  crossing points of different standard dilutions 
against log of amount of standard) generated using a dilution series of the standards. 
Amplification of the standard dilution series and of the target sequence is carried out 
in separate tubes. Comparing the Ct of the unknown samples with the standard curve 
allows calculation of the initial amount of target used in real-time PCR. A standard 
curve is generated for each of the individual targets being measured to ensure 
accurate reverse transcription and PCR amplification profiles (Bustin, 2000). The 
accuracy of this method depends largely on the accuracy of the standards and it is 
important to select an appropriate standard for the type of target to be quantified. 
Both of these points are discussed later on in this chapter.
Relative quantification
This type of quantification of mRNA determines the changes in steady state 
transcription of a gene (Bustin, 2000). In this approach, the ratio between the amount 
of target molecule and a reference molecule within the same sample is calculated. It
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is essential that the expression level of the reference molecule, such as a control gene 
(examples of common control genes are given in the next section), do not vary under 
experimental conditions or in different states of the same tissue (e.g. diseased vs 
normal). Their level is therefore used as a reference value for quantification. The 
relative quantification procedure varies depending on whether the target molecule 
and reference molecule are amplified with comparable or different efficiencies.
Different amplification efficiencies
Amplification efficiencies will differ between the target and reference molecules if 
primer binding sites, PCR product sequences and PCR product sizes differ in each 
(i.e. the reference molecule is different to the target). In this case two standard curves 
are generated, one for each. Given that the expression of the reference does not 
change in different samples, the ratio of the two PCR products varies according to 
the expression level of the target gene.
Comparable amplification efficiencies
If amplification efficiencies between target and reference molecules are the same 
then one standard curve is sufficient. The standard curve is produced as described in 
the previous section but with a dilution series of only the reference. Unknown 
amounts of target and reference in the same sample are calculated by comparing the 
Ct values with the standard curve of the reference sample.
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The use of ‘control genes’ for normalisation in quantitative PCR
‘Control genes’ or ‘housekeeping genes’, as they are sometimes called, are those 
genes that are constitutively expressed to maintain cellular function (Yamamoto et 
al. 1989). When using quantitative PCR technology, it is essential to take into 
account that there will be considerable variation of starting material between 
samples, especially if the samples have been obtained from different individuals. 
Ignoring this issue can lead to misinterpretation of the expression profile of any 
target genes being studied. This is where the concept of ‘normalisation’ against a 
‘reference’ becomes relevant. As mentioned in the previous section, expression of 
mRNA can be normalised to total RNA concentration. Here, equal amounts of total 
RNA (e.g. 1/xg) are taken from each of the samples and used to make the cDNA. 
When using this method it is essential to reverse transcribe all of the samples at one 
the time, using the same reagents and reaction conditions to minimise any operator 
error. When normalising to a control gene, the first thing that needs to be determined 
is whether the chosen gene is affected in any way by the experimental treatment and 
also if its expression levels are similar to those of the mRNA being studied 
(Schjerling, 2001). It is common to screen many genes until a suitable gene is found 
and the most common control genes used are listed in Table 2.2. Using control genes 
for correcting sample-to-sample variation seems to be an accepted method for 
minimising these errors. However, the problem when studying muscle arises when 
the intervention being studied is something like exercise, as a result of which many 
control genes commonly used for this purpose are affected.
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Abbreviation Name Function
/3-actin Beta actin Cytoskeletal structural 
protein
GAPDH Glyceraldehyde-3 - 
phosphate dehydrogenase
Oxidoreductase in 
glycolysis and 
gluconeogenesis
rRNA Ribosomal RNA Constitutes 85-95% of 
total cellular RNA
/32M Beta-2-microglobin Beta chain of major 
histocompatibilty 
complex class I molecules
a-actin Alpha actin Cytoskeletal structural 
protein
RPL13a Ribosomal protein LI 3a Structural component of 
the large 60S ribosomal 
subunit
UBC Ubiquitin C Protein degradation
HMBS Hydroxymethyl-bilane
synthase
Heme synthesis, 
porphyrin metabolism
HPRTI Hypoxanthine
phosphoribosyl-transferase
I
Purine synthesis in 
salvage pathway
SDHA Succinate dehydrogenase 
complex, subunit A
Electron transporter in the 
TCA cycle and respiratory 
chain
YWHAZ Tyrosine 3-
monooxygenase/tryptophan 
5- monooxygenase 
activation protein, zeta 
polypeptide
Signal transduction by 
binding to phosphorylated 
serine residues on a 
variety of signalling 
molecules
Table 2.2 11 commonly used control genes for normalisation in quantitative PCR. (Adapted 
from Vandesompele et al. 2002)
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2.3 General Methods and Materials
Vastus lateralis muscle samples from 2 healthy volunteers were used for method 
optimisation purposes. Details of the needle biopsy technique are described in the 
relevant sections in Chapters 3-5.
Total RNA isolation
Total RNA was extracted from muscle samples using Tri Reagent (Sigma, UK) 
according to the manufacturers recommendations. The frozen weight of the tissue 
samples was determined prior to homogenisation. Tissue samples were then 
homogenised in 0.5 ml Tri Reagent (lml/50-100 mg tissue) using a hand held Polytron 
homogeniser for 20-50 seconds. After homogenisation, the homogenate was spun at 
12,000 x g for 10 minutes at 4°C in a bench top centrifuge to remove any insoluble 
material. The supernatant, which contained RNA and protein, was then transferred to a 
fresh tube. To ensure complete dissociation of nucleoprotein complexes the samples 
were left to stand for 5 minutes at room temperature. 100/d chloroform was added to the 
tube (0.2ml/lml Tri Reagent). The samples were then shaken vigorously for 15 seconds 
and then allowed to stand for 2-15 minutes at room temperature. The resulting mixture 
was centrifuged at 12,000 x g for 15 minutes at 4°C. After centrifugation, the mixture 
separates into 3 phases: a red organic phase (containing protein), an interphase 
(containing DNA) and a colourless upper aqueous phase (containing RNA). The 
aqueous phase was transferred into a fresh tube and mixed with 250/d of isopropanol. 
The sample was then allowed to stand at room temperature for 5-10 minutes, after which 
it was centrifuged at 12,000 x g for 10 minutes at 4°C. The RNA precipitate formed a 
pellet on the side and bottom of the tube. The extracted RNA was dissolved in 
diethylpyrocarbonate (DEPC) treated water and stored at -70°C until required. Total
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RNA was then treated with 10 units of RQ1 RNase-ffee DNase (Promega, Madison, WI) 
at 37°C for 30 min followed by inactivation at 65 °C for 10 min in order to avoid 
amplification of contaminating genomic DNA. The entire extraction procedure was 
carried out in a fume hood due to the toxic nature of the chemicals used for RNA 
isolation.
Measurement of total RNA concentration
Total RNA concentration was determined by spectroscopy at 260 nm using the Gene 
Spec I (Naka Instruments). The quality of the RNA was then assessed by visual 
inspection of ethidium bromide stained 18s and 28s rRNA under ultra violet light.
Electrophoresis of RNA
To ensure the integrity of the RNA samples, total RNA was separated under 
denaturing conditions using formaldehyde agarose gel electrophoresis.
Preparation of 1.2% formaldehyde gel
3.6g of agarose was added to 231ml of DEPC-treated water and boiled for 2 mins to 
allow the agarose to dissolve. After cooling to 55°C, 60 ml of 5 x MOPS buffer 
(0.1M MOPS, pH 7.0, 40mM sodium acetate, 5mM EDTA, pH 8.0) and 9 ml of 37% 
formaldehyde were added. The gel was poured and allowed to set.
Preparation of RNA samples
5pg of total RNA was mixed with 4pl of 5 x MOPS buffer, 7pi of formaldehyde and 
20pl of formamide. Samples were incubated at 65°C for 15 minutes and then chilled 
on ice. After brief centrifugation, 4pl of gel loading buffer (50% glycerol, lmM
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EDTA pH 8.0, 0.25% bromophenol blue, 0.25% xylene cyanol FF) was added to 
each of the samples. Samples were then loaded onto the gel, which had been allowed 
to pre-run for 5 minutes at 5 V/cm and electrophoresed in lx MOPS buffer for 2-2.5 
hours at 80-100V. To confirm the integrity of RNA samples following 
electrophoresis, visual inspection of ethidium bromide stained 18s and 28s ribosomal 
RNA bands was performed under ultra violet light. All reagents were supplied by 
Sigma.
Handling RNA
Ribonucleases (RNases) are very stable and active enzymes capable of destroying 
RNA, even when present at very low concentrations. All plastic and glassware was 
therefore treated with diethyl pyrocarbonate (0.1% DEPC in water) to avoid any 
possible RNase contamination.
Primers for cDNA synthesis and PCR
Primer sequences were specifically designed from human mRNA sequences and 
accession numbers for these sequences are given in Table 2.3 below. All primers 
used for cDNA synthesis and real time PCR were designed using Omiga version 2.0 
software (Oxford Molecular, UK) and these were synthesised and purified by high- 
pressure liquid chromatography (HPLC) (Sigma Genosys, Cambridge, UK). Primers 
used for conventional RT-PCR in the study described in Appendix 1 were taken from 
Chew et al, 1995. Sequence analyses were performed using BLAST searches on the 
EMBL database. Nucleotide sequence alignments and pair-wise alignments for 
sequence comparisons and primer positioning were performed using the CLUSTAL 
W programme, part of the EMBL genome analysis facilities. Table 2.4 lists the
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sequences of all the primers (forward and reverse) used in the studies described in 
Chapters 3-5, given in the 5’ to 3’ direction.
Target Accession No
IGF-IEa X57025
IGF-IEb X57025/U40870
MGF U40870
a-actin AF182035
GAPDH NM002046
MyoD X56677
Table 2.3 The different mRNA targets investigated using real time quantitative PCR and 
their corresponding accession numbers.
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Primer Name Sequence Size (bp) Annealing T°
IGF-IEa forward GCCTGCTCACCTTCACCAGC 303 52
IGF-IEa reverse TCAAATGTACTTCCTTCTGGGTCTTG
IGF-IEb forward ATCTACCAACAAGAACACG 140 52
IGF-IEb reverse TACTTCCAATCTCCCTCC
MGF forward CGAAGT CTC AG AG AAGGAAAGG 150 54
MGF reverse ACAGGTAACTCGTGCAGAGC
a  actin forward CGACATCAGGAAGGACCTGTATGCC 313 52
a  actin reverse GAAGATTCGTCGTCCTGAGAAGTCG
GAPDH forward CC ACC AACT GCTT AGC ACC 500 57
GAPDH reverse GCCAAATTCGTTGTCATACC
MyoD forward GC AGGT GT AACCGT AACC 170 52
MyoD reverse ACGTACAAATTCCCTGTAGC
MGF-2 forward CC AT CT ACC AAC AAG AAC 449 58
MGF-2 reverse C AG AG AGG AATTT AGT GC
RT primer GAAACGCCCATC
Table 2.4 Primers used for real time quantitative PCR and conventional PCR given in the 5’ 
to 3’ direction with their corresponding annealing temperatures and the expected product 
size of the PCR products. Primes used for conventional RT-PCR, taken from Chew et al. 
1995 are named MGF-2 and are shown in ‘blue’. The sequence of the specific RT primer 
used for cDNA synthesis is given at the end.
First strand cDNA synthesis
Following RNA extraction, total RNA was then reverse transcribed into cDNA using 
Omniscript reverse transcriptase (Qiagen, UK). 0.5/xg o f total RNA was then mixed 
with DEPC treated water in a total volume o f 10/xl and heated to 65°C for 5 min 
before transfer to ice. The samples were then mixed with 2/xl First Strand Buffer 
(lOx), 2/xl dNTPs (5mM each), 50 pmol random primers or 15 pmol o f sequence 
specific primer, 1/ri RNase inhibitor (10 units/jiil) and 1/xl Omniscript Reverse 
Transcriptase (4 units//xl). The reaction volume was made up to 20/xl using DEPC
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treated water. The samples were then incubated at 37°C for 1 hour followed by 5 min 
at 93 °C to inactivate the reverse transcriptase.
RT-PCR
For initial PCR work (see Appendix I) conventional RT-PCR was used to determine 
the presence of the different IGF-I isoforms in human muscle. PCR reactions were 
set up in a volume of 50pl and each reaction mix contained 5 pi of lOx PCR buffer 
(100 mM Tris-HCl, 500 mM KC1 pH 8.3), 2pl of dNTPs (lOmM of each dATP, 
dCTP, dTTP, dGTP) (Bioline, UK), lp l forward primer (25pmoles), lpl reverse 
primer (25pmoles) and lpl of first strand cDNA. MgCk concentration was optimised 
for each PCR reaction and ranged between l.OmM to 3mM (Bioline, UK). The 
reaction components were gently mixed and briefly centrifuged. The samples were 
heat denatured at 94°C for 5 minutes and then 2.5units of Taq polymerase (Bioline, 
UK) were added. Amplification was then carried out for 35 cycles of consisting of a 
denaturation step at 94°C for 1 minute, an annealing step at the specific T°C of the 
target being amplified for 1 minute and a final elongation step at 72°C for 1 minute.
An additional elongation step at 72°C for 10 minutes was included at the end to 
ensure all PCR products had 3’ A overhangs to facilitate cloning of the PCR 
products. RT-PCR was performed on a conventional PCR machine (Hybaid PCR 
Express).
Real Time Quantitative PCR using SYBR Green I
Quantification of mRNA was carried out using LightCycler technology (Roche 
Diagnostics, UK). Reactions were performed in a volume of 20pl per capillary for the 
LightCycler format. The 20pl reaction mix contained lOpl of a SYBR green mix
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(QuantiTect, Qiagen, UK), 0.5-10pmol o f each forward and reverse primer, 2pi cDNA 
(made from 0.5pg RNA) and nuclease free water to make up the reaction volume.
SYBR green I was used as the method o f detection. A dilution series o f standard DNA 
(which contained the target sequence o f interest) o f ‘known’ concentrations was 
included in each run from which a standard curve was created (see Figure 2.6). It was 
relative to this standard curve that samples of unknown concentration were quantified. 
On completion o f the PCR, all PCR products formed were melted to attain a melting 
curve profile, which enabled the specificity o f the reaction to be determined. All runs 
were performed in duplicate and mean values were subsequently used for analysis.
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Figure 2.6. A typical standard curve generated from a dilution series of standard DNA of known 
concentration.
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Typical programme
A typical LightCycler programme protocol when using the QuantiTect SYBR Green 
PCR kits (Qiagen, UK) consists of four main steps:
Activation Step (1 cycle)
HotStarTaq DNA polymerase is activated by this heating step. HotStarTaq has no 
enzymatic activity at ambient temperatures and this prevents the formation of misprimed 
products and primer-dimers during reaction set-up and the first denaturation step. The 
enzyme is activated by a 15 minute incubation step at 95°C.
Amplification Step (35-55 cycles)
This step most commonly consists of three segments: (i) Denaturation at 94°C for 15 sec 
(ii) Annealing at a temperature approximately 5-8°C below the Tm of the specific 
primers being used for an optimised incubation time of between 20-30 sec, so as to 
increase the specificity of primer binding to target and (iii) Extension at 72°C for a time 
that is calculated depending on the length of the amplicon (approximately 5 sec for 
every lOObp of product) An additional fourth step can be included in the amplification 
step, where fluorescence acquisition is recorded at a temperature just below that of the 
specific product, so as to avoid any fluorescent signal from non specific products such as 
primer-dimers and to ensure accurate quantification of only the desired product. This 
step of either 3-4 segments is then repeated for 35-55 cycles depending on the amount of 
template DNA present.
Melting curve (1 cycle)
This step also consist of three segments: (i) a rapid denaturation at 95°C (ii) a short 
hold at a temperature approximately 10°C higher than the primer annealing
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temperature during amplification step and (iii) a slow denaturation at 95°C. During 
the slow denaturation step, fluorescence is measured continuously to generate a high- 
resolution melting curve for every sample.
Cooling
Following the melting curve step, the LightCycler instrument is cooled down to 40°C for 
30 sec. This is simply to allow the carousel to be lifted safely out of the instrument.
Data Analysis
There are two different methods of quantification i.e. calculating the crossing points 
on the LightCycler: the fit point method and the second derivative maximum method.
Fit point method
This method allows the user to set the ‘noise band’ according to the threshold in the 
log linear phase of PCR. ‘Fit points’ are defined as a number of reading points in the 
log linear phase, used for calculation of a straight line that represents the linear 
portion of the amplification plot. It is possible to change the number of fit points. The 
crossing point in this case is the cycle number at which the straight line (calculated 
using fit points) crosses the noise band.
Second derivative maximum method
The point at which the maximal increase of fluorescence within the log linear phase 
takes place is calculated by determining what is referred to as the second derivative 
maxima of the amplification curves. The cycle number at which this point is reached 
is calculated and recorded. With this method, it is not the operator that sets the noise
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band and thus is the preferred method of analysis, as it avoids any operator bias. This 
method was therefore used when analysing data from all the studies.
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Figure 2.7. An example of some of the different screens presented to the user. (A) shows an 
example of the screen the user is presented with once a run is complete. The top half of the 
screen shows a summary of the temperature cycling profile i.e. the 1 cycle activation step, 
the 35-40 cycle amplification step, and the 1 cycle melting curve step. The stage at which 
fluorescence is acquired is shown in purple. The bottom half of the screen displays the 
amplificaFrom this screen it is possible to view (B) -  which shows the quantitative values 
obtained relative to the standard curve and (C) -  which shows the melting curve profile of 
the specific products formed during the PCR.
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Gel Electrophoresis
PCR products were recovered from the glass capillaries by removing the plastic caps 
and inverting them into a 1.5ml eppendorf tube, which were then spun down in a 
bench top centrifuge at no higher than 3000 rpm. 20/d of these PCR products were 
mixed with 2/d of 6X Loading buffer (Fermentas, UK). The 2% agarose gel was 
prepared by adding 2g agarose to 100ml tris/acetate buffer (TAE) and heating in the 
microwave for approximately 2 mins to dissolve the agarose. After cooling slightly, 
ethidium bromide (lOmg/ml) was added to the mix, which was then poured/cast into 
a gel tank and left to set. The PCR products + loading buffer were then carefully 
loaded into the wells as was a size marker (DNA ladder, Fermentas, UK). The gel 
was left to run for approximately 45 mins at 100 volts until good separation of the 
dye fronts had been achieved. Target specificity was further confirmed by visualising 
the product bands under UV light.
Making standards
If making standards for use in real-time quantitative PCR, the bands were briefly 
visualised using a hand held trans-illuminator and then carefully excised from the gel 
using a clean blade (exposure to short-wave ultraviolet light was minimal in order to 
avoid the formation of pyrimidine dimers). These gel pieces containing the product 
of interest were then purified as described in the next section.
DNA purification
DNA was purified using Wizard PCR Preps DNA purification system, Promega, UK. 
Briefly, approximately 300 mg of the agarose slice was transferred to a 1.5ml 
microcentrifuge tube, to which 1ml of resin was added. This was heated to 65°C in a
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water bath until the agarose was completely melted. For each gel sample one Wizard 
Minicolumn was prepared into which the resin/DNA mix was pipetted. A plunger 
was slowly pushed through the syringe barrel gently pushing the mix into the 
minicolumn. 2ml of 80% isopropanol was then pipetted and pushed through the 
syringe barrel to wash through the column. The syringe was then removed from the 
minicolumn and this was placed into a 1.5ml microcentrifuge tube. The minicolumn 
was then centrifuged at 10 000 x g to dry the resin. The minicolumn was then 
transferred to a new microcentrifuge tube into which 50/d was applied. After waiting 
for one minute, the minicolumn was centrifuged at 10 000 x g for 20 seconds to elute 
the DNA fragment. The dsDNA concentration of the purified products was 
determined by absorbency at 260nm where absorbency of 1 cm path length cuvette at 
260nm is equivalent to 50pg/ml DNA. The purified DNA could be stored in the 
microcentrifuge tube at -20°C.
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2.4 Technique Development
The following section of this chapter will focus on optimisation strategies employed 
in developing a sensitive, reliable and reproducible quantitative PCR assay using 
LightCycler technology, for the study of IGF-I isoform expression in human skeletal 
muscle.
Optimisation Strategies
As mentioned earlier in this chapter, real-time quantitative PCR is a highly sensitive and 
versatile technique. However, for it to be reliable and reproducible requires extensive 
optimisation. How reliable and how reproducible depends largely on the target genes of 
interest and the levels at which they are expressed in the tissue being studied. 
Abundantly expressed genes prove least problematic to quantify compared with genes 
expressed at low levels, which can require extensive optimisation, particularly on the 
LightCycler set-up. The work in this thesis was concerned with the study of IGF-I and 
its isoforms in muscle. The technique therefore required extensive optimisation to ensure 
reliable and reproducible quantification of these, in particular MGF, as this proved to be 
the most problematic. The following section details optimisation strategies performed to 
ensure specific, sensitive and reliable quantification of IGF-I and its three isoforms in 
human skeletal muscle.
Primer Design
Primers for real-time PCR ideally need to generate a product of between 100-250 bp, the 
advantage of this being that shorter products amplify more efficiently than longer ones 
(Bustin, 2001). Smaller products are also more tolerant of reactions conditions, as they 
have a higher chance of being fully denatured during the initial denaturation step of
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PCR, thereby allowing the primers to bind more successfully to their complementary 
targets. Furthermore, with short products the extension time can be kept as little at 15 
seconds (5 seconds per lOObp, with a minimum extension time of 10 seconds), thereby 
considerably reducing the time it takes to complete a run and the chances of amplifying 
of genomic DNA. Primers that were used for real-time quantitative PCR on the 
LightCycler were designed using Omiga version 2.0 primer design software (Oxford 
Molecular, UK). The optimal length for individual primers is approximately 15-20 bp 
and the Guanine/Cytosine (GC) content should be between 40-60% with an optimum of 
approximately 50%. Ideally, the Tm of primer pairs should not differ by more than 
1-2 °C. When designing primers, it was ensured that the forward and reverse primers 
were located in different exons of the gene and that they preferably spanned an 
intron/exon boundary. This is one way of ensuring that the primers do not amplify 
genomic DNA. As an additional precaution, all RNA samples were treated with RNase- 
free DNase during the RNA extraction step. Specificity of the primer sets for the product 
of interest is essential. It was found that primers, which work well when using 
conventional PCR, don’t necessarily work well on the LightCycler system. Therefore, in 
some cases it was worthwhile designing 3-4 optimal primer sets simultaneously and 
screening them to determine the single most efficient pair. Figure 2.8 shows the melting 
curve profile of two different sets of primers for the same gene during the screening 
process. It should be noted that the single, sharp product peak seen in Figure 6B is the 
desired result. Any double peaks relate to primers miss-priming and annealing to non­
specific products. All primer sets used were synthesised by Sigma Genosys (UK), HPLC 
purified and made to a concentration of 0.05/miol.
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Figure 2.8. Melting curve peaks for two MGF primer sets (A and B) generated by the 
LightCycler software. (A) shows the curve generated from a sub-optimal primer set which gives 
rise to multiple peaks. These double peaks relate to the primers miss-priming. (B) shows the 
melting peak curve for an optimal pair of primers. The sharp and narrow single product peak 
relates to the primers annealing to a specific product. There is evidence of a small amount of 
primer-dimer in some samples. The larger primer-dimer peak relates to the ‘no-template’ control 
sample (negative control).
Total RNA concentration
Because o f the nature o f these studies, tissue size was always a limitation. It was 
therefore necessary to determine the lowest starting concentration o f total RNA that 
could be used to make cDNA, with which it was still possible to attain reliable and 
reproducible results. Different concentrations o f total RNA ranging from 0.1/xg, 0.2/tg to 
ljitg were used to make cDNA. This cDNA was then used to amplify the abundantly 
expressed target, GAPDH, and the low expression level target, MGF in duplicate runs 
on the LightCycler (see Table 2.5). The study showed that 0.5/tg o f  total RNA was the 
lowest starting concentration o f RNA that could be used to obtain reproducible results, 
particularly when amplifying low expression level targets such as MGF.
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RNA 
Cone (fig)
GAPDH 
Run 1 (ng)
GAPDH 
Run 2 (ng)
MGF 
Run 1 (ng)
MGF 
Run 2 (ng)
0.1 X X X X
0.2 2.3x1 O'3 2.7xl0'3 X X
0.5 5.2x1 O'3 5.1xl0‘3 3.3x10'8 3.2x10'8
1.0 8.6x1 O'3 8.6x1 O'3 SxlO-8 5.1xl0'8
Table 2.5 Table showing quantitative values from duplicate runs for GAPDH and MGF made 
from cDNA containing different amounts of starting material. Values are expressed as ng of ss 
PCR product. ‘X ’ denotes where the value was below the limit of detection.
Magnesium Concentration
The PCR buffer used in the DNA Master SYBR Green I kits (Roche, UK) required that 
a magnesium titration be carried out. The optimum Mg concentration at which the 
primers worked most efficiently was determined by carrying out Mg titrations between a 
range of l-5mM, for each of the genes of interest.
Annealing Temperature and Annealing Time
An appropriate annealing temperature (Ta) can be worked out using the following 
formula:
Ta = 2(A + T) + 4(G + C)
(A=adenine T=thymine G=guanine C=cytosine)
However, it was often the case that the optimum annealing temperature for each gene of 
interest needed to be determined by carrying out a series of runs in which the annealing 
temperature was increased or decreased in 1°C or 2°C increments. The annealing time 
also contributed to the efficiency with which the primers annealed optimally to the
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product of interest and minimally to any non-specific products. When using the Roche 
DNA Master SYBR Green I kits, the annealing time can lie anywhere between 1-5 
seconds for any gene analysed. Therefore, once the optimal annealing temperature was 
determined the optimal annealing time was decided by performing a series of runs with 
different annealing times.
Transfer RNA concentration
Transfer RNA (tRNA) reduces the formation of primer artefacts during quantitative PCR 
(Sturzenbaum, 1999) and was added to the LightCycler reaction mixture to avoid non­
specific binding of reagents to the Lightcycler glass capillaries. It was found that adding 
tRNA to the reaction mix also increased the efficiency of amplification of low-level 
transcripts such as MGF, by reducing any primer dimer formation. An optimum 
concentration of tRNA was determined by performing a tRNA titration at different 
concentrations.
Sequence Specific RT Priming
To facilitate the efficiency of reverse transcription (RT) in transcripts expressed at low 
levels (e.g. MGF), short specific primers 50-100 base pairs downstream of the PCR 
reverse primers were used. A specific RT primer (dodecamer) was designed downstream 
from the specific reverse primers for IGF-IEa and MGF to enhance the amplification of 
both of these isoforms in the samples. The position of the specific RT primer that was 
designed in relation to the reverse primers for MGF and IGF-IEa is shown in Figure 2.9.
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5 ’G T GAAGAT G CACACCAT GT CC T CC T CGCAT CT C TT CT A C C T G G C G C T G 
T G C C TG C T CACCTT C A C CAG CT CT G C C A C G G C T G G A C C G G A G A C G C T C 
T G C G G G G C T G A G C TG G T GG A TG C T CTT CAGTT C G T G T G T GGAGACAGG  
G G C TTTT  A TTT CAACAAG CCC ACAG G G T A TG G C T C C A G C A G T CGGAGG  
G C G C C T CAG ACAG GT AT C G T GGAT G A G TG CT G C TT C C G G A G C T GT GAT  
CT A A G G AG G CT G GAGAT GT ATT G C G C A C C C C T C A A G C C TG C C A A G T CA
G C T C G C T CT GT C C G TG C C C A G C G C C A C A C C G A C A TG C C C A A G A C C C A G
AAG T AT C A G C C C C C A T CT ACCAACAAG AACACG AAG T C T CAGAG AAGGA
GAAGT ACATTTGA|AG AACGCAAG T AGAGGG AG T GCAGGAAACAAGAAG
AAC TACAG G AT G TAG G AAG AC CCT CC T G AGGAGT GAAG A G T GACATG C  
CACCG CAG G ATCCTTT^^^H iH ^^BTAAACTTTG G AAC
A C C T A C C A A A A A A T A A G T T T G A T A A C A T T T A A A A H IM H H B B c c c c
AAT GAAAT AC AC AAGT AAACATT CC AAC ATT GT C TTT AG G AG T G ATTT GC  
ACCTTG CAAAAAT G G T CC T GG A G TT GGTAG ATT G C T G TT GAT C TTTT AT C 
AAT AAT G TT CT AT AG AAAAG AAAAAAAAAATT AT AT AT AT AT AT AT AT CTT A 
G T C C C TG C C T CT CAAGAGCCACAAATG CAT G G G T G TT G T AT AGAT CCAG  
TT  G CACT AAATT CC T CT CT GAAT CTT G G C TG C T GG A G C C A TT CATT CAGC  
AA C CTT G T CT AAGT G G TTT AT GAATT G TTT C CTT A TTTG C A C TT C TTT CTA  
CACAACT C G G G C T G TTT G TTTT ACA G T GT CT G A 3’
Exon 3 (157), Exon 4 (182), Exon 5 (49 bp) Exon 6 (344)
Figure 2.9. Part of the mRNA sequence of exons 3,4, 5 and 6 of the human IGF-I gene. Reverse 
primers for IGF-IEa and MGF are highlighted in yellow and blue respectively. The position of 
the specific RT primer in relation to reverse primers for IGF-IEa and MGF is shown highlighted 
in red.
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Generating standard curves
In order to generate a standard curve, at least 5 different concentrations of the 
standard DNA should be measured and the amount of unknown target should fall 
within the range tested. To ensure reproducibility, reactions should be carried out in 
duplicate.
Standards
When using ‘absolute’ quantification, as in this study, the copy number or 
concentration of the nucleic acids used as standards must be known. Furthermore, 
standards should have the following properties: (i) primer binding sites identical to 
the target being quantified (ii) sequence between primer binding sites identical or 
highly similar to target sequence and (iii) sequences upstream and downstream from 
the amplified sequence identical or similar to natural target.
The ‘type’ of standard used depends entirely on what type of nucleic acid is being 
quantified. RNA or DNA molecules can be used to quantify RNA or DNA 
respectively as can genomic DNA, plasmid DNA or PCR products. It was found that 
purified PCR products (see Methods and Materials) have the most comparable 
amplification efficiencies as samples. This may be because they have essentially 
undergone the same prior experimental treatment (i.e. RNA extraction and cDNA 
synthesis) as the sample being quantified.
Reproducibility of standard curves
With absolute quantification, it is essential to understand the importance of the 
quality of the standards used to generate the standard curve from which the
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concentration of unknown samples is determined. The amount of care that needs to 
be taken when designing, making and calibrating standards really depends on the 
research question being asked. If only relative changes are important, for example 
changes in gene expression in response to a treatment, it is probably not as important 
to know the actual concentration of the standards, it only matters that the standards 
are consistent. It is generally accepted that determining the concentration by 
absorbance at 260nm is a consistent method of calibrating standards (as long as the 
same purification procedure is always used). If the absolute quantity of target, rather 
than the ratios is of interest, greater care must be taken in determining the specific 
RNA levels.
Calibration of standard curves
As this work focuses largely on the changes in expression of the IGF-I isoforms in 
human muscle with exercise, it is important that the standards used to generate the 
curve are consistent and reproducible. As mentioned above, standards were made 
from purified PCR products. The concentration of these purified PCR products was 
determined by absorbance at 260nm. To avoid the effects of repeated freezing and 
thawing, after purification, the DNA was aliquoted into smaller volumes and stored 
at -20°C. On the day that quantitative PCR was performed, one of these aliquots was 
thawed, its concentration re-determined to see if there had been any changes to the 
concentration and then serially diluted for use in PCR. To determine the consistency 
of the standards, slope values from 6 separate standard curves used in the same study 
were compared (see Table 2.6). As the LightCycler carousel only allows a maximum 
of 32 samples to be loaded at one time, it was sometimes necessary to split analysis 
of samples into two or three, depending on how many samples there were for a
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particular study. In such cases it is essential that the standard curves between runs are 
directly comparable.
Separate
runs
Slope values Efficiency
1 -3.579 1.9
2 -3.537 1.9
3 -3.430 2.0
4 -3.483 1.9
5 -3.443 2.0
6 -3.508 1.9
Table 2.6 Variability of standard curves from 6 different runs from the same study.
2.2.1 Ensuring that standards and samples run with similar efficiency
To calculate the efficiency of a PCR run the following equation can be used:
Efficiency = i o 1/slope
Ideally, the PCR efficiency should be as close to ‘2’ as this would suggest a perfect 
PCR doubling with each cycle. It is possible to determine whether samples and 
standards are running at similar PCR efficiencies. This can be achieved by serially 
diluting a cDNA sample in the same dilution series as a set of standards (e.g. 10 fold 
dilutions). When programming the LightCycler, the cDNA samples are programmed 
in as standards with a ‘known’ concentration and then both dilution series of samples 
and standards are run within the same run. It is then possible to determine the slope 
values for each individual dilution series and these can be compared with one 
another.
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Fully optimised MGF run using Roche chemistry
A fully optimised run using the Roche reagents for a less abundantly expressed target 
such as MGF is shown in Figure2.10. To achieve this level of target specificity, the 
PCR reaction included the addition of tRNA, addition of an optimal amount of 
MgCl2 and fine-tuning of the annealing temperature and time used. Although the 
level of primer dimer is minimal it will still interfere with the true quantitative 
values. The LightCycler software provides an option to take into account any 
background fluorescence generated from the amplification of primer dimers, by 
enabling quantification to be carried above their melting temperature. However, this 
does not eliminate the fact that the PCR reaction is sub-optimal and primer dimers 
are still being formed.
Figure 2.10. A fully optimised run 
using Roche chemistry. The 
broader peaks denote primer 
dimers whereas the narrower peaks 
at a higher melting temperature the 
specific MGF product.
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Inconsistencies with Roche chemistries
Thus far all optimisation had been carried out using Roche chemistries. However, it 
was found that there were inconsistencies in the absolute values attained from the 
same sample when amplified using different stocks of SYBR Green I from the same 
batch, and these inconsistencies were even further compounded when using SYBR 
Green I from a different batch. It was also determined that a kit which could be used 
to amplify one gene e.g. GAPDH, would not necessarily work to amplify another 
gene e.g. IGF-IEa. A further problem was then detected with the DNA Master SYBR 
Green I Fast Start kits. It was found that using different concentrations of MgCl2 in 
the reaction mix as a part of the optimisation procedure would cause varying degrees 
of white precipitate formation in the glass capillary, over the course of the PCR. This 
undoubtedly interfered with the true quantitative values. In light of all of these 
problems it became necessary to investigate using an alternative chemistry for real 
time PCR.
Adapting the protocol for use with a different chemistry
All analysis for the studies detailed in Chapters 3-5 was performed using QuantiTect 
SYBR Green PCR kits (Qiagen, UK). These kits became available on the market in 
November 2001 and were specifically designed for use with two real-time PCR 
systems, one of which was the Roche LightCycler. Switching chemistries did require 
having to completely re-optimise the reaction conditions. However, the results 
obtained with these new kits proved to be highly reproducible, even when amplifying 
low copy number targets, which had previously proved to be most problematic.
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Optimisation of quantitative PCR using Qiagen QuantiTect kits
Unlike the Roche kits, these kits required less optimisation and were altogether more 
consistent. The most important consideration seemed to be the size and specificity of 
the primers. The annealing temperatures for all targets were also found to be 
considerably lower (sometimes more than 10°C) than had previously been the case 
with the Roche kits e.g. to amplify IGF-IEa using the Roche kits required an 
annealing temperature of 61 °C. Whereas, with the Qiagen kits the best annealing 
temperature for this target was 52°C. It was also no longer necessary to add and 
optimise the MgCb concentration with the Qiagen kits, as the QuantiTect SYBR 
Green PCR buffer employs a different system that contains a balanced combination 
of KCL and (NH^SO^ This is believed to promote a high ratio of specific to non­
specific primer binding during the annealing step of each PCR cycle, creating 
stringent primer annealing conditions, leading to increased PCR specificity. When 
using this buffer system, primer annealing is only marginally influenced by the 
addition of MgCh.
Fully optimised runs using Qiagen QuantiTect kits
Fully optimised runs for targets IGF-IEa and MGF are shown in Figure 2.11 below. 
The melting curve profiles of the quantitative runs show only a sharp narrow peak 
relating to the specific target of interest with no primer dimer peaks.
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Figure 2.11. Fully optimised runs for IGF-IEa and MGF using Qiagen QuantiTect 
chemistry. For each target of interest, the conditions are such that there is only amplification 
of specific product and no primer dimmer (shown by the series of coloured lines forming the 
peak). The no template (negative) control (flat blue lines), with no target mRNA contains no 
specific product hence is denoted by a flat line.
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2.5 Initial Studies using the LightCycler
Having established a fully optimised method for the quantification of IGF-I and its 
isoforms in human muscle, it was necessary to answer two critical questions. Firstly, 
how reproducible was the method on the LightCycler set-up? Secondly, given the low 
levels of expression of genes such as MGF, what was the optimal amount of cDNA to 
add to the reaction mix to increase the reproducibility within the run? The following two 
studies detailed below were performed to address these questions. Also, a third study 
was performed to determine whether different starting concentrations of total RNA were 
accurately reflected by the quantitative values calculated for a particular target. Details 
of RNA extraction, first strand cDNA synthesis, generating standards and real time PCR 
are given earlier in this chapter in section entitled General Methods and Materials.
101
Study 1: Intra-run reproducibility on the LightCycler 
Aim
To determine the intra-run reproducibility at different concentrations of GAPDH
9  Qplasmid DNA ranging from 1x10" -  1x10" ng / /d.
Methods
5 identical volumes (2jil) of the same concentration of GAPDH plasmid DNA were 
included in the same run. 7 separate runs containing different concentrations of plasmid
0 fiDNA ranging from 1x10" to 1x10" ng / fxl were then performed using the same reagents 
(SYBR Green I master-mix, Mg2+ and primers). From the quantitative values obtained 
for all 7 different GAPDH concentrations, the coefficient of variation of the 5 samples 
was calculated for each different concentration used.
Results
The results from this study are shown in Figure 2.12. The coefficient of variation 
decreases as the concentration of plasmid DNA increases. This shows that the intra-run 
reproducibility is therefore higher and more consistent at higher DNA concentrations.
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Figure 2.12. Intra-run reproducibility within a LightCycler run.
Conclusion
It was found that the reproducibility within a run was higher and more consistent at 
higher target concentrations, which was to be expected. However, this posed a problem, 
as some of the transcripts of the genes of interest were inevitably going to be present at 
very low concentrations, such as MGF. It was therefore important to carefully optimise 
conditions so that rare targets could be quantified reliably and reproducibly on the 
LightCycler system. The next phase was therefore to perform an experiment to 
determine how the intra-run reproducibility could be improved.
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Study II: Improving the intra-run reproducibility
Aim
To determine the effects of increasing the amount of DNA added to the reaction mix on 
the intra-run reproducibility, in particular at low concentrations of target.
Methods
Three separate runs were carried out in which the reaction mix contained three different 
volumes of plasmid DNA, these being 2pi, 5pi and lOpl respectively.‘These runs were 
then performed with 5 capillaries that contained the same amount of DNA i.e. the 5 
tubes in run 1 contained 2pi of plasmid DNA, the 5 tubes in run 2 contained 5 pi and the 
5 tubes in run 3 contained lOpl. These three runs were then repeated using three 
different concentrations of plasmid DNA: 1x10' ng / pi, 1x10' ng / pi and 1x10' ng / pi. 
The coefficient of variation was then determined for each volume of DNA added, and 
this was done for all three concentrations of target.
Results
The results from the run containing the three different volumes of plasmid DNA at a 
concentration of lxlO^ng / pi can be seen in Figure 2.13. It was observed that the intra­
run reproducibility increased by proportionally increasing the DNA volume added to the 
reaction mix.
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Figure 2.13. The effects of increasing DNA volume on the reproducibility within a run. Each 
point represents a mean of 5 different PCR reactions within the same run.
Conclusion
It would seem that when analysing samples where the target concentration is low 
such as with MGF, a proportionally larger volume of cDNA could be added to the 
reaction mix to ensure good reproducibility of results. In this case, as Roche buffers 
were used to make the cDNA (Expand Reverse Transcriptase, Roche Diagnostics) 
and to carry out the PCR, both systems were highly compatible with one another. It 
was therefore possible to add a cDNA volume which constituted up to 50% of the 
reaction volume (i.e. 10/d) without interfering with the PCR or causing any kind of 
PCR inhibition. However, it should be noted that for the studies reported in Chapters 
3-5 a different type of chemistry was used (see section on ‘Adapting the protocol for 
use with a different chemistry’), which produced more consistent and reproducible 
measurements, even at low target concentrations.
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Study III: Correlation between total RNA concentration and quantitative values
Aim
To establish whether mRNA concentrations of GAPDH determined by real time 
quantitative PCR on the LightCycler correspond to the original total RNA 
concentration used to make cDNA.
Methods
Three different starting concentrations of total RNA from a resting muscle sample 
were used to make cDNA, these were: 0.2/ig, 0.5/xg and 1/ig. First strand cDNA 
synthesis was performed at the same time using the same reagents and conditions for 
all three samples. Levels of expression of GAPDH mRNA were quantified using 
real-time quantitative RT-PCR relative to a set of standards, serially diluted in 10 
fold dilutions ranging from lng / /d to O.OOOOlng / /d (lx l0 '5ng / ill). Duplicate runs 
were performed. The ratios between GAPDH mRNA concentrations for the three 
samples were then compared with the original total RNA concentration added. 
Linear regression analysis was used to determine if there was any relationship 
between the initial concentration of total RNA used to make cDNA and the final 
GAPDH mRNA concentration determined by quantitative PCR.
Results
The ratios between GAPDH mRNA concentrations from the three different samples 
were found to be highly comparable to the original total RNA concentration used to 
make cDNA in both runs. These results are shown in Table 2.7 below.
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Ratios are calculated as follows:
For example, if  1.8x10'3ng = 1 as it is the highest concentration value.
A concentration o f  1.2x10'3ng is therefore 1.2x1 O'3 -s- 1.8x1 O'3 = 0.66, o f this.
Total RNA GAPDH 
concentration 
(Run 1)
Ratio GAPDH 
concentration 
(Run 2)
Ratio
lug 1.8xl0*3ng 1 2.7xl0'->ng 1
0.5/xg 1.2xl0‘3ng 0.66 1.8xl0 '3ng 0.68
0.2/xg lJxloA ig 0.1 2.9xl0 '4ng 0.11
Table 2.7 Comparison of starting RNA concentration with ratios of GAPDH mRNA 
concentration after quantitative PCR using the LightCycler. The ratios of GAPDH mRNA 
concentration are shown in red for 2 duplicate runs.
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Figure 2.14. Correlation between total RNA concentration and mean GAPDH mRNA 
concentration from 2 duplicate runs (r = 0.98).
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Conclusion
This study has shown that the original total RNA concentration used to make cDNA 
can be quite accurately reflected in the mRNA concentration of an abundantly 
expressed target such as GAPDH. The significant relationship (r = 0.98, P<0.05) 
between initial total RNA concentration and GAPDH mRNA concentration (Figure 
2.14) also highlights that performing first strand cDNA synthesis of samples at one 
time, using the same reagents and conditions is important to minimise operator error 
when analysing multiple samples. Even if the data is not normalised to a control gene 
such as GAPDH, it is beneficial to know that the reverse transcription procedure has 
been successful, and that there is essentially an equal concentration of mRNA 
between all samples. Control genes can therefore also prove useful as an initial check 
of the quality and concentration of cDNA, and should be amplified from the same 
sample that will subsequently be used for analysis of other targets of interest. 
Running an initial check in this way is extremely useful, as it is difficult to determine 
the concentration of cDNA by absorbance at 260nm due to the high concentration of 
interfering dNTPs.
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Chapter 3
Expression of IGF-I splice variants in young and old human 
skeletal muscle after a single bout of high resistance exercise
109
3.1 Introduction
The ageing process is associated with a progressive decrease in skeletal muscle mass. 
This time dependent muscle loss is a major cause of disability, frailty and loss of 
independence in the elderly, due mainly to the associated loss of muscle strength and 
power (Harridge and Young, 2000). We know that strength training exercise 
increases muscle mass and strength in young individuals. The responsiveness of aged 
muscle to strength training has also been confirmed by longitudinal studies of 
previously non-active elderly people. Progressive resistance training trials in healthy 
elderly women aged 76-93 years (Skelton et al. 1995) and frail, institutionalised 
subjects aged 72-98 years (Fiatarone et al. 1994, Harridge et al. 1999), confirm that 
elderly muscle remains responsive to training.
The mechanisms involved in increasing muscle mass with strength training are still 
not fully understood. However, IGF-I has been shown to have an important role in 
the hypertrophic adaptation of muscle to overload. Studies in support of this have 
been detailed in Chapter 1. Briefly, the role of IGF-I as a potential hypertrophic 
agent in both young and older muscle was shown in studies where a 15% increase in 
muscle size and strength of young animals was reported following injection of a viral 
construct containing IGF-I (Ea isoform) cDNA. In the older animals, the injected 
muscles were 27% stronger than controls and there was also evidence of a prevention 
of age related loss of muscle mass (Barton-Davies et al. 1998). Furthermore, a recent 
study in which a transgenic mouse model overexpressing the same isoform (termed 
m.IGF-I in this case) in skeletal muscle was shown to have pronounced muscle 
hypertrophy (Musaro et al. 2001). The role of the different isoforms of IGF-I in 
muscle hypertrophy has been less extensively studied. The two muscle isoforms of
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IGF-I: IGF-IEa and MGF, have however been shown to be positive regulators of 
muscle growth, as their expression has been shown to increase in animal muscles 
which have been subject to stretch and stimulation (Yang et al. 1996; McKoy et 
al. 1999; Hill et al. 2003). IGF-I is thought to increase muscle mass through two main 
mechanisms. The first of which is through the stimulation of protein synthesis and 
decreasing the rate of protein degradation in muscle tissue (Bark et al. 1998), and the 
second is through the activation of satellite cells. Upon activation, these cells rapidly 
upregulate MyoD, a member of the myogenic regulatory transcription factors 
(MRFs) (Comelison and Wold, 1997).
Apart from the preliminary finding that MGF is expressed in man (Yang et al. 1996), 
little is known about the regulation of different IGF-I isoforms in human skeletal 
muscle. The present study was therefore undertaken to study the effects of an acute 
bout of high resistance weightlifting exercise (the type known to result in muscle 
hypertrophy) on the different IGF-I transcripts in human skeletal muscle, shortly 
after the end of exercise. This was in relation to age, MyoD expression and MyHC 
isoform composition of the muscle.
The main aims of this study were:
(i) To determine whether IGF-IEa and MGF mRNAs responded differently 
to high resistance exercise in human skeletal muscle.
(ii) To determine whether there was an age related impairment in the 
expression of IGF-IEa or MGF mRNA after high resistance exercise.
(iii) To confirm the localisation of MGF mRNA to within the muscle fibres.
I l l
(iv) To ascertain if there were any correlations between the mRNA expression 
of IGF-IEa or MGF and MyoD in the ‘short-term’ response to high load 
exercise.
(v) To compare the MyHC isoform composition of young and old individuals 
and to determine whether there was any relationship between muscle 
composition and IGF-I isoform expression.
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3.2 Methods and Materials 
Subjects
Eight healthy young men (age 29.5 ±1.5 years, body mass 81.1 ± 2.4 kg, height 
179.3 ±1.8 cm) and 7 elderly men (age 74.4 ±1.8 years, body mass 74.7 ±2.1 kg, 
height 177 ± 2.3 cm) defined as healthy according to the criteria of Greig et al 
(1994), participated in this study. All subjects were given an oral and written briefing 
of the study before signing informed consent forms. The study was approved by the 
Ethics Committee of the Royal Free Hospital and all procedures were performed 
according to the Declaration of Helsinki.
Study design
After habituation to the knee extensor weight lifting apparatus (Ultimate Workout, 
Nottingham, UK), each subject completed a one repetition maximum (1-RM) test one 
week before the study day to determine the maximum load that could be lifted with one 
leg when carrying out knee extensor exercise (Figure 3.1). On the day on which 
measurements were made, subjects performed a standardised warm up which comprised 
cycling at 50 watts for 5 minutes on a cycle ergometer (Cybex -  Metabolic Systems) and 
light stretching exercise. With the test leg they then performed 10 sets of 6 repetitions of 
the knee extensor muscles at 80% of their 1-RM. A 2-minute rest period was given 
between sets and the subjects were encouraged throughout. If it was apparent that the 
subjects were not going to complete 10 sets of 6 repetitions, then the weight was 
lowered to ensure completion of the exercise protocol. The contra-lateral leg served as a 
control. Following 2 Vz hours of recovery, a muscle biopsy was taken from the exercised 
(test) and non-exercised (control) leg.
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Figure 3.1. A young subject performing knee extensor weightlifting exercise.
Muscle biopsy procedure
Following local anaesthesia (1% lignocaine), muscle biopsies were taken from the 
vastus lateralis muscle using the percutaneous needle biopsy technique (Bergstrom, 
1962) with applied suction. The sample obtained from each biopsy was divided into two 
pieces. The first piece was quick frozen in liquid nitrogen for use in quantitative RT- 
PCR analysis and for electrophoretic separation o f the MyHC isoforms. The second 
piece was orientated longitudinally, mounted in embedding medium (optimum cutting 
temperature compound (OCT)), and frozen in isopentane cooled to the temperature o f 
liquid nitrogen.
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RNA extraction
Total RNA was extracted from the test and control muscle samples using Tri Reagent 
(Sigma) as described in Chapter 2, Methods and Materials.
Measurement of total RNA concentration
The quality of the RNA was assessed as described in Chapter 2, Methods and Materials. 
Electrophoresis of RNA
To ensure the integrity of the RNA samples, total RNA was separated under denaturing 
conditions using formaldehyde agarose gel electrophoresis. This procedure has been 
detailed in Chapter 2, Methods and Materials.
Primers used for cDNA synthesis and quantitative PCR
To facilitate the efficiency of reverse transcription (RT) in transcripts expressed at 
low levels, such as MGF, short sequence specific dodecamers 50-100 base pairs 
downstream of the reverse PCR primers for both MGF and IGF-IEa were specifically 
designed from the mRNA sequences. The oligonucleotide sequences for this specific 
RT primer and those used in real time quantitative PCR are given in Table 2.4 
Chapter 2. For amplification of all other targets, random hexamers (dN)6 (Roche) 
were used for first strand cDNA synthesis.
First strand cDNA synthesis
0.5pg total RNA was reverse transcribed into cDNA as described in Chapter 2, Methods 
and Materials.
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Real time quantitative PCR
Quantification of the mRNA message coding for a-actin, IGF-IEa, and IGF-IEc (MGF) 
and the myogenic regulatory factor MyoD was performed using LightCycler technology 
(Roche Diagnostics, UK). Details of this method are given in Chapter 2, Methods and 
Materials. Runs were performed in duplicate and mean values were subsequently used 
for analysis.
Gel electrophoresis
PCR products were recovered from the glass capillaries by removing the plastic caps and 
inverting them into a 1.5ml eppendorf tube, which were then spun down in a bench top 
centrifuge at no higher than 3000 rpm. Target specificity was further confirmed by 
running these samples on a 2% agarose gel as described in Chapter 2, Methods and 
Materials.
DNA purification
Initially, to confirm the identity of the PCR products, these were purified using Wizard 
PCR Purification kit (Promega,USA), details of which are given in Chapter 2, Methods 
and Materials.
Cloning of PCR products
To confirm their identity, PCR products were cloned into specifically designed vector 
systems such as pGEM-T (Promega, USA) following DNA purification before being 
sent off for sequence analysis.
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Ligation
3jj,1 of purified PCR product was ligated to 50ng of PGEM-T vector in a final volume 
of lOpl, containing ligation buffer, T4 DNA ligase (3 Weiss untis//xl) (Promega kit). 
Ligation reactions were mixed by pipetting then incubated overnight at 4°C to 
produce the maximum number of transformants.
Transformation
Transformation of JM109 High Efficiency Competent Cells (Promega,US A) was 
carried out as follows: 50pl of cells were directly pipetted into a fresh 1.5ml 
eppendorf tube containing 2pl of the ligation reaction. The vials were gently flicked 
to mix and then incubated on ice for 20 minutes. The cells were then heat-shocked 
for 45-50 seconds in a water bath at exactly 42°C, followed by incubation on ice for 
2 minutes. 950pl of SOC medium (at room temperature) was added to each vial and 
these were incubated in a rotary shaker (-150 rpm) for lhour at 37°C. The 
transformation culture was plated on LB agar plates containing 50pg/ml ampicillin, 
which had been coated with 40pl X-gal (40mg/ml) and 40pl isopropyl- 1-thio-jS-D- 
galactoside (IPTG). The plates were incubated at 37°C overnight.
Colony selection
Positive transformants were initially identified by blue/white colony selection. 
Colony PCR was performed on a selection of white colonies. Those that were found 
to contain the insert of interest were cultured overnight using a small-scale plasmid 
preparation system - Wizard Minipreps DNA Purification System (Promega, UK). 
lOpg of each mini-prep DNA was then sent off for sequence analysis. After 
confirmation of the identity of the PCR products it was not necessary to run the PCR
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products on an agarose gel. Target specificity confirmed using the melting curve 
profile feature.
SDS PAGE of MyHC isoforms
The relative proportions of the three MyHC isoforms (MyHC 1, 2a and 2x) present in 
the vastus lateralis muscle from each of the young and old subjects was determined 
by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS PAGE) 
(Andersen and Aagard, 2000).
Preparation of solutions and samples for SDS PAGE 
Sample buffer stock solution
The sample buffer stock solution contained 6.25ml of 0.5M Tris (pH 6.8), 10ml of 
10% SDS, 10ml glycerol and 2.5ml /3-mercaptoethano 1. The solution was made up to 
50ml using distilled water. Bromophenol (25mg) was added in order to stain the 
solution.
Muscle tissue preparation
Before adding the stock solution, the muscle tissue was homogenised manually with 
a pestle and mortar. Each sample had 500/d of sample buffer added to the tube. The 
mixture was then heated to 97° C for 3 minutes.
SDS gel preparation
The SDS PAGE gel electrophoresis system is a discontinuous system consisting of a 
stacking gel and a resolving gel. For the stacking gel a 4% solution was used in order 
to align the contractile proteins prior to separation.
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Resolving gel preparation
A 7% resolving gel was made up with the following reagents: Acrylamide -  Bis 
(100:1) (3.13ml), Lower Tris (pH 6.8) (1.34ml), Distilled H2O (1.05ml), Glycine 
(1.0ml), 10% SDS (0.4ml), Glycerol (3.0ml), APS (100/d) and TEMED (8/d). In 
order to set the resolving gel a set of glass plates was positioned in a cradle designed 
to hold the resolving gel plates. Approximately 4ml of the solution was poured into 
the space between the glass plates. The solution was allowed to set for approximately 
2 hours prior to loading the stacking gel.
Stacking gel preparation
A stacking gel was made up using the following reagents: Acrylamide -  Bis (37:5:1) 
(0.5ml), Upper Tris (pH 8.8) (1.25ml), Distilled H20 (3.25ml), APS (50/d) and 
TEMED (10/d). This solution was poured on top of the resolving gel and allowed to 
set for a further 1 hour.
A running buffer consisting of 50ml buffer concentrate (BioRad Tris, Glycine) added 
to 450ml distilled H20 pre cooled to approximately 5° C was placed into the running 
tank and the samples are loaded into the stacking gel wells. A further 200/d of /3- 
mercaptoethanol was added to the centre of the tank prior to running. The gels were 
set to run for approximately 26 hours at 5° C at 80v.
Sample staining
The gels were removed from the glass plates and placed into a small container. The 
gels were rinsed for approximately 10 minutes in distilled water this was then 
repeated. Next, the gels were covered with 20ml ‘simply blue safe stain’ (Invitrogen,
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UK) (LC6060) and were left to stain for approximately 1 hour, depending on the 
required intensity and the amount of protein present. The stained gels were then 
rinsed again in distilled water for approximately 2 hours, which decreased the 
background staining. This improved protein band resolution during light 
densitometry.
Light densitometry
After staining, the resolving gels were placed into a BioRad densitometer (BioRad 
Geldoc 2000). The gels were scanned and the density map produced along with a 
calculated proportional percentage with respect to the separate myosin isoform bands 
using the associated software (BioRad Quantity 1, version 4.2). The gel background 
was subtracted from the protein band density in order to align the baseline to zero.
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In-situ hybridisation 
Tissue preparation
Transverse serial sections (10-pm thick) of the vastus lateralis muscle were cut using 
a cryostat microtome (LEICA CM3050) at -20°C and applied to super-frost 
premium plus-coated glass slides (BDH). All sections were allowed to air-dry for at 
least 10 minutes. The sections were then fixed in DEPC-treated PBS containing 4% 
paraformaldehyde pH 7.5 for 5 minutes at 4°C, washed with DEPC-treated PBS pH 
7.4 and stored at -70°C until further processing.
Probe preparation
Primers were synthesized (Sigma-Genosys) using T7 and SP6 promoter sequences 
with part of the 49bp MGF sequence from exon 5 of the IGF-I gene included in each 
primer.
The sense (forward) primer used was SP6 + MGF part of sequence: 
TGATTTAGGTGACACTATAGAATCTAGAACACTGACATGCCCAAGA
The antisense (reverse) primer used was T7 + MGF part of sequence: 
TGTAATACGACTCACTATAGGGAAGCTTTGCACTTCCTCTACTTGTGT
RT-PCR was performed in order to amplify MGF flanked by T7 and SP6 promoter 
sequences. 1 pi of purified MGF plasmid DNA prepared as described in Chapter 2, 
Methods and Materials was amplified using the primers above in 2x50 pi reactions, 
as described in Chapter 2, Methods and Materials. PCR amplification consisted 35 
cycles of denaturation at 94°C for 1 minute followed by annealing at 61°C for 1
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minute and elongation at 72°C for 1 minute. 2pl of the PCR products were then run 
on a 1.2% agarose gel to confirm the size o f the bands (figure 3.2). Following gel 
electrophoresis, the PCR products were purified (Wizard PCR Preps DNA 
purification, Promega) and their concentration determined by spectroscopy at 260 nm 
using the Gene Spec I (Naka Instruments).
200bp
100bp
80bp
Figure 3.2. 1% agarose gel showing purified MGF plasmid flanked by T7 and SP6 
promoter sequences, following PCR amplification. PCR consisted 35 cycles of denaturation 
at 94° for 1 minute, annealing at 60°C for 1 minute and elongation at 72°C for 1 minute. The 
picture shows PCR products at approximately lOObp obtained using T7 and SP6 primers 
with part of MGF sequence included. Lane 1 - lOObp DNA size marker, lanes 2 and 3 MGF 
PCR product.
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RNA labelling with DIG-UTP by in vitro transcription with SP6 and T7 RNA 
polymerases
PCR-fragments with RNA polymerase promoters ligated at their 5’ terminus act as 
templates for transcription. DIG-11-UTP is incorporated by SP6, T7 at 
approximately every 20-25th nucleotide of the transcript. The standard labelling 
reactions for SP6 (sense) and T7 (antisense) digoxigenin-labelled RNA probes 
accordingly, were as follows: the following reagents were added to a microfiige tube 
on ice: 200ng of PCR product, 2pi of lOxDIG RNA Labelling mix, 2pl of lOx 
transcription buffer (400mM Tris-HCl, pH 8.0; 60mM MgCk, lOOmM DTT, 20mM 
spermidin), sterile RNase-ffee water to a final volume of 18 pi and 2 pi RNA 
polymerase (SP6 or T7 respectively). After mixing and centrifuging briefly, the 
reactions were incubated at 37°C for 2hours. The reactions were stopped by adding 
2 pi 0.2M EDTA-solution, pH 8.0 on ice. The protocol and reagents used were by 
Boehringer Mannheim.
In-situ hybridisation standard procedure (Boehringer Mannheim) 
pre-hybridisation
Sections were washed 2x5 minutes with DEPC-treated PBS, pH 7.4 and then washed 
further 2x5 minutes with DEPC-treated PBS containing lOOmM glycine. These were 
then treated for 15 minutes with DEPC-treated PBS containing 0.3% Triton-X-100 
and then washed 2x5 minutes with DEPC-treated PBS. Permeabilization of the 
sections was performed for 30 minutes at 37°C with TE buffer (lOOmM Tris-HCl, 
50mM EDTA, pH 8.0) containing lpg/ml RNase-free Proteinase- K (Sigma). They 
were then post-fixed for 5 minutes at 4°C with DEPC-treated PBS containing 4%
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paraformaldehyde and washed 2x5 minutes with DEPC-treated PBS. To acetylate, 
the slides were placed in containers on a rocking platform and incubated with 0.1M 
triethanolamine (TEA) buffer (Sigma), pH 8.0 containing 0.25% (v/v) acetic 
anhydride for 2x5 minutes. Acetic anhydride (Sigma) is highly unstable so it was 
added just before incubation. The sections were then incubated at 37°C for an hour 
with pre-hybridisation buffer (4xSSC (lxSSC= 150mM NaCl, 15mM sodium citrate, 
pH 7.2- Sigma) containing 50% v/v deionised formamide (Sigma)). Pre-hybridisation 
buffer was drained from the slides and hybridisation buffer was applied containing 
lOpg per 100ml of hybridisation solution of the DIG-labelled SP6 and T7 RNA 
probes. Sections were covered with cover slips (BDH) and incubated at 42°C 
overnight in a humid chamber.
Preparation of hybridisation buffer
This consisted: 40% deionised formamide, 10% dextran sulfate, lx Denhartd’s 
solution (0.02% Ficoll, 0.02% polyvinylpyrrolidone, lOmg.ml RNase-free bovine 
serum albumin), 4x SSC, lOmM DTT, 1 mg/ml yeast t-RNA and 1 mg/ml denatured 
salmon sperm DNA and was added shortly before hybridisation. (All reagents used 
were provided by Sigma).
Post-hybridisation
Coverslips were removed by immersing the slides in 2xSSC for 5-10 minutes in 
different containers for the two RNA probes and the sections were washed in a 
shaking water bath at 37°C 2x15 minutes with 2xSSC and 2x15 minutes with lxSSC. 
To digest any single-stranded (unbound) RNA probe the sections were incubated for 
30 minutes at 37°C in NTE buffer (500mM NaCl, lOmM Tris, ImM EDTA, pH 8.0)
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containing 20pg/ml RNase A (Sigma). They were then washed 2x30 minutes in a 
shaking water bath at 37°C with O.lxSSC.
Immunological detection
Sections were washed 2x10 minutes in a shaking platform with Buffer 1 (lOOmM 
Tris-HCl, pH7.5 and 150mM NaCl). They were then incubated for 30 minutes with 
blocking solution (Buffer 1 containing 0.1% Triton X-100 and 2% normal sheep 
serum (Sigma)).The Blocking solution was taken off and sections were incubated for 
2 hours in a humid chamber with Buffer 1 containing 0.1% Triton X-100, 1% normal 
sheep serum and 1 in 500 dilution of sheep anti-DIG-alkaline phosphatase (Fab 
fragments) (Boehringer Mannheim). They were then washed 2x10 minutes with 
Buffer 1 in a shaking platform. After which the sections were incubated for 10 
minutes with Buffer 2 (lOOmM Tris-HCl, pH 9.5, lOOmM NaCl and 50mM MgCb).
The sections were covered with colour solution containing 10ml of Buffer 2, 45 pi 
nitroblue tetrazolium (NBT), 35pi 5-bromo-4-chloro-3-indolyl-phosphate (BCIP or 
X-phosphate), both by Boehringer Mannheim and lmM levamisole (Sigma) and 
incubated for 6 hours (following optimisation) in a humid chamber in the dark.
The colour reaction was stopped by incubating the slides in Buffer 3 (lOmM Tris- 
HCl, pH8.1 and lmM EDTA) and then washed in distilled water. Sections were 
mounted with an aqueous mounting solution.
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Negative controls
Negative controls used: (i) tissue mRNA was digested with RNase prior to in-situ 
hybridisation, (2) hybridisation was also performed with SP6 sense probe and (2i) the 
anti-DIG antibody was omitted.
Care was taken to prepare all solutions with DEPC-treated distilled water (0.1% 
diethylpyrocarbonate-DEPC, Sigma). Different glassware was used for pre and post 
hybridisation steps and baked at 180°C to avoid RNase contamination. Gloves were 
used throughout the procedure.
Statistical analysis
Data are given as means ±SE. Comparisons between paired and unpaired data were 
made using the Wilcoxon’s signed rank test and the Mann Whitney test respectively. 
Non-parametric tests were chosen because inspection of the raw data suggested that 
the distribution of values or change in values did not follow a normal distribution. 
Linear regression analysis (Spearman’s product moment) was used to compare 
association between variables. The level of statistical significance was taken as 
P<0.05.
It should be noted that the measurement error will increase the random variation 
when comparing groups of subjects (as done in this chapter and chapter 4 where old 
subjects are compared with young subjects). Taking the average of duplicate 
measurements will therefore decrease the random variation and increase the power to 
show true differences.
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3.3 Results
Differences in the weight lifted by young and old subjects
The mean (+SE) 1-RM for the young subjects was 41.9±4.3 kg, which was 
significantly greater than for the old subjects (20.6±1.6 kg). The mean weight lifted 
by the two groups on the first and last sets was 34.5+3.6 and 33.4+3.5 and 16.5+1.3 
and 15.2+1.2 kg for the young and elderly subjects respectively.
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Figure 3.3. Mean 1-RM lifted by young (n=7) and old subjects (n=7). Values are expressed 
in kg (+SEM). * Significant difference from old (P<0.05).
*
Young Old
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Integrity of total RNA
Total RNA was extracted from the vastus lateralis muscle of young and old subjects 
from the control and exercised legs. The integrity of RNA was assessed by running a 
1.2% agarose formaldehyde gel and visual inspection of ethidium bromide stained 
18s and 28s ribosomal RNA bands was performed under ultra violet light. An 
example of an ethidium bromide stained gel is shown in Figure 3.4.
Electrophoresis of PCR products
The PCR products were recovered at the end of the PCR reaction and specificity of 
the real time quantitative PCR reaction was further confirmed by running the PCR 
products on a 2% agarose gel. Visual inspection of the ethidium bromide stained 
bands was performed under ultra violet light. The sizes of the products relative to a 
standard size marker (lOObp DNA ladder), which was also run alongside the samples 
on the gel, were determined as were any non-specific PCR amplifications such as 
primer dimers. An agarose gel picture of all four PCR products (IGF-IEa, MGF, 
O'-actin and MyoD) is shown in Figure 3.5. The specificity of the PCR conditions can 
be seen by the absence of any primer dimers. If present, these would have been a lot 
smaller than the specific products and approximately 40-50bp.
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Figure 3.4. Electrophoresis of total RNA extracted from the vastus lateralis muscle of a 
young and an old subject. Lanes 1 and 2 are pre and post exercise samples from a young 
subject and lanes 3 and 4, control and exercised samples from an older subject.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
a - a c t i n
Figure 3.5. 2% agarose gel picture showing PCR products for each of the targets measured. 
4 products are shown for each target - these correspond to a young subject (control and 
exercised leg) and an old subject (control and exercised leg). Lanes l and 10 - lOObp D N A  
size marker, lanes 2-5 - IGF-IEa, lanes 6-9 -  MGF, lanes 11-14 -  a-actin and lanes 15-18 -  
MyoD.
Alpha actin expression
To assess that the percentages of muscle mRNA to total RNA had not changed 
within the 2.5 hour period and that there was equal RNA and cDNA loading between 
samples, a-actin mRNA levels were measured and found not to be significantly 
different between the control and exercised legs. This would suggest that for the 
purpose of this study, a-actin could have been used as a suitable control gene to 
which the data could have been normalised.
Expression of IGF-I isoforms after exercise 
MGF
Levels of MGF mRNA are shown in Figure 3.6. At rest, MGF mRNA levels averaged 
6.6x10'8ng/jug RNA in the young subjects. This was not different to the elderly subjects. 
However, in the young subjects a significantly higher level of MGF mRNA was 
observed in the exercised leg when compared with the control leg. The increase ranged 
from 2% to 864%. In contrast to the young subjects, three of the elderly subjects showed 
lower values in the exercised compared to the control leg, therefore there was no 
significant difference observed in MGF mRNA levels between their exercised and 
control legs.
IGF-IEa
The levels of IGF-IEa mRNA are shown in Figure 3.7. IGF-IEa values were higher 
than that of MGF by 2-3 orders of magnitude. (10'5 vs 10‘8). As with MGF, baseline 
levels of IGF-IEa at rest were not significantly different between the young and older 
subjects. However, in contrast to MGF there was no significant change in IGF-IEa 
expression observed in either the young or the older individuals.
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Figure 3.6 Individual MGF mRNA levels in young (n=8) and old (n=7) subjects in the 
control and exercised (Ex) muscles. Values are expressed as ng of mRNA per fig total RNA. 
Black line represents subject RS who showed the greatest increase in MGF mRNA after 
exercise. * Significant increase in MGF mRNA 2.5 hours after exercise in the young subjects 
(P<0.05).
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Figure 3.7. Individual IGF-IEa mRNA levels in young and old subjects in the control and 
exercised (Ex) muscles. Values are expressed as ng of mRNA per fig total RNA.
132
M G F
I G F - I E a
7 2 -
7 0 -
£  1 4 -
a  12-  
6  1 0 -
-12
-10
CD
LL
Control Exercised
O)
CO
o
O'
E
05
CO
LLI
o
Figure 3.8. The MGF and IGF-IEa responses in the control and exercised leg for subject RS. 
Values are expressed as ng of mRNA per fig total RNA.
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MyoD expression after exercise in young and old subjects
The resting values o f MyoD in older subjects were significantly higher than those 
observed in the young subjects (P<0.05). Despite there being an -80%  increase in MyoD 
mRNA after exercise in the young subjects, this was not statistically significant.
201<
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Figure 3.9. MyoD mRNA levels in young and old subjects in control and exercised muscles. 
Values are expressed as ng of mRNA per jig total RNA (mean +SE). * Significant difference 
between baseline levels of MyoD compared with old subjects (P<0.05).
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MyHC composition
For each of the subjects MyHC isoform composition of the quadriceps muscle was 
determined by SDS PAGE. Only one subject (RS) expressed any observable amounts 
of the fast MyHC-2x isoform (see Figure 3.10). As a result the data are expressed as 
a percentage of the total MyHC-1 and MyHC-2 (MyHC-2a and 2x) content and is 
summarised in Table 3.1.
The quadriceps muscle of the elderly subjects was found to contain a significantly 
lower proportion of fast MyHC-2 isoforms than the young subjects. The relative 
percentage of MyHC-2 for the young and elderly subjects was 44% and 27% 
respectively (Table 3.1). No relationship was observed between muscle myosin 
heavy chain isoform composition and IGF-I isoform expression, either at rest or after 
the change induced by the exercise challenge.
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MyHC-1 (%) MyHC-2 (%)
Young
27+4*
Table 3.1 Relative MyHC isoform composition of the vastus lateralis muscle in young (n=8) 
and old (n=7) subjects as determined by SDS-PAGE. Values are expressed as mean ± SE.
* Significantly different from young
M y H C - 2 x  
M y H C - 2 a  
M y H C - 1
Figure 3.10. Electrophoretic separation of MyHC isoforms using SDS PAGE. Lane 1 shows 
a typical example of the MyHC isoform composition of the vastus lateralis muscle observed 
in young and old subjects. Lane 2 shows subject RS with a total 33% MyHC-2x. None of the 
other subjects showed any detectable amounts of this isoform.
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Localisation of MGF mRNA in human muscle
MGF mRNA expression within the muscle fibres studied by in situ hybridisation is 
shown in Figure 3.11. Hybridisation with the MGF antisense probe resulted in 
staining of MGF within the muscle fibres themselves, with staining appearing to be 
more concentrated around the periphery of the fibre. MGF mRNA was present in 
both the control and exercised muscle samples as shown by the quantitative PCR 
data. In sections treated with the sense probe, no such staining was observed.
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Figure 3.11. In situ hybridisation o f  antisense (A) and sense (B) DIG labelled MGF cRNA  
probe through the vastus lateralis muscle o f  a young subject 2 lA hours after the end o f  
exercise. The use o f  fresh frozen tissue has resulted in diminished tissue preservation, which 
caused a high background staining. The arrows marked on Figure 3.11A point to specific 
staining (dark purple) and show that it was localised to the periphery o f  the muscle fibres.
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3.4 Discussion
This study has shown that resting human skeletal muscle expresses at least two isoforms 
of IGF-I, the first being the main isoform expressed by the liver, IGF-IEa, and the 
second a splice variant, MGF. It has also shown that they differ markedly in their 
relative expression, with the mRNA of MGF being expressed at lower levels than that of 
IGF-IEa by two to three orders of magnitude. In the young subjects, expression of MGF 
mRNA was significantly increased after the single bout of high load weightlifting 
exercise, whilst there was no such increase observed in the older subjects. In contrast to 
MGF, IGF-IEa mRNA showed no significant change with exercise. Previous studies on 
animal muscle have shown that following overload there is an increase in the expression 
of IGF-I mRNA in muscle (DeVol et al. 1990; Czerwinski et al. 1994; Adams and 
Haddad. 1996, Yang et al. 1996; Adams, 1998). More recently, Bamman et al (2001) 
reported a 62% increase in IGF-I mRNA concentration in human muscle 48 hours after a 
single bout of eccentric resistance type exercise. However, this study did not 
differentiate between the different isoforms of IGF-I expressed in muscle. In the main, 
this study was concerned with the short-term response to exercise, therefore expression 
of these muscle IGF-I isoforms was studied 2V% hours after the end of an acute exercise 
bout both in young and old individuals. The results from the present study suggest that 
the expression of these gene products is independently controlled. This is evidenced by 
the fact that in contrast to MGF, no significant increase in IGF-IEa mRNA was observed 
after exercise in the young subjects and secondly, no association between the expression 
of the two mRNAs was observed.
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Independent expression patterns of IGF-IEa and MGF in response to exercise
Sensitivity of MGF to mechanical signals has been highlighted in animal studies where 
passive stretch (Yang et al. 1996), and to a greater extent stretch combined with 
electrical stimulation (McKoy et al. 1999), increases MGF mRNA expression in muscle. 
However, the effects of MGF mRNA levels on subsequent protein expression levels and 
the degree to which these levels affect muscle growth remain to be determined. Studies 
in animal muscle have also shown that IGF-IEa and MGF behave independently of each 
other in response to overload, and support the suggestion that MGF is a transient and 
activity sensitive growth factor (Yang et al. 1996; McKoy et al. 1999; Owino et al. 2001; 
Haddad and Adams, 2002; Cheema et al, unpublished observations). For example, the 
study by Owino et al (2001) in which the soleus and plantaris muscles of rats were 
overloaded using the technique of muscle tendon ablation, showed that IGF-IEa and 
MGF mRNAs responded differently to this challenge. Following 5 days of overload, 
MGF mRNA showed a marked increase in the overloaded muscles when compared to 
control, whereas IGF-IEa appeared relatively insensitive to the challenge. A more recent 
study which determined the effects of a single or two bouts of resistance exercise in rats, 
on the expression IGF-I and MGF mRNA, concluded that a single bout of resistance 
exercise stimulated a relatively rapid increase in MGF and, to a lesser extent that of IGF-
I. Two bouts of exercise resulted in sustained increases in MGF and IGF-I mRNAs that 
were more pronounced when the rest intervals were longer (Adams and Haddad, 2002). 
Work by Hill and Goldspink (2003) supported the idea of this quite independent 
expression pattern of the two isoforms, with MGF being upregulated as an initial 
response to injury, followed the upregulation and sustained expression of IGF-IEa. 
Furthermore, in vitro studies in differentiated myoblasts, which have been embedded in 
a collagen matrix have also shown that the two isoforms behave independently of one
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another after being subjected to varying degrees of strain (Cheema et al. unpublished 
observations). In contrast to animal muscle, this study has shown that there is a 
considerable degree of variation between individuals in the response to exercise, for 
example one young subject showed a particularly dramatic increase in MGF mRNA 
with exercise, whilst no change in IGF-IEa mRNA levels were seen (comparison of 
MGF vs IGF-IEa mRNA response in this subject RS is shown in Figure 3.8). The 
findings of the present study therefore support the notion that IGF-IEa and MGF are 
differentially regulated.
Expression of IGF-I and its isoforms in aged muscle
The muscles of older animals have been shown to recover less well from contraction- 
induced injury, when compared to young animals (Brooks and Faulkner, 1990; Faulkner 
et al. 1995). In these studies isometric force was used to characterise the force deficit 
obtained following a number of high force pliometric (eccentric contractions) in young 
and old mice. This is in accord with a recent report in which the muscles of old rats 
overloaded by synergistic muscle tendon ablation showed an attenuated MGF response 
(Owino et al.2001). In the young animals, MGF expression increased by -1000% after 
5 days of muscle overload as compared with only -250% for the 24 month old animals. 
The magnitude and duration of the challenge and likely local tissue damage caused is 
greater than that seen in the present study, but the data are in general agreement, with the 
older men in the present study not showing any significant increase in MGF mRNA 
levels after exercise. In the work by Faulkner and colleagues, the mice performed 
extensive eccentric (damaging) contractions, whereas subjects in the present study 
performed both eccentric and concentric contractions. The comparatively smaller 
magnitude of response observed in the present study is likely to be explained by the fact
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the overall challenge to the human muscles was not as severe as that given in the animal 
experiments. The effects of performing eccentric only exercise in humans, on the 
expression of these growth factors in muscle is described in the next chapter.
In a study investigating IGF-I peptide levels in human muscle following 10 weeks of 
strength training in old men and women (aged 72 -  98 years), it was shown that there 
was a -500% increase in the levels of IGF-I within the muscle fibres of these subjects 
after the training period, as determined using immunohistochemistry (Fiatarone-Singh et 
al. 1999). This demonstrates that IGF-I peptide levels are increased in older muscles as 
a result of longer-term exercise training. Indeed, the results of longitudinal strength 
training studies have confirmed that the muscles of even very elderly people are able to 
hypertrophy response to resistance exercise (Fiatarone et al. 1990; 1994; 1999; Harridge 
et al. 1999). The 12 weeks of training contrasts with the single exercise bout in the 
present study. This matter is explored later in Chapter V. Furthermore, in the study by 
Fiatarone-Singh et al (1999), the effects of exercise training on IGF-I peptide levels in 
young individuals were not investigated to determine if there was an age related 
difference in the muscle IGF-I response to exercise. In addition, the antibody used for 
immunohistochemical analysis was a general IGF-I antibody, which made no 
distinctions between the different isoforms of IGF-I. It was therefore not possible to 
determine the relative contributions of the different IGF-I isoforms to the increase seen 
in muscle mass in that study.
MyoD Expression in Aged and Exercised Muscle
Like IGF-IEa, MGF contains exons 3 and 4 which encode the signalling peptide. It is 
therefore likely to play a role in increasing protein synthesis but possibly not to the same
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oextent, as reflected by the lower expression levels of MGF (10' ng) when compared to 
IGF-IEa (10'6ng). There is some evidence that MGF may be involved in the initial 
activation of satellite cells, with the E domain of the protein thought to be responsible 
for this action. In this regard, recent cell culture studies on C2/C12 cells treated with 
either MGF or IGF-I peptides suggest that MGF may play a different role in the process 
of satellite cell activation to IGF-I. In this study, MGF was shown to initiate satellite 
cell proliferation, whilst IGF-I initiated proliferation but then also promoted their 
differentiation into myotubes (Yang and Goldspink, 2002). The early induction of MGF 
mRNA in muscle reported in the present study following exercise would support this 
idea. As detailed in Chapter I, satellite cells are small mononucleate muscle stem cells 
located between the sarcolema and basal lamina of muscle fibres. Recently, the link 
between satellite cell number and myofibre size has been demonstrated in both untrained 
and hypertrophied human muscle fibres (Kadi and Thomell. 2000). These cells, when 
activated, are believed to proliferate and differentiate into myoblasts which then fuse 
with existing fibres, thus providing new nuclei to maintain the DNA to protein ratios of 
fibres undergoing hypertrophy.
As the present study was concerned with the short-term response to exercise, the MRF 
MyoD was believed to be the most suitable marker of satellite cell activation following 
local injury to the muscle. This was based on findings that MyoD is the first and most 
abundantly expressed myogenic regulatory gene in activated satellite cells (Smith et al.
1993). Further studies in satellite primary cell culture found that MyoD mRNA 
increased before proliferation, whereas the appearance of myogenin mRNA appeared to 
coincide with the process of differentiation (Smith et al. 1994). A later study by 
Comelison and Wold (1997) analysed the expression of the MRF genes in cultures of
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mouse satellite cells prepared from isolated myofibres. In this in vitro study they 
concluded that activated satellite cells began by either expressing MyoD or myf5. A 
more recent in vivo study confirmed these findings, highlighting that MyoD was 
expressed by activated satellite cells as early as 3 hours after muscle damage (Cooper et 
al. 1999). Furthermore, MyoD has been reported to be a reliable marker of activated 
satellite cells (Koishi et al. 1995), as it has only been shown to be present in detectable 
amounts in proliferating but not quiescent satellite cells (Yablonka-Reuveni and Rivera,
1994). Since MyoD mRNA levels in the present study were measured in total RNA 
extracted from homogenised muscle samples, it was not possible to determine whether 
expression of this MRF was derived exclusively from satellite cells. Since MyoD 
expression is primarily thought to originate from satellite cells, this was believed to be 
highly likely. Nevertheless, the possibility that some of the MyoD mRNA measured may 
have originated from the muscle fibre nuclei cannot be excluded.
In agreement with previous observations, we report that baseline levels of the 
transcription factor MyoD are higher in the muscles of older individuals when compared 
with young (Musaro et al. 1995; Marsh et al. 1997; Owino et al. 2001). It is not fully 
understood why aged muscle should express elevated baseline levels of myogenic 
factors such as MyoD, although it has been suggested that it may reflect a continued 
attempt to maintain muscle specific expression and ameliorate muscle atrophy (Marsh et 
al. 1997). In the young subjects there was a tendency for an increased (~80%) 
expression of MyoD following exercise whilst in the old subjects MyoD values were 
essentially unchanged. The myogenic response to a single bout of weightlifting exercise 
has been shown to be impaired in old muscle (Tamaki et al. 2000). Muscles, which were 
sampled through out the post exercise period showed that MyoD mRNA levels were
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lower in older rats when compared to young. The results of the present study are in 
general agreement with this, although the shorter time point (2.5 hours) at which the 
samples were taken after exercise may have been insufficient time to allow for 
completion of the myogenic regulatory response to the exercise stimulus.
MyHC isoform expression in young and old muscle
The hypertrophic response to strength training exercise has been reported to be greater in 
type 2 fibres, which express the MyHC-2a and 2x isoforms (Tesch et al. 1985; Kadi et 
al. 1999; Aagaard et al. 2001; Andersen and Aagaard, 2001). The quadriceps muscles of 
the old subjects in the present study comprised a significantly lower proportion of 
MyHC-2 isoforms compared to the young subjects (Table 3.1). This is most likely a 
reflection of a selective atrophy of type 2 fibres (Klitgaard et al. 1990). It might be 
suggested that it is this pattern of expression, which accounts for the somewhat 
attenuated response of MGF to the exercise protocol in the older subjects. However, we 
observed no association between the change in MGF and the MyHC composition of the 
quadriceps muscle in either young or old individuals, or when both age groups were 
considered together. Despite this, it was interesting to find that the one young subject 
(RS) to express a detectable amount of MyHC-2x (33%) also showed the most marked 
MGF response (864% increase) to the exercise challenge (black line in Figures 3.6). The 
MyHC-2x isoform is particularly expressed in muscles that have been subject to disuse 
(Andersen & Aagaard, 2000 Andersen et al. 1996, Harridge et al. 2002). This particular 
subject, whilst not completely inactive (1 game of football per week) was the least active 
of all the subjects. It might be speculated that the large increase in MGF mRNA relates 
to either an isoform specific (i.e. MyHC-2x) response, or a sensitivity to overload, which 
may reflect the training status of the muscle. Had all the subjects in our study been
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relatively inactive, we may have found a relationship between MyHC-2x expression and 
MGF. In general, those individuals who are unaccustomed to exercise suffer from 
muscle soreness / damage more so than those who are more active. There would 
therefore be less muscle damage as a result of exercise and possibly an attenuated MGF 
response in these more trained individuals. This is in general agreement with the results 
of a recent study by Tipton et al (1999), which showed that protein synthesis rates were 
reduced in trained subjects when compared with untrained subjects, following a single 
bout of eccentric weightlifting exercise. Both these data, and the data from the present 
study would therefore suggest that trained muscle is in someway less sensitive to the 
mechanical signals provided by exercise. It would be of interest to study the responses 
of these muscle IGF-I isoforms in trained vs non-trained individuals, to establish 
whether the training status of muscle affects the extent of the response.
Conclusion
This study reports the expression of two splice variants of the IGF-I gene present in 
human skeletal muscle: IGF-IEa, the main isoform expressed hepatically and MGF, an 
activity sensitive local growth / repair factor. In young subjects, the splicing of these 
isoforms appears to differ in response to a single bout of high resistance weightlifting 
exercise, with MGF being upregulated and the IGF-IEa isoform remaining unchanged. 
The magnitude of the response does not appear to be related to MyHC composition, but 
may be related to the underlying training status of the muscle. In contrast to the young 
subjects, older subjects who performed the same relative intensity of exercise showed a 
tendency for an attenuated MGF response, which would be in agreement with recently 
reported animal studies. The type of exercise undertaken in the present study, if 
performed regularly, promotes muscle growth. Whether the MGF response to overload
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is selective to the eccentric or lengthening component of the exercise, which is 
associated with muscle damage, remains to be determined. This question is addressed, in 
part, in the next chapter, in which the MGF response after an acute bout of eccentric 
only cycling exercise was investigated in young and old individuals.
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Chapter 4
Expression of IGF-I splice variants in young and old human 
skeletal muscle after a single bout of eccentric cycling 
exercise
148
4.1 Introduction
Conventional resistance exercise i.e. lifting and lowering of a weight either ‘free’ or 
in the confines of a piece of apparatus, usually comprises a combination of 
concentric and eccentric contractions. However, as mentioned in Chapter 3, the 
mechanisms by which resistance training induces myofibre hypertrophy are still not 
fully understood, but may relate in part to the micro-damage caused by the eccentric 
component of the exercise. During a concentric contraction, the muscle produces 
tension while shortening, whereas during an eccentric contraction (also termed 
lengthening, stretching or pliometric contractions) a contracting muscle is forced to 
lengthen whilst producing force. The force generated during an eccentric contraction 
is greater than that of a concentric contraction. High intensity eccentric exercise in 
untrained subjects is associated with increased levels of myofibre enzymes in 
plasma, ultrastructural damage of the muscle fibres and an acute inflammatory 
response in the muscle leading to oedema, infiltration of inflammatory cells and 
muscle soreness (Evans et al. 1986). For example, a number of studies to date have 
demonstrated that eccentric exercise results in an increase in serum creatine kinase 
(CK) levels 24-48 hours after the exercise bout, which may persist for 3-6 days 
(Manfredi et al. 1991; Bruunsgaard et al. 1997). Changes in muscle ultrastructure, 
such as sarcolemmal disruption, swelling or disruption of the sarcotubular system, 
distortion of the myofibrils’ contractile components, cytoskeletal damage and 
abnormalities to the extracellular myofibre matrix, have also been reported in both 
animal (Armstrong et al. 1983; McCully and Faulkner, 1985; Lieber and Friden 
1988) and human (Newham et al. 1983; Friden et al. 1983; Friden et al. 1984) 
models following eccentric contractions. Recent work by Yu et al, (2004) suggests 
that many of the signs which are associated with muscle damage are in fact the
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hypertrophic invasion of satellite cells into undamaged muscle cells. This is 
interesting, as it conflicts somewhat with the current dogma that exercise which 
causes hypertrophy is preceded by muscle damage. The inflammatory response to 
strenuous exercise has also been extensively studied. During eccentric exercise, 
myofibres are mechanically damaged and this process stimulates the local production 
of inflammatory cytokines such as tumour necrosis a  (TNF- a), interleukin (IL)l/3, 
IL-6 and IL-1 receptor agonist (IL-lra) (reviewed by Pedersen et al. 1998). Whether 
these events are causally related to the growth response remains unknown; however, 
hypertrophy is blunted if the eccentric component is omitted from conventional 
resistance training (Hather et al. 1991). In the study by Hather et al (1991) a 
combination of concentric/eccentric training induced hypertrophy in both type 1 and 
type 2 muscle fibres, whereas there was no hypertrophy of the type 1 fibres, and a 
reduced response in type 2 fibres after concentric only exercise. Thus indicating that 
the eccentric component of exercise was necessary for maximising the hypertrophy 
response.
As has been extensively discussed, IGF-I is believed to play a significant role in this 
hypertrophic adaptation of muscle to exercise; yet the number of studies conducted 
to date which examine the muscle IGF-I response to resistance exercise in human 
muscle are limited. Furthermore, human studies, which have investigated the effects 
of concentric vs eccentric contractions and muscle IGF-I expression, are even less 
well documented. One such study by Bamman et al (2000) investigated the effects of 
concentric vs eccentric loading on muscle IGF-I mRNA concentration. This study 
found that IGF-I mRNA levels were significantly elevated after eccentric but not
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concentric exercise. Thus suggesting that IGF-I mRNA in the muscle was more 
sensitive to the eccentric component of exercise.
The study described in Chapter 3 utilised a high resistance knee extensor exercise 
protocol, which comprised a combination of both the concentric and eccentric 
contractions. Briefly, this study described a significant increase (ranging from 2%- 
864%) in MGF mRNA in the muscles of young individuals, but no significant 
increase in the older subjects in the short term after exercise. Eccentric differs from 
concentric exercise in that it uses less ATP per unit force generated, and is therefore 
less metabolically demanding. However, eccentric exercise also results in a higher 
degree of muscle soreness following the exercise bout, as discussed, and there is 
evidence that this is due to a greater amount of muscle fibre damage. It would 
therefore be of interest to determine whether carrying out eccentric only exercise 
elicits a significant MGF response in older muscle given that MGF production is 
thought to be both mechano-sensitive and extremely sensitive to damage (Hill and 
Goldspink, 2003).
The main aims of this study were:
(i) To determine the IGF-IEa and MGF mRNA responses after a single bout 
of eccentric cycling exercise.
(ii) To determine whether the response in elderly individuals differs to that 
observed in young subjects.
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4.2 Methods and Materials
This study was carried out in collaboration with Professor Bente Klarlund Pedersen, 
Department of Infectious Diseases, Copenhagen Muscle Research Centre, 
Rigshospitalet, Copenhagen, Denmark, as a part of a European collaborative project, 
the Pan European Network into Ageing Muscle (PENAM). The amount of tissue 
available for analysis was limited. The MGF and IGF-IEa mRNA data presented in 
this chapter therefore relates to fewer subjects than those investigated in the original 
study by Toft et al. 2002. Subject recruitment, exercise training, and muscle 
sampling procedures were carried out in their laboratory. Any data generated in their 
laboratory is clearly indicated and has been reproduced with their permission.
Subjects
10 healthy young (age 20-27 years, height 176-187 cm, weight 72-89 kg) and 10 
healthy elderly (age 67-75 years, height 172-191 cm, weight 70-89 kg) subjects 
participated in this study. Subjects were not specifically trained but they were 
recreationally active, performing exercise 1-3 days per week for 1-2 hours. Before 
inclusion subjects were screened for systemic disorders by blood sample analysis and 
physical examination. All elderly subjects underwent an electrocardiogram (ECG) 
and were screened for arthrosis of lower limb joints by X-ray and physical 
examination. Informed consent was obtained from all subjects, and studies were 
performed in accordance with the Declaration of Helsinki. The experimental protocol 
was approved by the local ethics committee for Copenhagen and Frederiksberg 
Communities, Denmark.
152
Study Design
2 weeks before the experimental day, maximal oxygen uptake (VO2 m ax), maximal 
heart rate, and maximal concentric workload were determined during an incremental 
concentric exercise test on the same cycle ergometer as used for the eccentric 
exercise (Figure 4.1). A concentric exercise protocol was used in this test so as to 
avoid causing any muscle damage. Values for muscle mass, VO2 max, maximal heart 
rate, and maximal concentric workload in young and old subjects are given in Table 
4.1.
Young Old
Muscle mass, 2 legs (kg) 17.3 (15.6-18.3) 20.9 (18.8-22.2)
V 0 2 max (ml.kg'Vmin'1) 56.1 (37.4-64.1) 29.3 (19.3-33.7)
Max HR concentric (beats/min) 186(175-198) 155 (132-167)
Concentric workload at V 02 ^  (W) 265 (230-366) 119(94-214)
Table 4.1 Subject values for muscle mass, V 02 max, maximal heart rate, and maximal 
concentric workload. Values are medians and ranges are given in parentheses. 
Abbreviations: HR -  heart rate, V 02 max -  maximal 0 2 uptake. (Toft et al. 2002)
Eccentric Exercise Protocol
The eccentric exercise consisted of 60 minutes of opposing the rotation of the pedals 
down to 60 rpm. Subjects performed the following program of six working intervals: 
0-6 minutes at 50%, 6-12 minutes at 75%, 12-20 minutes at 100%, 20-25 minutes at 
130%, 25-40 minutes at 100%, and 40-60 minutes at 75% of the load eliciting 
concentric VO2 max, as described by Bruunsgaard et al (1997). The workloads were 
chosen to give the same relative increases in VO2 max and heart rate. An example of 
the cycle ergometer used for this type of exercise is shown in Figure 4.1.
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Experimental Protocol
Subjects were asked to refrain from any strenuous exercise for 7 days before the 
experimental day. On the study day, subjects reported to the laboratory after an 
overnight fast. After resting for 10 minutes on the cycle ergometer, subjects 
performed the eccentric exercise program. ECG and heart rate were continuously 
monitored throughout the exercise. VO2 was recorded after 30 minutes (during a 
steady state period o f  100% of the load eliciting concentric VO2 max), and workload 
was noted continuously. After completion o f the exercise, subjects rested and were 
provided with carbohydrate-rich food and drinks for 4 hours after the exercise. 
Subjects were advised to refrain from any strenuous physical activity for 5 days after 
the exercise.
Figure 4.1. An elderly subject performing eccentric ‘reverse pedal cycling’ exercise, while 
continuously monitoring heart rate and 0 2 consumption.
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Muscle Biopsies
Following local anaesthesia (1% lignocaine), muscle biopsies were taken from the 
vastus lateralis muscle before exercise, then 2% hours after the end of the exercise 
bout. Samples were immediately frozen and stored at -70°C.
RNA Extraction
Total RNA was extracted from the muscle samples using Tri Reagent (Sigma) and 
the quality of the RNA was assessed as described in Chapter 2, Methods and 
Materials.
First strand cDNA synthesis
0.5pg total RNA was reverse transcribed into cDNA as described in Chapter 2, Methods 
and Materials.
Real Time Quantitative PCR
Quantification of the mRNA message encoding the isoforms IGF-IEa and IGF-IEc 
(MGF) was performed using LightCycler technology (Roche Diagnostics) with SYBR 
green I as the method of detection as described earlier in Chapter 2, Methods and 
Materials. The sequences of the primers used are given in Table 2.4 in Chapter 2. 
Quantitative PCR runs were performed in duplicate and mean values were subsequently 
used for analysis.
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Gel Electrophoresis
PCR products were recovered from the glass capillaries by removing the plastic caps and 
inverting them into a 1.5ml eppendorf tube, which were then spun down in a bench top 
centrifuge at no higher than 3000 rpm. Target specificity was further confirmed by 
running these samples on a 2% agarose gel as described in Chapter 2, Methods and 
Materials.
Creatine Kinase
Blood samples were obtained pre exercise then 2 hours after the end of exercise from 
the antecubital vein. Levels of CK were measured in lithium heparinized plasma with 
automated enzyme reactions (Hitachi Systems 717: Boehringer Manheim 
Diagnostica, Germany). Details of this method are given in Toft et al. 2002.
Statistical Analysis
Data are given as means ±SE. Comparisons between paired and unpaired data were 
made using the Wilcoxon’s signed rank test and the Mann Whitney test respectively.
CK data were analysed using a paired t-test. The level of statistical significance was 
taken as P<0.05.
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4.3 Results
Serum creatine kinase levels in young and old subjects after the exercise
The mean (+SE) values for serum creatine kinase before exercise were 157.2±33.5 
U/l and 113.3±19.6 U/l in young and old subjects respectively. These levels were 
significantly elevated to 506.5±71 U/l and 149.6±22.4 U/l in the 2 hours post 
exercise samples in young and old subjects.
Control 
|  Exercised
Young
Figure 4.2. Mean levels o f  creatine kinase in young and old subjects. Values are expressed 
in U  /1  (+SEM). * Significant difference from before exercise (Control) (P<0.05). Data 
reproduced by kind permission o f Dr Anders Toft.
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Expression of IGF-I isoforms after eccentric cycling exercise 
MGF
Levels of MGF mRNA are shown in Figure 4.3. Before exercise, MGF mRNA levels
o
averaged 9.9 10" ng in the young subjects. This was not different to the elderly subjects. 
In both young and old subjects, significantly higher levels of MGF mRNA were 
observed in samples obtained 2.25 hours after the end of exercise when compared with 
the before exercise samples.
IGF-IEa
The levels of IGF-IEa mRNA are shown in Figure 4.4. IGF-IEa values were higher 
than that of MGF by 2-3 orders of magnitude. (10"5ng vs 10"8ng). As with MGF, 
levels of IGF-IEa before exercise were not significantly different between the young 
and old subjects. However, in contrast to MGF, there was no significant change in 
IGF-IEa expression observed in either the young or the older individuals as a result 
of the exercise challenge.
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Figure 4.3. Individual MGF mRNA levels in young (n=9) and old (n=8) subjects in the 
control (Ctrl) and exercised (Ex) muscles. Values are expressed as ng of mRNA per /ig total 
RNA. * Significant increase in MGF mRNA 2lA hours after the end of exercise in both 
young and old subjects (P<0.05).
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Figure 4.4. Individual IGF-IEa mRNA levels in young (n=8) and old (n=10) subjects in the 
control (Ctrl) and exercised (Ex) muscles. Values are expressed as ng of mRNA per fxg total 
RNA. Colours reflect same subjects in Figure 4.3.
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4.4 Discussion
This study has shown that levels of MGF mRNA increase in both young and old 
individuals in the short term following a single bout of eccentric exercise. The type 
of exercise performed in the present study induced a large degree of muscle soreness 
and damage, as indicated by the elevated levels of serum CK in the post exercise 
samples. However, with this prolonged protocol (i.e. lasted one hour) the absolute 
forces generated were not as high as those that can be obtained with conventional 
resistance training, and might therefore not result in muscle hypertrophy. Similar to 
the study in Chapter 3, mRNA levels of IGF-IEa showed no significant change with 
eccentric only exercise in either age group. Thus supporting the hypothesis that both 
isoforms are differentially regulated.
IGF-I expression after muscle damaging exercise
In a study of young military recruits, Hellsten et al (1996) reported increased 
numbers of IGF-I immunoreactive capillaries and satellite cells in the vastus lateralis 
muscle after 7 days of intense military training, that included 150 km of terrain 
marching carrying a 30 kg load (gear). In this study, the increased IGF-I staining was 
also accompanied by a six-fold increase in serum CK activity. Thus indicating that 
there was a large degree of muscle damage as a result of the exercise undertaken. 
Studies investigating the muscle IGF-I response following concentric vs eccentric 
training in human muscle are rare. One such study by Bamman et al (2000) used leg 
squatting exercise with resistance to concentrically or eccentrically train the 
quadriceps muscles in young subjects, before determining their muscle IGF-I 
response 48 hours after the end of exercise. Subjects performed 8 sets of 8 repetitions 
with resistance at 85% and 110% of their 1-RM for the concentric and eccentric
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exercise protocols, respectively. Mean levels of IGF-I mRNA increased after both 
concentric and eccentric loading. However, it was only after eccentric loading that 
IGF-I mRNA levels were significantly increased from baseline (-62%). Thereby 
suggesting that overall IGF-I mRNA in muscle was more sensitive to the eccentric 
component of exercise. The method used for measuring levels of IGF-I mRNA in 
this study was not strictly quantitative, and was described by the authors as a 
qualitative RT-PCR method. It involved performing conventional RT-PCR, then 
running the PCR products on a Southern gel and measuring the band densities using 
densitometry. For standardisation, data was normalised to GAPDH. As discussed in 
Chapter 2, when normalising to a control gene, the first thing that needs to be 
determined is whether the chosen gene is affected in any way by the experimental 
treatment and also if its expression levels are similar to those of the mRNA being 
studied. Because no trustworthy control gene exists within muscle tissue, attempts to 
validate the chosen control should always be performed to ensure that it does not 
change with the particular intervention being studied (Schjerling, 2001). Otherwise 
normalisation to total RNA has been suggested to be the most reliable method, 
particularly in human muscle biopsy samples (Tricarico et al. 2002). Bamman et al 
do not describe any experiments performed to validate the use of GAPDH as a 
control gene. Furthermore, the primers used for detection of IGF-I in that study were 
general primers that did not differentiate between the different isoforms.
The much larger increase observed in levels of MGF mRNA after eccentric exercise 
in the present study (-186% from baseline in young subjects) can possibly be 
explained by different time points at which the biopsies were taken. Samples were 
taken in the short term following exercise in the present study, whereas in the study
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by Bamman et al samples were taken 48 hours after the end of exercise. The varied 
responses could also possibly be explained by the different exercise protocols 
performed by the subjects in both studies. In the present study one hour of eccentric 
cycling exercise induced severe muscle damage and soreness, but the absolute forces 
generated would have been much lower compared with the heavy resistance type 
eccentric exercise performed in the study by Bamman et al, which is known to result 
in hypertrophy. Thus it is difficult to strictly compare the two exercise modes 
directly as the exercise used in the present study could probably be described as a 
severe muscle damaging protocol as opposed to a more ‘hypertrophic’ protocol in the 
study by Bamman et al.
The optimum time point for an acute post-exercise elevation in muscle IGF-I is 
unknown. However, the smaller response observed in this study could also, in part, 
be attributed to the previously reported speed with which MGF mRNA increased in 
response to exercise, also evidenced by the study in Chapter 3. It is therefore possible 
that the MGF response had peaked soon after exercise and was beginning to diminish 
by 48 hours. Furthermore, the present study made no comparison with the IGF-I 
mRNA response following a comparable bout of concentric exercise.
Several studies have indicated that older animals are more susceptible to acute 
eccentric exercise-induced muscle damage than are young animals (Brooks and 
Faulkner, 1990; McBride et al. 1995), whereas the results from studies in human 
muscle are less clear. For example, Manfredi et al (1991) reported that following an 
acute bout of eccentric exercise designed to elicit muscle damage; older men had 
higher levels of muscle damage than compared with younger men. In this study,
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>90% of muscle fibres from the older subjects exhibited muscle damage. This was 
compared with 5-50% damaged muscle fibres reported in a study of young subjects 
after a similar exercise protocol (O’Reilly et al. 1987). More recent electron 
micrography studies, assessing ultrastructural muscle damage in young and old 
individuals have reported a higher degree of muscle damage in elderly women when 
compared with young women, after a 9 week period of heavy resistance strength 
training (Roth et al. 2000). Interestingly however, a similar study by the same group 
comparing muscle damage in young vs old men concluded that both young and older 
men exhibited a similar increase in muscle damage after 9 weeks of heavy resistance 
strength training (Roth et al. 1999).
CK is an intramuscular enzyme responsible for maintaining adequate ATP levels 
during muscle contraction. Increased serum CK levels following periods of activity 
are indicative of an increased permeability or breakdown of the membrane 
surrounding the muscle cell. The severity of muscle damage caused by the exercise 
in the present study was reflected by the increased levels of serum CK in both young 
and old individuals 2 hours after the end of the eccentric cycling exercise bout. 
However, despite showing an increase, the CK response was somewhat blunted in 
the older subjects when compared with the young. This cannot be explained with 
certainty, given that some of the elderly subjects required hospitalisation due to the 
severity of muscle soreness experienced in the days following the exercise (personal 
communication Bente Klarlund Pedersen). The high degree of muscle damage 
caused in the present study coupled together with the increase in MGF mRNA 
observed in both young and old individuals after exercise, would suggest that MGF
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activity is somehow linked to the mechanisms involved in tissue regeneration and 
repair after mechanical damage.
Conclusion
This study has shown that eccentric cycling exercise increases the expression of 
MGF mRNA in young, but also older individuals in the short term after exercise. It 
has also confirmed the finding in Chapter 3 that the two isoforms, IGF-IEa and 
MGF, are differentially regulated in human muscle in response to exercise. The type 
of exercise undertaken in the present study induced severe muscle damage. This 
resulted in a significant (32%, P<0.05) increase in MGF mRNA in the old subjects. 
In contrast, a lower (14%, not significant) increase was observed after the 
weightlifting exercise. This might suggest that myofibrillar disruption and/or 
sarcolemmal damage caused by eccentric exercise may play a role in activating MGF 
expression in older muscle.
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Chapter 5
The effect of recombinant human growth hormone (GH) and 
resistance training on IGF-I mRNA expression in the muscles 
of elderly men
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5.1 Introduction
Circulating IGF-I is predominantly liver derived and is produced in response to 
growth hormone (GH) secretion from the anterior pituitary, with its primary role 
believed to be in promoting the differentiation and growth of skeletal muscle during 
development (Daughaday et al. 1986; reviewed by Cohick and Clemmons, 1993). It 
is now a generally accepted phenomena that liver derived circulating IGF-I is not 
essential for normal postnatal body growth (Yakar et al. 1999; Sjogren et al. 1999) 
and that the modified somatomedin hypothesis (Chapter 1), whereby GH promotes 
postnatal body growth mainly through the local production of IGF-I in non-hepatic 
tissues such as muscle, is largely responsible for muscle growth in adulthood.
Studies have shown that local IGF-I synthesis may be partially GH-dependent in 
some IGF responsive tissues (Isaksson et al. 1982; 1987). Much of the work carried 
out to date studying the effects of GH regulation of IGF-I gene expression in skeletal 
muscle has predominantly been in rodent muscle. In vivo studies have shown that 
injection of GH leads to increased levels of IGF-I mRNA in rat skeletal muscle 
(Isgaard et al. 1988; 1989; Gosteli-Peter et al. 1994). In support of the idea of a 
direct effect of GH on skeletal muscle, increases in the tyrosine phosphorylation of 
the cytoplasmic tyrosine kinase Janus kinase-2 (JAK2), signal transducer and 
activator of transcriptions factor-5 (Stat5), insulin receptor substrates 1 and 2 (IRS-1 
and IRS-2) and SHC have been observed in rat skeletal muscle within 5 minutes of 
GH injection (Chow et al. 1996; Thirone et al. 1999). Furthermore, there is evidence 
of a GH-dependent change in chromatin structure of the rat IGF-I gene. The 
emergence of this GH-inducible deoxyribonuclease-I (DNase-I)-hypersensitivity site 
(HS), which is located within the second intron of the IGF-I gene, supports the idea
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of an enhanced IGF-I gene transcription by GH (Rotwein et al. 1993; Thomas et al.
1995). However, it is still not clear whether GH acts directly on human skeletal 
muscle to stimulate growth through expression of IGF-I, despite there being evidence 
to suggest that human skeletal muscle expresses the different isoforms of the GH 
receptor (Martini et al. 1995; Ballesteros et al. 2000). Furthermore, the extent to 
which GH regulates the different IGF-I isoforms in human skeletal muscle has yet to 
be determined.
Characteristically, with increasing age there is a loss of muscle mass and strength, as 
well as a gradual decline in circulating GH levels (Rudman et al. 1981). There are 
reports that GH administration increases fat free mass and decreases fat mass in 
elderly individuals (Rudman et al. 1990; Holloway et al. 1994; Yarasheski et al. 
1995; Lange et al. 2000). However, its effects in further augmenting the strength 
gains seen with resistance training alone are still a matter of much debate. So far, 
there have been a limited number of animal (Andersen et al. 2000) and human 
(Welle et al. 1996) studies that have shown an additional effect of GH 
supplementation compared with just training. Exercise has been shown to influence 
both circulating (Brahm et al. 1997) and muscle IGF-I expression levels as evidenced 
by the studies in the two previous chapters. It is also known that the muscles of even 
very elderly individuals can hypertrophy in response to resistance training (Fiatarone 
et al. 1990; 1994; 1999; Harridge et al. 1999), but the coupling to local growth factor 
expression still remains to be determined. The present study was therefore conducted 
to study the effects of GH and resistance training on local growth factor expression 
in the muscles of elderly subjects.
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The main aims of this study were:
(i) To determine which isoforms of IGF-I in muscle are influenced by GH.
(ii) To see how GH administration might interact with mechanical signals 
provided by high resistance exercise in elderly individuals.
(iii) To determine the extent to which the mRNA of the different isoforms of IGF- 
I could be upregulated in elderly people in response to a period of strength 
training, with the addition of studying the effects of exercise training on an, 
as yet little studied, IGF-I isoform (IGF-LEb).
To achieve these aims, muscle samples were studied which had been obtained from 3 
groups of elderly men who had either i) received daily injections of recombinant human 
GH ii) had in addition to receiving GH, undertaken 12 weeks of resistance training or iii) 
undertaken 12 weeks of resistance training without receiving GH injections (placebo).
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5.2 Methods and Materials
This study was carried out in collaboration with Professor Michael Kjaer’s group at 
the Sports Medicine Research Unit, Bispebjerg Hospital, Copenhagen, Denmark. All 
subject recruitment, training, GH administration and muscle sampling procedures 
were carried out in their laboratory and are reported in Lange et al (2002). Any data 
generated in their laboratory is clearly indicated and has been reproduced with their 
permission.
Subjects
31 healthy male subjects participated in the original study reported by Lange et al 
(2002). However, for the present study tissue was available for 19 of these subjects. 
The original study also included a placebo only group from whom muscle biopsies 
were not obtained.
19 healthy, elderly male subjects participated in the study; age 74 ± 1 year (70-82) 
[mean ± SEM (range)]; height, 174 ± 1cm (163-186); body weight, 80.8 ± 1.8kg 
(63.1-100.3); body mass index, 26.7 ± 0.5kg m'2 (20.9-32.8); body fat mass, 22.9 ± 
1.2kg (10.9-38.9), body fat percentage 28.0 ± 1.0% (14.9-40.0). Before inclusion, 
each subject underwent a medical evaluation, including medical history, physical 
examination, routine blood tests, and an exercise electrocardiogram. Exclusion 
criteria were metabolic, cardiac and malignant disease, anaemia, hormonal 
replacement therapy, and medication with a  or /3 blockers. Informed consent was 
obtained from all subjects and procedures were performed according to the 
Declaration of Helsinki n. The study was approved by the Ethics Committee for 
Medical Research in Copenhagen and by the Danish National Board of Health.
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Study design
Subjects were assigned to either resistance training (3 sessions / week, 3-5 sets of 8- 
12 repetition maximum per session) with placebo (RT group, n=6), resistance 
training combined with rhGH administration (RT + GH group, n=6) or rhGH alone 
(GH group, n=7) in a randomised, placebo-controlled and double-blinded 
experimental design.
Administration of recombinant human GH
Recombinant human GH or placebo (GH - Norditropin PenSet 24; placebo - 
Norditropin PenSet 24 Placebo; both from Novo Nordisk, Denmark) was 
administered daily through subcutaneous injection in the thigh. After careful 
instruction subjects were able to self-administer either GH or placebo at home in the 
evening. The dose of GH administered was 0.5 IUm'2 rising to 1.5 IUm'2. Subjects 
were weighed, checked for oedema and questioned about side effects on a weekly 
basis. If any side effects were apparent, the dose of GH was reduced by 50% until the 
side effects had disappeared or were deemed acceptable by both the subject and the 
investigator.
IGF-I
Blood was sampled at baseline and after 12 weeks from the antecubital vein into 
sealed vials without any additives. The blood was allowed to clot for 15 minutes at 
room temperature and was then centrifuged for 15 minutes at 4°C. The resulting 
serum was stored at -80°C until further analysis. Circulating total IGF-I levels were 
measured using Radio Immuno Assay (RIA) as described by Juul et al. 1994).
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Briefly, serum was extracted by acid ethanol and was cryoprecipitated prior to 
analysis to remove any interfering binding proteins.
Muscle cross sectional area
Magnetic resonance imaging (MRI) measurements were made at baseline and after 
12 weeks. 2D Tl-weighted fast field echo (TR/TE, 500/14 ms; FOV180; matrix 512 
x 512; slice thickness, 6 mm) MR images (Philips, Gryoscan ACS-NT 1.5 T, Best, 
Holland) were obtained at a level positioned two thirds proximal along an axis 
connecting a fix point at the tibial eminentia intercondylaris with a fix point at the 
femoral trochanter major. The rectus femoris, vastus lateralis, vastus intermedius, 
and vastus medialis were identified and their circumference and cross sectional area 
(CSA) were determined. Total quadriceps CSA was calculated by adding the area of 
the four individual muscle groups together. An estimate of subcutaneous fat CSA 
was determined by subtracting the leg CSA within the muscle fascia from total leg 
CSA.
Muscle Biopsies
Following local anaesthesia of the overlying skin (1% lidocaine), muscle biopsies 
were obtained from the right vastus lateralis muscle at baseline, 5 weeks and 12 
weeks. In the two training groups biopsy samples were obtained 24h after completion 
of the last training session. Samples were immediately frozen in liquid nitrogen and 
stored at -70°C.
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RNA extraction
Total RNA was extracted from the muscle samples using Tri Reagent (Sigma) and 
the quality of the RNA was assessed as described in Chapter 2, Methods and 
Materials.
First strand cDNA synthesis
0.5 jig total RNA was reverse transcribed into cDNA as described in Chapter 2, Methods 
and Materials.
Real time quantitative PCR
Quantification of the mRNA message encoding the two isoforms IGF-IEa and IGF-IEc 
(MGF) and a third isoform IGF-EEb (details of optimisation given below) was performed 
using LightCycler technology (Roche Diagnostics) with SYBR green I as the method of 
detection as described in detail in Chapter 2, Methods and Materials. The sequences of 
the primers used are given in Table 2.4 in chapter 2. Quantitative PCR runs were 
performed in duplicate and mean values were subsequently used for analysis.
To ensure unbiased analysis, real time quantitative PCR was carried out blind and the 
identity of the samples was only revealed after the mRNA measurements had been 
made.
Gel electrophoresis
PCR products were recovered from the glass capillaries by removing the plastic caps and 
inverting them into a 1.5ml eppendorf tube, which were then spun down in a bench top 
centrifuge at no higher than 3000 rpm. Target specificity was further confirmed by
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running these samples on a 2% agarose gel as described in Chapter 2, Methods and 
Materials.
Optimisation of IGF-IEb
Expression levels of a third isoform of the IGF-I gene were also investigated in the 
present study. Primers suitable for use on the LightCycler system were designed from 
the human mRNA sequence of IGF-IEb. Both accession numbers and primer sequences 
are given in Tables 2.3 and 2.4 in Chapter 2. Quantification of mRNA encoding this 
isoform in muscle biopsy samples was optimised using the QuantiTect chemistries 
(Qiagen, UK), given that this was the first time that IGF-IEb was being investigated in 
human muscle. The optimisation strategies described in Chapter 2 were used to ensure 
amplification of a specific product with no interfering primer dimer. PCR products from 
initial runs were run on an agarose gel, gel extracted, DNA purified and sent off for 
DNA sequence analysis to ensure specificity of the amplification. The methods for these 
procedures are described in Chapter 2, Methods and Materials. The melting curve profile 
of a fully optimised IGF-IEb run is shown in Figure 5.1. Due to a shortage of material, 
measurements of IGF-IEb mRNA were only made in the group that carried out 
resistance training only.
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Figure 5.1. Fully optimised run for IGF-IEb using Qiagen QuantiTect chemistry.
Statistical analysis
Data are presented as means +SEM. ANOVA followed by the Student-Newman- 
Keuls post hoc test was used to determine whether MGF and IGF-IEa expression 
levels were significantly different between the RT only, RT+GH and GH only groups 
and also within groups at each time point studied. Statistical significance was 
accepted at the P<0.05 level. Linear regression studies were used to describe the 
relationship between levels o f MGF mRNA and muscle CSA at baseline and 
between levels o f serum total IGF-I and IGF-IEa mRNA and MGF mRNA in 
muscle.
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5.3 Results
Absolute values of IGF-IEa and MGF mRNA
Baseline levels o f both IGF-IEa and MGF mRNA in the group that received GH 
treatment alone were found to be significantly higher than baseline levels for these 
isoforms in the other two treatment groups. These values have been highlighted in 
blue in Table 5.1. For the purpose o f  clarity, the data has been analysed and 
discussed as a percentage change from baseline after 5 and then 12 weeks o f 
treatment.
IGF-IEa Baseline 5 weeks 12 weeks
RT
RT+GH
GH
5.3 ± 0 .7 a 
6.1 ± 0 .9 a 
10.5 ± 1.5
9.4 ± 1.9 Ta 
15.3 ± 2.5 ta  
34.7 ± 7.4 f
10.2 ± 1.0 Ta 
14.8 ± 2 .8 +a 
23.1 ± 2 .2
MGF Baseline 5 weeks 12 weeks
RT
RT+GH
GH
1.7 ± 0.2 a 
2.2 ± 0.5 a 
4.9 ± 1.2
4.7 ± 1.1 Tb 
10.1 ± 1.3 f
5.8 ± 1.2 b
4.1 ± 0 .4  +
7.8 ± 1.3 f
7.8 ± 1.6
Table 5.1 Mean values of IGF-IEa and MGF mRNA at baseline, after 5 weeks and after 12 
weeks of RT, RT+GH or GH administration alone. Data are expressed as ng of single 
stranded (ss) PCR product / jug total RNA. Levels of expression for IGF-IEa are 10'5 ng and 
for MGF, 10'8 ng .f Significant difference from baseline, * from 5 weeks (p<0.05). 
a Significant difference from GH,b from RT+GH at given time point (p<0.05)
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Effect of GH administration on IGF-IEa and MGF mRNA
GH administration alone was shown to have a marked effect on IGF-IEa mRNA 
levels. This isoform was increased by 237% (p<0.05) after 5 weeks o f GH treatment 
and remained elevated from baseline after 12 weeks. In contrast, levels o f MGF 
mRNA showed very little change after 5 weeks o f GH administration but showed a 
significant increase from both the baseline (80%, P<0.05) and the 5 week time point 
after 12 weeks, although this was still to a much lesser degree than the change 
observed in levels o f IGF-IEa.
GH only
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Figure 5.2. % Change from baseline in IGF-IEa and MGF mRNA levels in the GH group. 
Values are +SEM: n=7. * Significant difference from baseline # from 5 weeks (P<0.05). + 
Significant difference in % change between isoforms (P<0.05).
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Effect of resistance training on IGF-IEa and MGF mRNA
After 5 weeks o f  resistance training (RT group), both IGF-IEa (68%) and MGF 
(163%) transcripts were significantly elevated when compared to baseline. 
Interestingly however, the change in levels o f MGF mRNA at this time point was 
significantly greater than the change in IGF-IEa. mRNA levels o f both MGF and 
IGF-IEa remained significantly elevated from baseline after 12 weeks, but there were 
no further significant changes observed at this time point.
■  5  w e e k s
■  12  w e e k s
Figure 5.3. % Change from baseline in IGF-IEa and MGF mRNA levels in the RT group. 
Values are +SEM: n=6. * Significant difference from baseline.f Significant difference in % 
change between isoforms (P<0.05).
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Effect of resistance training and GH on IGF-IEa and MGF mRNA
In the group where resistance training was combined with GH administration 
(RT+GH group), substantially greater increases in both IGF-IEa (167%) and MGF 
mRNA expression (456%) were observed at the 5-week time point compared with 
the group that carried out training alone. Again, there were no further significant 
changes seen after 12 weeks. Furthermore, when GH administration was combined 
with resistance training, the change in MGF mRNA levels was greater than the 
change in IGF-IEa mRNA, although the difference did not quite reach significance 
(PO .066).
RT+GH
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■  5  w e e k s
■  1 2  w e e k s
IGF-IEa MGF
Figure 5.4. % Change from baseline in IGF-IEa and MGF mRNA levels in RT+GH group. 
Values are +SEM: n=6. * Significant difference from baseline.
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Comparison between treatment groups
Analysis o f  the combined responses o f  IGF-IEa and MGF mRNAs in the 3 treatment 
groups highlights the smaller MGF mRNA response to GH treatment alone, but 
comparative sensitivity to training and furthermore to training combined with GH. 
The somewhat reciprocal response o f IGF-IEa, with its mRNA being highly 
responsive to GH treatment alone but comparatively less sensitive to training is also 
highlighted.
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Figure 5.5. Comparison of the MGF and IGF-IEa mRNA responses in the 3 treatment 
groups. Values are +SEM: * Significant difference from baseline.+ Significant difference in 
% change between isoforms (P<0.05).
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IGF-IEb mRNA Expression after Resistance Training
Expression levels o f this isoform were low and in the 10' ng range. Baseline levels of 
IGF-IEb mRNA (4.2x10 '8ng) were significantly increased by approximately 75% 
(P<0.01) after 5 weeks o f  training (7.1x10' ng). By the 12 week time point, they had
o
declined to levels similar to those observed at baseline (4.7xl0'°ng, P<0.01). A 
comparison o f the IGF-IEb response compared with those o f IGF-IEa and MGF in 
the same subjects are shown in Figure 5.7.
RT only
0  w k s  5  w k s  1 2  w k s
Figure 5.6. Levels of IGF-IEb mRNA at baseline, after 5 and 12 weeks of RT. Values are 
+SEM: n=5. * Significant difference from baseline# from 5 weeks (P<0.01).
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Figure 5.7 Comparison of the IGF-IEb mRNA response with those of IGF-IEa and MGF 
after 5 and 12 weeks in the same subjects. Values are +SEM (n = 4).
There were differences in the absolute levels of expression between IGF-IEa, IGF- 
IEb and MGF transcripts. IGF-IEa mRNA was expressed at higher levels when 
compared to IGF-IEb and MGF by 2-3 orders o f magnitude (10‘5ng vs 10'8ng).
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Circulating IGF-I
Measurements o f  circulating levels o f total IGF-I were made in all subjects from all 
three intervention groups at baseline, 5 and then 12 weeks. There were no significant 
differences observed in baseline levels o f IGF-I between the three groups. In the two 
groups receiving GH, serum IGF-I levels increased significantly from baseline to 12 
weeks, whereas no change was observed in the resistance training only group from 
baseline to 12 weeks. (Lange et al. 2002).
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Figure 5.8. Levels of circulating IGF-I at baseline, 5 weeks and 12 weeks in the 3 
intervention groups (n = 24): RT, RT+GH and GH. Values are expressed as +SEM.
* Significant difference from baseline (P<0.05). Data reproduced by kind permission of Dr 
Kai Lange.
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Muscle cross sectional area
Measurements of muscle cross sectional area were made in all subjects from the 
three intervention groups at baseline and then after 12 weeks. There were no 
significant differences observed in baseline measurements of muscle cross sectional 
area between the RT and RT+GH groups. However, the group that received GH 
alone had significantly higher muscle CSA at baseline compared with the other two 
groups. This was unusual and could not be explained with certainty, as the subjects 
had not received any GH prior to the start of the study. Furthermore, the samples 
were analysed in a blind fashion and only decoded after analysis. In the two 
resistance training groups (RT and RT+GH), muscle CSA increased significantly 
from baseline to 12 weeks, whereas no change was observed in the group that 
received only GH (Lange et al. 2002).
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Figure 5.9. Measurements of muscle CSA at baseline and 12 weeks in the 3 intervention 
groups (n = 24): RT, RT+GH and GH. Values are expressed as +SEM.
* Significant difference from baseline# between baseline levels (P<0.05). Data reproduced 
by kind permission of Dr Kai Lange.
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Correlation between circulating IGF-I and IGF-IEa and MGF mRNA in muscle
After 12 weeks of GH treatment alone, there was a significant correlation (r =0.81, 
p<0.05) between the change in levels of serum IGF-I and the change in levels of 
IGF-IEa produced by the muscle (Figure 5.9) but not with MGF (r = 0.43). However, 
after 12 weeks of GH treatment in combination with RT, there was no significant 
relationship between the change in serum IGF-I and the change in muscle IGF-IEa 
(r = 031), but a significant relationship with the change in muscle MGF mRNA 
(r=0.83, p<0.05) (Figure 5.10). There were no significant correlations observed 
between the change in serum IGF-I concentrations and either of the muscle growth 
factors IGF-IEa and MGF in the RT only group.
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Figure 5.10. Relationship between the change in serum IGF-I levels and the change in 
muscle IGF-IEa after 12 weeks of GH administration alone (r = 0.81, P<0.05).
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Figure 5.11. Relationship between the change in serum IGF-I levels and the change in MGF 
mRNA after 12 weeks of GH combined with RT (r = 0.83, P<0.05).
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Correlation between muscle CSA and MGF mRNA at baseline
Significant differences in baseline levels of both IGF-IEa and MGF mRNA were
observed between the three groups RT, RT+GH and GH only. Levels o f both IGF- 
IEa and MGF mRNA were higher in the group that received GH treatment only 
when compared to the other two training groups. When related to muscle size, as 
determined by nuclear magnetic resonance imaging (NMRI) (Lange et al. 2002), a 
significant correlation was observed between baseline levels o f MGF mRNA and 
quadriceps cross sectional area (CSA) (r = 0.58, P<0.05). There appeared to be no 
significant relationship between muscle size and levels o f IGF-IEa and no further 
correlations were observed between changes in IGF-I mRNA expression and muscle 
morphology over the training period.
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Figure 5.12 Relationship between baseline levels of MGF mRNA and muscle CSA 
(r = 0.58, P<0.01).
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5.4 Discussion
This study has revealed three key findings. Firstly, GH administration in elderly 
people appears to have differential effects on the mRNA expression of the isoforms 
of IGF-I expressed in muscle. GH seems to upregulate IGF-I expression, in an 
isoform and time specific manner with the preferential upregulation of the IGF-IEa 
isoform. However, in contrast, when exercise is combined with GH administration 
the mechano-sensitive isoform, MGF, is more markedly upregulated. Secondly, this 
study demonstrates that older muscles are able to upregulate both IGF-EEa and MGF 
mRNA in muscle in response to a period of prolonged resistance training. This is in 
contrast to the results shown in Chapter 3 where a single bout of high resistance 
exercise had no effect on either of these isoforms in older subjects, at least when 
measured 2lA hours after the end of the exercise bout. Thirdly, this study has also 
shown that the exercise training intervention upregulates a third isoform of the IGF-I 
gene, IGF-IEb.
GH regulated IGF-I expression in muscle
GH stimulates post-natal growth of the body in general through induction of IGF-I 
gene expression (Sadowski et al. 2001). Although the liver is the major site of GH- 
regulated IGF-I production, there is evidence to suggest that GH is able to regulate 
IGF-I gene expression in other non-hepatic tissues including the kidney, bone, 
intestine and skeletal muscle in an autocrine / paracrine fashion (Isaksson et al. 1982; 
1987). Increased IGF-I mRNA levels have been observed in the muscles of GH- 
treated hypophysectomized rats (Murphy et al. 1987; Isgaard et al. 1989; Gosteli- 
Peter et al. 1994) and the muscles of rats implanted with GH-secreting cells (Turner 
et al. 1988). In vitro studies have also shown that C2C12 skeletal muscle cells
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respond rapidly to GH administration with increased tyrosine phosphorylation of the 
GH receptor (GHR) and increases in IGF-I mRNA expression (Sadowski et al. 
2001). However, whether GH directly stimulates IGF-I mRNA expression in human 
skeletal muscle has remained somewhat unclear (Taaffe et al. 1996; Welle and 
Thornton, 1997). The present study therefore aimed to determine whether GH 
differentially affects the different isoforms of IGF-I.
The effects of GH administration in elderly people
GH release in response to resistance exercise is markedly attenuated with increasing 
age both in the untrained and trained state (Pyka et al. 1994; Zaccaria et al. 1999). 
Several studies have shown that GH administration in elderly people decreases fat 
mass and increases fat free mass (Rudman et al. 1990; Papadakis et al. 1996; Taaffe 
et al. 1994; Yarasheshki et al. 1995; Lange et al. 2000; Lange et al. 2002). However, 
despite increasing fat free mass, GH administration has not been shown to increase 
muscle mass or strength in healthy elderly individuals (Papadakis et al. 1996; Lange 
et al. 2002). Furthermore, trials in elderly people where GH administration has been 
combined with resistance training, GH does not seem to augment the strength gains 
obtained from exercise training (Taaffe et al. 1994; Yarasheshki et al. 1995; Lange et 
al. 2002). This is in contrast to studies in aged rats, which have reported gains in 
muscle mass and tetanic tension when GH administration is combined with cycling 
exercise (Andersen et al. 2000).
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Differential regulation of IGF-IEa and MGF by GH
The findings in the present study confirm the increase in IGF-I mRNA in the muscles 
of older people reported by Brill et al. (2002), who administered daily injections of 
GH over a one month period. However, the present study shows that there is an 
isoform specific response, with IGF-IEa (main liver isoform) being the most 
responsive to GH administration. Earlier studies investigating GH-regulated IGF-I 
mRNA expression in human skeletal muscle of elderly subjects had reported no 
consistent increases in IGF-I mRNA levels after 10 weeks of GH administration 
(Taaffe et al. 1996) or in muscle biopsy samples taken 10 hours after a single 
subcutaneous injection of GH (Welle and Thornton, 1997). However, these previous 
studies did not distinguish between the different isoforms of IGF-I expressed in 
muscle. As previously discussed, the IGF-I gene has two promoter regions, with 
transcripts initiating at promoter 2 believed to be GH sensitive (Lyall, 1996). 
Therefore, the suggestion that the two isoforms are regulated differently, with IGF- 
IEa being GH responsive and MGF appearing relatively insensitive to GH treatment 
would further support the results of the study in Chapter 3, which suggested that the 
two isoforms behave independently from one another. In support of this, another 
study showed that when rat muscles are exercised, MGF mRNA is expressed earlier 
than IGF-EEa (Haddad and Adams, 2002). Also, a later study showed that following 
local muscle injury the IGF-I gene is spliced to produce the MGF transcript, which 
precedes muscle satellite cell activation (Hill and Goldspink, 2003). After a few 
days, it appears that it is then spliced towards IGF-IEa. Thereby highlighting the idea 
that these are different growth factors with different functions and expression 
kinetics.
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Baseline differences in IGF-IEa and MGF expression
Baseline levels of both IGF-IEa and MGF mRNA in the group that received GH 
treatment alone were found to be significantly higher than baseline levels for these 
isoforms in the other two treatment groups. This cannot be explained with certainty, 
as all of the samples were analysed randomly and in a blind fashion and only re­
coded once quantification and analysis were complete. The possibility that this 
treatment group had received a dose of GH prior to the baseline biopsy being taken 
was also explored, however, all biopsy samples were taken before any GH had been 
given.
Changes in the expression of IGF-IEa and MGF mRNA in elderly people with 
prolonged resistance training
The study in Chapter 3 suggested that older muscles are less able to upregulate MGF 
mRNA when compared to young muscle following mechanical loading. Expression 
of MGF mRNA in the young subjects in that study significantly increased 2% hours 
after the end of a single bout of high resistance exercise whereas levels of IGF-IEa in 
both young and older subject groups showed no significant change with exercise. 
The present study however has clearly shown that following a 12-week period of 
progressive resistance training, even muscles of elderly individuals are able to 
significantly upregulate both IGF-IEa and MGF mRNAs. Levels of IGF-IEa were 
significantly increased after 5 weeks of resistance training and further increased at 
the 12-week time point when compared to baseline (68% and 103%). Interestingly, 
MGF levels in the present study were more sensitive to the training regime than IGF- 
IEa (168% and 169% from baseline). The comparative sensitivity of MGF compared 
with IGF-IEa to training would add weight to the suggestion made earlier in Chapter
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3, that being, when other studies such as the one by Fiatarone-Singh et al (1999) 
report an increase in IGF-I levels after resistance training, this might reflect an 
increase in MGF rather than IGF-IEa. As with the aforementioned study, the present 
study did not evaluate young subjects within the same study. This would be an 
invaluable exercise if we were to determine if there is an age related impairment to 
the upregulation of the different IGF-I isoforms in muscle with training. At present 
however no conclusions can be drawn on this issue.
Changes in the expression of IGF-IEa and MGF mRNA in elderly people with 
resistance training in combination with GH supplementation
Previous studies have investigated the effects of combining resistance training with 
GH supplementation on muscle mass and strength in elderly individuals (Taaffe et al. 
1994; Yarasheshki et al. 1995). The present study also combined these two stimuli. 
In this group of individuals, levels of IGF-IEa mRNA were no greater than those 
observed with either resistance training or GH administration groups. In contrast 
however, levels of MGF mRNA observed at both 5 and 12 weeks were markedly 
higher when compared with the GH only and RT only groups respectively. This 
suggests that GH administration results in a greater upregulation of the IGF-I gene in 
muscle which, when combined with high resistance exercise causes splicing towards 
the MGF isoform. Due to the dramatic increase observed in levels of MGF in 
response to resistance training combined with GH, it could be speculated that the 
long term effects (i.e. beyond 12 weeks) of combining these treatments may lead to 
an increase in muscle mass. Indeed, even in the GH only group it is possible that the 
increased levels of MGF mRNA observed after 12 weeks may have resulted from 
more of the primary transcript being available for splicing as a result of the
193
mechanical activity caused by habitual levels of physical activity. Furthermore, a 
significant association was observed between basal levels of MGF and quadriceps 
CSA as determined by MRI (Figure 5.12). This might provide some tentative 
evidence for the long-term regulation of muscle mass by the expression of local 
growth factors.
The relationship between circulating and muscle IGF-I
Circulating IGF-I is almost exclusively derived from the liver in response to GH 
secretion from the anterior pituitary. However, it has also been shown that the 
exercising muscle itself takes up GH during exercise and consequently releases IGF- 
I, thus providing a local contribution to circulating IGF-I (Brahm et al. 1997). In the 
present study, an increase in resting levels of circulating IGF-I was seen from 
baseline to 12 weeks in subjects receiving exogenous GH (Lange et al. 2002), but no 
further increase in IGF-I levels were seen in the RT+GH groups. Interestingly, the 
change in circulating IGF-I levels in the GH only group correlated with the change in 
IGF-IEa mRNA (r = 0.81, P<0.05), but not MGF mRNA (r = 0.43), in muscle. There 
was no such relationship between the change in circulating IGF-I and the mRNA of 
IGF-IEa (r = 0.45) or MGF (r = -0.53) in muscle, in the RT only group. In contrast, 
in the RT+GH group the change in circulating IGF-I was related to the change in 
MGF (r = 0.83, P<0.05), but not IGF-I Ea (r = 0.31). This suggests that GH 
administration may lead to an overall upregulation of the IGF-I gene in muscle, as 
well as in the circulation. Also, that isoform expression is regulated by physical 
activity, such that when combined with mechanical overload the IGF-I gene favours 
splicing towards the MGF isoform. The contribution of IGF-IEa and MGF to the 
circulating IGF-I levels may be a simple reflection of their increased expression in
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the different experimental groups. Thus suggesting that under certain conditions 
MGF might contribute significantly to circulating IGF-I levels.
GH and strength training
Measurements made by Lange et al (2002) in subjects from the present study showed 
that after 12 weeks of training, the gain in muscle mass and strength was actually no 
different in the group that strength trained whilst receiving GH (RT+GH) compared 
with the group that strength trained only. This finding is in agreement with previous 
studies in both old (Taaffe et al. 1994; Yarasheski et al. 1995) and young men 
(Yarasheski et al. 1992). Although one such study by Welle et al (1996), reported 
that GH treatment did further improve training induced muscle strength in healthy 
elderly men. In the present study (Lange et al. 2002) the increase in muscle mass and 
strength tended to be higher than in the group that trained whilst receiving GH 
treatment compared with the group that carried out strength training alone, however 
these changes were not significant. The possibility that a longer training period 
would have resulted in a greater increase in muscle mass and strength in the group 
that trained in combination with receiving GH cannot be excluded, and might be 
suggested by the MGF mRNA response seen in this group in the present study. 
Alternatively, it might be that the overload provided by training provides a sufficient 
stimulus for the upregulation of MGF at levels, which are optimal for muscle repair 
and adaptation, at least in healthy older people undergoing exercise training.
Changes in the expression of IGF-IEb with resistance training
An additional finding in the present study is the change in expression of a third 
isoform of the IGF-I gene, IGF-IEb. There are three alternative splicing sites at the
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3’ end of IGF-I transcripts, which generate different E peptides with a common 16 
amino acid N-terminal sequence and alternative C-terminal sequences. Transcripts 
containing Eb are more abundant in the liver, whereas transcripts containing Ea are 
commonly expressed in extra-hepatic tissues (Adamo et al. 1993; Stewart and 
Rotwein, 1996). It was possible to measure levels of this isoform as a part of this 
study as the optimisation process for different primers on the LightCycler was an 
ongoing process, with quantification of this isoform proving most difficult. A 
number of different primer sets were designed before a suitable pair was found. As 
with MGF and IGF-IEa, IGF-IEb is upregulated as a result of strength training 
exercise. The precise role of this isoform in muscle is unclear and further studies are 
required to elucidate its role.
Conclusion
This study demonstrates that elderly people can upregulate three isoforms of IGF-I in 
muscle as a result of high resistance training. The administration of recombinant GH 
alone, and in combination with exercise, has demonstrated that there is differential 
regulation of at least two isoforms of IGF-I, IGF-IEa and MGF. The data supports 
the argument that the IGF-I gene favours splicing towards the MGF isoform with 
increased mechanical activity provided by high resistance exercise. This might 
provide some evidence for the long-term regulation of muscle mass by the 
expression of local growth factors. These effects have been summarised in Figure 
5.13 below. Whether higher levels of MGF induced as a result of combining GH 
with exercise induce further adaptations in muscle beyond 12 weeks remains to be 
determined.
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Figure 5.13 Diagram showing some of the possible signalling pathways involved leading to 
IGF-I gene transcription if GH were to regulate its expression in muscle following either I. 
GH treatment alone or H GH+RT. m  shows how RT alone may affect MGF and IGF-IEa 
mRNA levels. Preferential splicing towards IGF-IEa ( ) or MGF ) after each
intervention is shown by the relative proportion of each isoform present, after splicing of the 
IGF-I gene in the nucleus. Abbreviations: JAK, Janus kinase; STAT, signal transducers and 
activators of transcription; SOCS, suppressors of cytokine signalling; IRS, insulin receptor 
substrate; SHP2, protein tyrosine phosphatase. (Adapted from Le Roith et al. 2001).
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Summary and Conclusions
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Summary and Conclusions
The aim of this thesis was to study the expression of splice variants of IGF-I in 
human skeletal muscle, with particular reference to age and exercise. To this end a 
new technique for the detection and accurate quantification of these mRNA 
transcripts was developed. Preliminary experiments in young subjects which used 
conventional PCR methods and which utilised the syringe needle aspiration 
technique of muscle sampling, revealed that the isoform most commonly expressed 
in the liver IGF-IEa, as well as the mechano sensitive isoform, MGF, were present in 
both resting and post exercise muscle samples (see Appendix 1). This was contrary 
to an earlier experiment performed in one subject, which had not been able to detect 
MGF in resting muscle (Yang et al. 1996). This finding coupled with technological 
advancements lead to the development of a new method for both detecting and 
quantifying these IGF-I transcripts using a real time quantitative PCR technique 
based on LightCycler technology. Time was taken to develop and optimise this 
method so that it would be possible to measure changes in expression of IGF-I 
isoforms in muscle with exercise. Initial experiments, had utilised the syringe needle 
aspiration technique. This is somewhat less invasive than the conventional needle 
biopsy technique, and has the advantage of allowing multiple sampling. However, it 
became clear that the target mRNA concentration in these samples was below a 
reliable detection limit of the real time PCR set-up (see Appendix 2). Thus, 
subsequent experiments were performed using the conventional needle biopsy 
method.
The expression of IGF-IEa and MGF mRNAs were studied in young and old subjects 
2Vi hours after the end of an acute bout of high resistance weightlifting exercise.
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Based on earlier animal experiments (Owino et al. 2001), it was hypothesised that 
older muscle would show a reduced MGF response after the exercise challenge. This 
study revealed that in young subjects, there was a distinct difference in the 
expression pattern of the two IGF-I isoforms in response to a single bout of high 
resistance weightlifting exercise, with MGF being upregulated and the IGF-IEa 
isoform remaining unchanged. In contrast, and in general agreement with the animal 
experiments, older subjects were less responsive. It was concluded that the two 
isoforms of IGF-I were differentially regulated in young muscle in response to a 
single bout of high resistance weightlifting exercise. There did not appear to be any 
relationship between the magnitude of the response and the MyHC composition of 
the muscle, but it was suggested that the underlying training status of the muscle 
might play some part in determining the degree of responsiveness. The type of 
exercise performed in this study is known to result in muscle hypertrophy. It is 
known that IGF-I has an anabolic action and that it can increase rates of muscle 
protein synthesis and that the activation of satellite cells is required for hypertrophied 
fibres to maintain their DNA to protein ratios (Kadi and Thomell, 2000). The role of 
MGF in satellite cell activation was highlighted in a recent cell culture study where 
C2C12 cells were treated with either MGF or IGF-I peptides. In that study MGF 
appeared to initiate satellite cell proliferation, whilst IGF-I promoted the 
differentiation of these cells into myotubes (Yang and Goldspink, 2002). Also that 
MGF expression precedes that of IGF-IEa and markers of satellite cell activation 
following muscle damage (Hill and Goldspink, 2003). However, to link these events 
it was important to consider the type of exercise in relation to muscle hypertrophy.
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In order to determine whether the MGF response was selective to the eccentric 
lengthening component of a muscle contraction, the mRNA responses of both IGF- 
IEa and MGF were studied in young and old subjects that had performed one hour of 
reverse pedal cycling eccentric only exercise. This type of exercise evoked a high 
degree of muscle soreness and damage, as was indicated by the elevated serum CK 
levels in the subjects after the exercise challenge. However, due to the relatively low 
absolute forces generated with this prolonged exercise protocol, it was unlikely to 
result in muscle hypertrophy. Interestingly, 2.25 hours after the end of this acute bout 
of this highly damaging exercise, this study revealed that both young and old 
subjects exhibited a marked increase in their MGF mRNA levels. While mRNA 
levels of IGF-IEa showed no significant change at the same time point. These data 
supported the findings in Chapter 3 that these isoforms were differentially regulated 
in human muscle shortly after the end of exercise. In contrast to the weightlifting 
exercise, the older subjects showed a significant upregulation of MGF. These data 
might therefore suggest that MGF expression in muscle may, in part, be linked to the 
myofibrillar disruption and/or sarcolemmal damage caused by eccentric exercise.
Although, the data reported in Chapter 3 implies a lack of response on the part of the 
older subjects, it is now established that progressive resistance training can increase 
muscle mass in elderly individuals. Furthermore, previous studies in elderly subjects 
have also shown an increase in IGF-I protein levels following a 10 week period of 
resistance training (Fiatarone et al. 1999). Thus, it may be that there is an age-related 
change in the sensitivity to a single exercise bout, or that there is slower expression 
(i.e. greater then 2.5 hours) in the older compared to the young muscle. The 
experiments conducted in Chapter 5 were designed to measure the effects of a period
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of strength training on these different IGF-I splice variants. These experiments also 
allowed an investigation into whether the local IGF-I response in human skeletal 
muscle is in any way under the control of GH. In this experiment elderly subjects 
were randomly assigned into one of three intervention groups: a group that received 
daily injections of GH, and two groups that underwent a 12 week resistance training 
programme either with or without (placebo) GH treatment. In addition, it was now 
possible to study the response of a third isoform, IGF-IEb in relation to resistance 
training. The results of the study demonstrated that elderly people could significantly 
upregulate all three isoforms of IGF-I in muscle after a period of high resistance 
training. Interestingly, GH administration was shown to have differential effects on 
the mRNA expression of the two isoforms IGF-IEa and MGF in muscle, with GH 
administration seeming to favour upregulation of the IGF-IEa isoform. This is 
perhaps not unexpected as in the liver it is the IGF-IEa isoform which is essentially 
under the control of growth hormone. However, with increased mechanical activity 
in the form of resistance training, there was marked upregulation of the MGF 
isoform. This response was further enhanced in the group where resistance training 
was combined with GH. These data would therefore suggest that GH induced an 
overall upregulation of the IGF-I gene, and that splicing towards the MGF isoform 
was favoured with increased mechanical activity.
In conclusion, the development of a real time quantitative PCR method that can 
measure changes at the mRNA level has allowed both short-term and long-term IGF- 
I isoform responses to exercise to be assessed in young and old human skeletal 
muscle. It is becoming more apparent that local growth factors are not only essential 
for muscle growth and repair, but that within the IGF-I gene family different
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isoforms exist as a result of alternative splicing, which may have different 
physiological roles. Whilst the work in this thesis has concentrated on the expression 
of IGF-I transcripts in human muscle studied in vivo, future work will need to 
measure the resultant levels of protein expression. The combination of both in vivo 
and in vitro studies should help characterise the precise physiological roles of these 
different isoforms.
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Appendix 1
Human muscle sampling using syringe needle aspiration
Initial experiments involved using the syringe needle aspiration technique to obtain 
muscle tissue. This technique is similar to that of an intra-muscular injection. It involves 
inserting a 19-gauge needle into the belly of the muscle, creating a vacuum with a 20ml 
syringe and then agitating the needle three to four times before withdrawing the needle. 
A ‘tiny’ amount of muscle tissue is recovered using this technique, but there is enough 
to extract total RNA and consequently make cDNA for RT-PCR.
Expression of IGF-I isoforms in human skeletal muscle 
Rationale
An initial experiment by Yang et al, 1996, where MGF was detected in human muscle 
for the first time was performed in one subject. In this experiment, the individual 
performed half an hour of intense eccentric exercise of the forearm flexor muscles. 
Using the syringe needle aspiration technique, a muscle sample was taken from the 
biceps brachii muscle 2 hours after completion of the exercise. A second sample was 
also taken from the contralateral muscle, which served as a non-exercised control. This 
study detected MGF mRNA in the eccentrically exercised arm, but not in the 
contralateral control muscle. Thereby suggesting that MGF was not present in resting 
human muscle. Since this study was performed in only one subject it was necessary to 
repeat the experiment in a number of subjects before any conclusions could be drawn. 
To perform a pilot study, 4 young subjects were used to determine the expression profile 
of this isoform in the vastus lateralis muscle after a single bout of eccentric box-stepping 
exercise. Syringe needle aspiration samples were obtained at multiple time points 
following the exercise bout, details of which are given below. A number of factors had 
to be taken into consideration when designing this pilot study. Firstly, the experiment
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described by Yang et al (1996) sampled the biceps brachii muscle. Since this is not a 
naturally weight bearing muscle such as the vastus lateralis, it is possible that there may 
have been baseline differences in the levels of MGF mRNA simply as a result of the 
vastus lateralis being a weight bearing, locomotory muscle.
Study protocol
In order to test the validity of the syringe needle aspiration technique as a reliable 
method of muscle sampling, we conducted a pilot study in four healthy young female 
volunteers (aged 22-25 years), using a box stepping model of damaging eccentric 
exercise. The subjects performed 40 minutes of repetitive box-stepping exercise on a 
box 47 cm high in time with a metronome. Duplicate syringe needle aspiration samples 
were taken from the vastus lateralis muscle of both the concentrically and eccentrically 
exercised legs before exercise, then 2 hours, 6 hours and 2 days after the end of the 
exercise bout. Total RNA was extracted from the muscle sample. Since the samples 
were so small, it was not possible to quantify total RNA concentration using 
spectrophotometry. All of the RNA extracted was therefore reverse transcribed using 
oligo(dT)17 to make first strand cDNA. Details of RNA extraction and first strand 
cDNA synthesis are given in Chapter 2, Methods and Materials. The cDNA was then 
amplified using conventional PCR as described in Methods and Materials. The primers 
used to amplify the MGF product were taken from Chew et al (1995). The forward and 
reverse primer sequences are given in Chapter 2, Table 2.4. These primers yielded a 
449bp product.
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Results
a-actin and myosin screening
Samples were initially screened using both myosin and a-actin primers to confirm the 
presence of muscle mRNA. Muscle sampling using the syringe needle aspiration 
technique was successful in obtaining muscle tissue, as following RT-PCR all samples 
were found to contain both myosin and a-actin.
Key Finding
The results from this pilot study revealed that MGF mRNA was present in muscle 
samples taken both before and post exercise (Figure A 1.1). This study also revealed that 
conventional PCR methods could be used quite reliably to determine the presence of this 
isoform in human muscle in samples obtained using the syringe needle aspiration 
technique. The original idea behind performing this study was to determine the time 
point after exercise that MGF mRNA could be detected, and this approach would have 
proved useful had we not detected MGF mRNA in the samples taken before exercise. 
Since MGF mRNA was detected in both before and post exercise samples, it became 
necessary to develop a technique that would allow quantification of the mRNA levels of 
isoforms such as MGF, in order to establish whether there was a change in their 
expression with exercise.
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B efo n ^ x erc ise  Sam ples
*  MGF (449bp)
Figure A 1.1. 2% agarose gel picture showing amplification of MGF mRNA following 40 
minutes box-stepping exercise.
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Quantitative PCR of muscle samples obtained using syringe needle 
aspiration
Aim
The purpose of this pilot study was to determine whether muscle samples obtained 
using the syringe needle aspiration technique could be used for quantitative PCR on 
the LightCycler system.
Background
Since the amount of tissue obtained when using this muscle sampling technique was 
so small (less than lmg), the concentration of total RNA could not be determined 
using spectrophotometry prior to generating cDNA. It was therefore not possible to 
normalise to total RNA concentration. The alternative was to normalise levels of 
IGF-I isoform mRNA to a control gene (i.e. relative quantification). Finding a 
suitable control gene, which is unchanged by the intervention being studied, is 
always a lengthy procedure and can involve testing the validity of many genes before 
a suitable one is found. Initial experiments looked at the possibility of using GAPDH 
for this purpose. Previous experiments to optimise the GAPDH primers on the 
LightCycler system were performed using tissue that had been obtained using the 
needle biopsy technique (which yields approximately 50mg of tissue). Here, the 
starting RNA concentration used to make cDNA was typically 0.5 fig. These early 
optimisation experiments had revealed that GAPDH mRNA was abundantly 
expressed in muscle tissue and also that the primer pairs designed worked efficiently 
to yield a specific PCR product with no primer dimer. A typical example of a melting 
curve profile of GAPDH is shown in Figure A 2.1 below.
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Figure A 2.1. A fully optimised GAPDH run on the LightCycler showing a sharp narrow 
specific product peak and no primer dimer, except that generated in the no template control 
sample.
Measurement of GAPDH mRNA in samples from box-stepping study
Using real time quantitative PCR to analyse these samples proved extremely 
problematic. Although it was possible to amplify the abundantly expressed gene 
GAPDH to a certain degree using this approach, the results were inconsistent and 
unreliable. An example o f the amplification profile obtained from a run with 4 
standards and 8 samples is shown in Figure A 2.2. The standards amplified with few 
problems and yielded the desired specific product, as reflected by the melting curve 
profile shown in Figure A 2.2. However, the ‘unknown’ cDNA samples proved 
difficult to amplify, and amplified less efficeintly at much later cycle numbers. The 
resulting melting peaks o f the samples were also broad and out o f sync with those of 
the standards. Adding more cDNA (up to 10 pi in the 20 pi PCR reaction) made very
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little difference to the quality o f the PCR, thus suggesting that the initial target 
concentration was below the detection limit of the LightCycler.
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Figure A 2.2. (A) amplification profile and (B) melting curve profile 
amplification of GAPDH mRNA in samples from box-stepping study.
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melting peaks of 
standards
obtained after
Measurement of IGF-IEa mRNA in samples from box-stepping study
Unlike GAPDH mRNA, which could be amplified to a certain degree, IGF-IEa 
mRNA could barely be amplified at all using this method. Figure A 2.3 shows the 
amplification profile of a run with 6 IGF-IEa standards and the same 8 cDNA 
samples used to amplify GAPDH. The amplification efficiencies between standards 
and samples were clearly very different, which would immediately suggest that any 
quantitative values obtained were inaccurate. Furthermore, the melting curve profile 
shown in Figure A 2.3 revealed that there was a large degree of primer dimer for 
both the standards and samples and barely any specific product being amplified.
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Figure A 2.3 (A) amplification profile and (B) melting curve profile obtained after 
amplification of IGF-IEa mRNA in samples from box-stepping study.
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Conclusion
These pilot studies revealed that real time quantitative PCR could not be used 
reliably to measure levels of either GAPDH or IGF-IEa mRNA in tissue samples that 
had been obtained using syringe needle aspiration. It is likely that because of the 
small sample size and subsequently low starting total RNA concentration, that the 
target concentration in the cDNA samples was below a reliable detection limit for the 
LightCycler set-up. As it was believed that these problems were largely related to the 
small tissue size, it became necessary to change the method used to obtain tissue. 
The needle biopsy technique described by Bergstrom et al. 1962 was subsequently 
used to obtain muscle tissue.
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k n o w n  to  express a t least tw o  iso fo rm s  o f  IG F-I a n d  it has b een  
re p o rte d  th a t in re sp o n se  to  o v e rlo ad  th e  m uscles  o f  aged ra ts  are  
less able to  u p re g u la te  th e  sp lice  v a r ia n t o f  IG F -I te rm e d  M G F 
(O w in o  et al. 2001). In  th e  p re s e n t s tu d y , ap p ro v e d  by the  local 
e th ics c o m m itte e , we a im ed  to  d e te rm in e  w h e th e r  th e re  w ere any 
ag e-re la ted  d ifferences  in M G F  m R N A  ex p re ss io n  in  h u m a n  
m uscle  s h o rtly  a fte r a b o u t o f  h ig h  res istan ce  exercise.
Fo llow ing  p r io r  d e te rm in a tio n  o f  th e  m a x im u m  one-legged  knee  
e x ten so r lift ( 1-R M ) a t least 1 w eek  b e fo re  th e  ex p e r im e n ta l day, 
e ight h ea lth y  y o u n g  (2 6 -3 6  y ears) a n d  seven  h ea lth y  o ld e r  
(7 0 -8 2  years) m en  p e rfo rm ed  ten  sets o f  six re p e titio n s  o f  knee 
ex ten so r exercise, lifting  a n d  lo w erin g  a m ass equal to  8 0 %  of 
th e ir  1-RM . T w o  m in u te s  passive recovery  was g iven betw een  
each set. F o llow ing  local an aes th esia  (1 %  lig n o ca in e) , m uscle  
b iopsies w ere o b ta in e d  fro m  th e  v astu s  la te ra lis  m uscle  o f  the  
exercised  (te s t)  a n d  n o n -ex e rc ised  (c o n tro l)  legs 2.5 h  a fte r the  
end  o f  th e  exercise  session  u s in g  th e  need le  te c h n iq u e . S am ples 
w ere im m e d ia te ly  fro ze n . S u b s e q u e n t q u a n tif ic a tio n  o f  th e  
m R N A  o f  the  tw o  IG F-I iso fo rm s  in m uscle  (M G F  a n d  IF G -IE a) 
w as p e r fo rm e d  u s in g  a q u a n t i ta t iv e  rev e rse  t r a n s c r ip t io n -  
p o ly m erase  c h a in  re a c t io n  (R T -P C R ) m e th o d  (L ig h tC y d e r , 
R oche  U K ).
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Figure 1. MGF mRNA expression (m ean ± S .E .M .)  in muscles 
of young (n = 8) and older (n = 7) men before and after
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w eight-lifting exercise. ‘ Significant difference between 
control and exercise samples (P < 0.05, W ilcoxon’s signed 
rank test).
T h e  m e a n  (±  s . e .m . )  1-R M  fo r th e  y o u n g  su b jec ts  w as 41.9 ± 4.3 
versus 20.6 ± 1 .6  kg fo r th e  o ld e r  su b jec ts  ( P < 0 .0 5 ) .  W h en  
n o rm a lise d  to  to ta l RNA c o n te n t,  levels o f  IG F-IE a w ere n o t 
d iffe ren t d iffe ren t b e tw een  th e  y o u n g  a n d  o ld  su b jec ts  (6.3 ± 0.9 
versus 6 .9 ±  1.0 x  1 0 '5 ng  m R N A //*R N A ) an d  no  chan g e  was 
o b serv ed  as a re su lt o f  th e  exercise  b o u t.  M G F  m R N A  levels at 
rest w ere  low er th a n  th o se  o f  IG F -IE a , b u t w ere  a lso  n o t d iffe ren t 
be tw ee n  th e  y o u n g  an d  o ld  su b jec ts  (Fig. 1). In  th e  y o u n g  
su b jec ts , a s ig n ifican tly  h ig h e r level o f  M G F w as o b serv ed  in the  
test leg w h e n  c o m p a re d  w ith  th e  c o n tro l  leg (P < 0 .05). H ow ever, 
no  d ifference  w as o b se rv ed  b e tw een  th e  test a n d  c o n tro l legs in 
th e  e lderly  sub jects .
T hese  da ta  sh o w  th a t fo llow ing  a s ta n d a rd ise d  b o u t o f  h igh  
re s is ta n c e  w e ig h t- l if t in g  e x e rc ise , th e re  is an  a g e - re la te d  
d iffe ren ce  in  M G F  gene ex p re ss io n . T h e  d a ta  in  y o u n g  sub jec ts  
also  suggest th a t  th e  M G F  a n d  IG F -IE a iso fo rm s  are  d ifferen tia lly  
reg u la ted  in  h u m a n  skeleta l m u scle .
Owino, V. etal. (2001). FEBS Lett. 505, 259-263.
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T h e  in f lu e n c e  o f  f a t ig u e d  a n t a g o n i s t s  o n  n e t  s ta t ic  k n e e  
e x te n s io n  t o r q u e
J.G .M . B eltm an , A. de H aan , A .). S a rg ean t, C .N . M ag an a ris  and  
D. Ball
Centre fo r  Biophysical and  C linical Research in to  H u m a n  M ovem ent, 
M anchester M etropolitan  University, Alsager, U K and  In stitu te  fo r  
F u n d a m e n ta l a n d  C lin ica l H u m a n  M o v e m en t Sciences, Vrije 
Universiteit, A m sterdam , The N etherlands
N et kn ee  e x te n s io n  to rq u e  is a fu n c tio n  o f  ag o n is t e x ten sio n  
to rq u e  a n d  o p p o s in g  a n ta g o n is tic  to rq u e . It has b een  p ro p o se d  
th a t  an ta g o n is tic  activ ity  m ay  be fu n c tio n a l in  s tab iliz in g  a n d /o r  
p ro te c tin g  th e  jo in t .  T h e  p re s e n t s tu d y  has  e x a m in e d  th e  
hy p o th e sis  th a t, a fte r fa tig u in g  th e  a n ta g o n is t h a m s tr in g  m uscles, 
a h ig h e r n e t e x ten sio n  to rq u e  w o u ld  be fo u n d , w h ich  w o u ld  be 
re la ted  to  th e  deg ree  o f  fa tigue . M o reo v er, it was investigated  
w h e th e r  such  a n  inc rease  w as d iffe ren t b e tw een  knee  angles.
Seven, re c re a tio n a lly  active  m a les  p e rfo rm e d  iso m e tric  M V C s at 
th e  fo llow ing  knee  angles: 90 , 70, 50 a n d  30 deg  knee  flex ion. 
T h e re a fte r , su b jec ts  p e rfo rm ed  m ax im a l e ffo rt d y n a m ic  flexion 
c o n tra c tio n s  (180  deg  s ' 1) u n til  to rq u e  h a d  d e c lin ed  - 5 0 % ;  th is  
was im m ed ia te ly  fo llow ed  by a kn ee  e x te n s io n  M V C . T h is  
seq u en ce  was re p ea ted  fo u r tim es  a n d  ra n d o m is e d  fo r all knee 
angles. EM G  m e a su re m e n ts  o f  m . b icep s  fe m o ris  w ere  tak en  in 
e x te n s io n  c o n tr a c t io n s .  A n ta g o n is t  av e rag e  re c tif ie d  va lu e  
(E M G ar) w as n o rm a liz e d  to  th e  m ax im a l flex ion  E M G ar at the  
sam e  k n ee  ang le . V o lu n ta ry  a c t iv a tio n  (V A ) a n d  m ax im a l 
to rq u e -g e n e ra tin g  cap ac ity  (M T G C ) o f  th e  m . q u a d ric e p s  w ere 
d e te rm in e d  u s in g  s u p e r im p o se d  e lectrica l s t im u la tio n .
D y n am ic  to rq u e  dec lin e  a fte r th e  fa tig u in g  b o u t o f  flexion  
c o n tra c tio n s  w as 48 ± 1 1 % .  T h e  W ilc o x o n  s igned  ra n k  test 
sh o w ed  n o  s ig n ific an t effect o f  fa tigue  a t th e  d iffe ren t knee  angles 
o n  E M G ar, M V C  to rq u e  a n d  M T G C , n o r  w as th e re  a s ig n ifican t 
e ffec t o f  k n e e  a n g le  o n  E M G ar (P > 0 .0 5 ). E M G Jr w as
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T h e  effec t o f  g ro w th  h o r m o n e  a d m in is t r a t io n  a n d  s t r e n g th  
t ra in in g  on  IG F -IE a  a n d  M G F  m R N A  e x p re s s io n  in  e ld e rly  
m e n
M. H am eed * t. K .H .W . L ange t, J.L. A ndersen§, P. Schjerling§, 
M. K jaerf, G. G o ld sp in k f and  S.D.R. H arridge* t
*Department o f Physiology, t M C R Unit Royal Free and University 
College Medical School, London, tSports Medicine Research Unit, 
Bispebjerg Hospital, Copenhagen, Denmark and  $Department o f  
Molecular Muscle Biology, Copenhagen Muscle Research Centre, 
Denmark
The m R N A  o f tw o iso form s o f the IGF-I gene has been show n to 
be expressed in h u m an  m uscle. O ne, IGF-IEa, is sim ilar to  the 
systemic, liver-type IGF-I, w hilst a second, M GF, is p ro d u ced  in 
muscle response to m echanical overload o r dam age. Recent 
studies o f h u m an  m uscle sam ples ob ta ined  sho rtly  after a single 
bou t o f h igh-resistance exercise suggest tha t IGF-IEa and  M GF 
m RN A  transcrip ts  are d ifferentially  regulated  (H am eed  et al. 
2003). The p resen t s tudy  was aim ed at d e te rm in in g  the effects of 
recom binan t grow th h o rm o n e  (rh G H ) adm in is tra tion  w ith and 
w ithou t resistance tra in in g  in elderly  subjects on the m R N A  
expression o f the  tw o d ifferent iso form s o f  IGF-I.
H ealthy elderly m en  (aged 74 ± 1 years, m ean  ±  S.E.M.) were 
assigned to e ither resistance tra in in g  (3 sessions/w eek, 3 -5  sets of 
8—12 repe tition  m ax im um  per session) w ith placebo (RT group , 
n = 6), RT co m b in ed  w ith  rhG H  ad m in is tra tio n  (R T + GH  
group, n = 6) o r rhG H  alone (G H  group , n =  7) in a random ised , 
p lacebo-con tro lled , d o u b le -b lin d ed  design (Lange et al. 2002). 
A dm in istra tion  o f  GH occu rred  daily th ro u g h  subcu taneous 
injection in the th igh  (0.5 IU  r r f 2 rising to 1.5 IU m~2). Following 
local anaesthesia (1 %  lidocaine), m uscle b iopsies were ob ta ined  
from  the  right vastus lateralis m uscle at baseline, 5 weeks and 
12 weeks. In the tw o tra in ing  groups the  b iopsies were ob ta ined  
24 h after com ple tion  o f  the last tra in in g  session. Sam ples were 
im m ediate ly  frozen in liquid  n itrogen . IGF-IEa and M GF mRNA 
tra n s c r ip ts  w ere analysed  u sing  a q u a n tita tiv e  reverse 
tra n sc r ip tio n -p o ly m erase  chain  reac tio n  (R T -PC R ) m e th o d  
(LightC ycler, R oche UK).
After 5 weeks o f  GH  a d m in is tra tio n  w ith o u t exercise (G H ), 
IGF-IEa had  increased, by on  average 226% , in con trast to  M GF 
m RNA levels, w hich w ere unchanged  (Table 1). H ow ever, there 
was a significant increase in b o th  IG F -IE a  (77 and 145% ) and 
M GF m R N A  levels (200 and  35 4 % ) in the RT and RT + GH 
groups, respectively, at this tim e p o in t. A fu rth e r 7 weeks o f GH  
adm in is tra tion  resu lted  in a s ignificant increase in M GF (6 3 %  
relative to baseline), bu t no  o th e r significant changes in M G F or 
IG F-IEa m RN A  were observed betw een 5 and  12 weeks.
T ab le  I. M G F  an d  IG F -1 Ea m R N A  levels p re , a f te r  5 w eeks an d  
afte r 12 w eeks o f  e ith e r  res is tan ce  t ra in in g  (R T ), res is tan ce  
tr a in in g  a n d  rh G H  a d m in is t r a t io n  (R T  + G H )  o r  rh G H  
a d m in is tra t io n  o n ly  (G H )
P re  P o s t 5 w eeks P o st 12 w eeks
IG F -IE a
RT 5.3  ±  0.7" 9.4 ± 2 .0 t" 10.2 ±  l.O t"
R T +  GH 6.2 ±  0.8" 15.2 ±  2 .6 t" 14.8 ±  2 .8 t"
G H 10.6 ±  1.4 34.6 ±  7.4T 23.2  ±  2.2
M G F
RT 1.6 ± 0 .2 " 4.8  ± 1.2t* 4.2 ±  0 .4 |
R T  + G H 2.2 ±  0.6" 10 ±  1.4f 7.8 ±  1 .2 t
G H 4.8 ± 1.2 5.8 ±  1.2* 7.8 ± 1 .6 t t
Data are expressed as ng mRNA//ig RNA. For IGF-IEa 10~5 ng, 
for MGF 10'* ng. TSignificant difference from 0 weeks, I  from 
5 weeks (P < 0 .05 ). “Significant difference from GH, ‘from 
RT + GH at given time point (P < 0.05). Data are means ± s . e .m . 
and analysed using ANOVA followed by Student-Newman- 
Keuls post-hoc tests.
The results suggest tha t M G F m R N A  expression  in m uscle is less 
sensitive to  GH  ad m in is tra tio n  th an  IG F-IEa, at least in elderly 
subjects. H ow ever, w hen m echan ical load ing  in the form  of 
resistance tra in in g  is com bined  w ith  G H  (R T + G H ), b o th  M GF 
and  IG F -IE a  m RN A  levels are enhanced , w hich m ay reflect an 
overall up -reg u la tio n  o f  tran sc rip tio n  o f the  IG F-I gene p rio r  to 
splicing. Previously rep o rted  da ta  from  th is s tudy  show ed no 
greater increase in m uscle streng th  and  cross-sectional area with 
RT + G H  co m pared  w ith  RT (Lange et al. 2002).
Hameed M et al. (2003). /  Physiol (in the Press).
Lange KHW et al. (2002). J Clin Endocrinol Metab 87, 513-523.
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with substrate breakdown, protein turnover, glycolysis and oxidative 
phosphorylation. Interestingly, several novel genes associated with 
growth suppression were also identified. Their possible involvement 
with IGF signalling is being examined.
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Differential expression of equine myosin heavy chain 
mRNA and protein isoforms in a limb muscle 
K. EIZEMA, M. VAN DEN BURG, 
E.G. DINGBOOM and W.A. WEIJS
Division o f Anatomy, Department o f Pathobiology, Fa­
culty o f Veterinary Science, Yalelaan 1, 3584 CL Utrecht, 
The Netherlands
The horse is one o f the few animals kept and bred for its athletic 
performance and as such an interesting model for human sports 
performance. The major structural protein in skeletal muscle, myosin 
heavy chain (MyHC) is thought to be primarily transcriptionally 
controlled. To investigate the expression o f the MyHC genes on the 
transcriptional level we isolated cD N A s encoding the adult equine 
MyHC isoforms. The m RNA expression was compared to the protein 
expression on a fiber-to-fiber basis using in situ hybridization (non­
radioactive) and immunohistochemistry in a biopsy (m. gluteus 
medius) from an adult untrained horse. Marked differences were 
detected between the expression o f  MyHC transcripts as compared to 
MyHC protein isoforms. Mismatches were primarily due to the 
presence o f  hybrid fibers expressing two fast (2ad) MyHC protein 
isoforms, but only one fast (mainly 2a) MyHC R N A  isoform. This 
discrepancy was most likely not due to differential m R N A  expression 
o f myonuclei. Currently we are extending these analyses to horses o f  
different ages and training status.
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The effects of eccentric exercise on IGF-I isoform 
expression in the muscles of young and elderly people 
M. HAMEED1, A.D. TOFT2, B.K. PEDERSEN2, 
S.D.R. HARRIDGE3 and G. GOLDSPINK1
1 Royal Free & University College Medical School, 
Department o f Surgery, Rowland Hill Street, London 
NW3 2PF, U K ; 2 Department o f  Infectious Diseases 7641, 
Copenhagen Muscle Research Centre, Rigshospitalet, 
Blegdamsvej 9, DK-2100 Copenhagen, Denmark; 3Royal 
Free & University College Medical School, Department o f  
Physiology, Rowland Hill Street, London NW3 2PF, UK
The m RNA expression levels o f  two splice variants o f the insulin like 
growth factor-I(IGF-I) gene (IGF-IEa and M GF) were studied 
following muscle damaging eccentric exercise. Subjects (10 young, 
20-27 years and 10 elderly, 67-75 years) completed 60 min o f reverse 
pedal cycling at the same relative oxygen uptake. Muscle biopsy 
samples were obtained from the quadriceps muscle before and 2 Vi h 
after completion o f  the exercise. Expression levels o f  the IGF-I 
transcripts were determined using real-time quantitative RT-PCR  
using specifically designed primers. N o  difference was observed 
between the resting levels o f  the two isoforms between the two age 
groups. Eccentric cycling exercise resulted in a significant increase in 
M GF m R N A  in the young, but not in the elderly subjects. N o  changes 
in IGF-IEa m RNA levels were observed as a result o f  the exercise in 
either group. These data are in general agreement with a previous 
study (Hameed et al., 2003) in which a one off bout o f  high resistance 
weightlifting exercise was performed. The studies suggest that there is 
an impaired M GF response in elderly muscle. The response in young 
subjects also supports the suggestion that the two isoforms M G F and
IGF-IEa are differentially regulated in human skeletal muscle follow­
ing exercise.
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Adaptation of fast-twitch hindlimb muscle to exercise 
training in mice 
J.A.L. JENESON, A. SCHOT, B.J.L.J. JOOSTEN,
A. DOORNENBAL and M.E. EVERTS 
Department o f Physiology, Division o f Pathobiology, 
School o f Veterinary Medicine, Utrecht University, The 
Netherlands
The adaptive response o f fast-twitch hindlimb muscle to mild exercise 
training was investigated in C57BL/6WT mice. Mice ran 0.5 km per 
day on a treadmill at a speed o f  16 m/min against an 11° incline for 
6 weeks. Intact EDL muscles o f CON and EXE mice were isolated and 
characterized mechanically and energetically at 20°C (Jeneson et al., J  
Muscle Res Cell M otil 23: 22) N a +/K +-ATPase in CON and EXE 
tibialis anterior and gastrocnemius muscles were determined by 3H- 
ouabain-binding (Kjeldsen et al., 1986, Pflugers Arch 406: 529-535.). 
N o change in N a +/K +-ATPase activity was found (CON: 
386 +  70 pmol/g wet wt). Peak tetanic, but not twitch force o f  EXE 
EDL was lower than CON (22.8 +  1.5 vs. 29.0 +  4.9 N /g  (« =  5)). 
Serial stimulation at 2 Hz caused progressive fatigue and slowed 
relaxation in CON, but less so in EXE. Oxygen consumption during 
contraction at 0.5, 1 and 2 Hz was higher in EXE than CON at all 
frequencies. Nonlinear curve fitting predicted a 1.5-fold higher 
mitochondrial Fmat for EXE EDL than CON (4.5 +  0.3 vs.
3.1 +  0.3 nmol 02/s/g). These results suggest that adaptations o f 
mouse hindlimb FT muscle to mild endurance training are restricted to 
the supply-side o f cellular energy balance.
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The effect of mechanical overload on the composition and 
turnover of regulatory proteins in skeletal muscle 
P. KAASIK, K. ALEV, A. PEHME, K. REISBERG 
and T. SEENE
Jakobi 5., University o f Tartu, Chair o f  Functional 
Morphology, Tartu, 51014, Estonia
The purpose o f  this study was to find changes in tropomyosin (TM), 
troponin (Tn) and their relations with MyHC isoforms’ composition 
and turnover rate during 2-week overload in skeletal muscle. 16-17- 
week-old male rats o f the Wistar strain were used. M. Plantaris o f one 
hindlimb was overloaded by unilateral removal o f  one its synergists m. 
Gastrocnemius. TM subunits and TnT isoforms were separated by 
12.5% SDS-PAGE in the presence o f  3.5 M  Urea. TM-subunits and 
TnT isoforms were identified by their known molecular weights and by 
Western blotting. MyHC isoforms were separated by 7.2% SDS- 
PAGE. Our results showed that in overloaded m. Plantaris the 
development o f  compensatory hypertrophy caused increase in the 
relative content o f  b-TM and decrease in the relative content o f a-TM. 
The turnover rate o f  TM increased from 0.50 ±  0.03 to 0.62 ±  0.04; 
P  < 0.05) during overload. During the chronic overload the relative 
content o f  the TnT2f decreased significantly and the content o f  the 
TnT3f increased. At the same time the T n T lf showed the tendency to 
decrease. The decrease o f the TnT2f and the increase o f TnT3f may 
show the changes in the skeletal muscle contractile properties towards 
the slow-twitch, as the concomitant change in the MyHC isoform 
pattern towards the increase o f M yHC I, Ha was found in our study. 
The turnover rate o f  TnT did not change significantly (from
0.98 ±  0.6 to 0.90 ±  0.7) during overloading. Taking also into 
account the increase o f  b-TM subunits during chronic overload, we
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HAMEED, M., S.D.R. H A R R ID G E, and G . G OLDSPINK . Sarcopenia and hypertrophy: A  role for insulin-like growth 
factor-1 in aged muscle? Exerc. Sport Sci. Rev., Vol. 30, No. 1, pp 15-19, 2002. Sarcopenia is the loss o f muscle mass associated 
with the aging process. Although systemic or circulating growth hormone and insulin'like growth factor-1 levels fall as we age, this is 
likely to be of lesser importance in regard to muscle mass than the role o f locally produced insulin-like growth factor- 1 s generated in 
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INTRODUCTION
Sarcopenia is the loss of muscle mass th a t is associated w ith 
the aging process. T he loss of muscle mass is, in part, respon­
sible for the decline in the functioning of muscle as we get 
older. This decline m ight be in its m echanical function (i.e., 
generating force, power, or braking m ovem ent) or in its roles 
as a dynamic m etabolic store, a generator of heat, or as a form 
of protective padding. In  addition, the decline in mass also 
accounts for a significant proportion of the decline observed 
in maximal aerobic power w ith increasing age. As physical 
function declines w ith age, simple daily tasks such as rising 
from a chair unaided or clim bing stairs become increasingly 
more difficult and, eventually, impossible to perform. This 
has im portant consequences for older people whose quality of 
life is reduced through a loss of independence and increased 
reliance upon others and also for the strain  put upon health  
and social services charged with the care of an increasingly 
aging population.
So why is muscle lost w ith increasing age? A t the  anatom ­
ical level it is clear th a t the loss of muscle is a reflection of a 
reduction in the num ber of muscle fibers and a reduction in 
the size of individual muscle fibers, notably the fast Type II 
fibers. However, although the aging muscle has lower rates of 
muscle protein synthesis (2,11), the m echanism s tha t may
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underlie this process of sarcopenia are unclear. This short 
review will focus upon a possible role for insulin-like growth 
factor (IG F -1) in sarcopenia.
POSSIBLE CAUSES OF SARCOPENIA
Despite the fact tha t age-related muscle loss and weakness 
seem synonymous to the changes associated with decreased 
physical activity, it is clear th a t this is no t necessarily the 
case. T he atrophy associated w ith muscle unloading results in 
reversible atrophy of individual fibers and no t a loss of fibers, 
whereas a loss of muscle mass is seen even in older people 
who m ain tain  very high levels of physical training (i.e., 
master athletes).
T he rate at w hich muscle protein is synthesized is reduced 
in later life. Balagopal et al. (3) showed tha t whole body 
protein  synthesis was 19% lower in older individuals (77 ±  
2 yrs) w hen compared w ith younger individuals (23 ±  1 yr). 
More specifically, muscle protein  synthesis was 55% lower, 
whereas synthesis rates of nonm uscle proteins rem ained the 
same. T his was in general agreem ent w ith the results of an 
earlier study by W elle et al. (11) who showed that the 
fractional rate of myofibrillar protein synthesis was 28% 
lower in older (62 -81  yrs) compared with younger (21-31 
yrs) men. In addition to overall changes in protein synthesis, 
there are a num ber of structural and com positional differ­
ences th a t are characteristic of the aging muscle. A loss of 
contractile  proteins relative to o ther cell com ponents and 
increased am ounts of connective tissue and intram uscular fat 
have been reported. W hethe r there is a change in the relative 
distribution of the main histochem ically determ ined fiber 
types w ith aging rem ains som ewhat unclear, although it is
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certain th a t there are less fast myosin heavy chain  isoforms 
(in part due to the atrophy of the faster Type II fibers).
Hypertrophy is the increase in muscle size that occurs as an 
adaptation to increased muscle loading, which in humans is 
most easily achieved through strength training and results from 
a net increase in protein turnover. It is clear that because 
hypertrophy is limited to the muscle exercised and not to all 
muscles, there are “local" factors regulating this process. There 
is now good evidence to suggest that IGF-1 plays a key role in 
the hypertrophic adaptation of muscle to exercise.
INSULIN GROW TH FACTOR-1 (IGF-1)
M ature IG F-1 is a 70-am ino acid single-chained polypep­
tide with many three-dim ensional structural similarities to 
the proinsulin molecule. It has an im portant role in the 
regulation of somatic growth, developm ent, and differentia­
tion. IGF-1 is synthesized in the liver as a consequence of 
growth horm one (G H ) secretion from the anterior pituitary 
gland. This “systemic” IGF-1 prom otes cell division and is 
generally responsible for norm al growth and developm ent. 
However, it is now know n th a t IGF-1 is synthesized “locally” 
and has potential autocrine/paracrine actions. Local IGF-1 
synthesis is thought to be partially G H  dependent in some 
IGF-responsive tissues. However, in o ther tissues such as 
skeletal muscle, local IGF-1 expression seems to be G H  
independent. It is now know n tha t IGF-1 exists in m ultiple 
isoforms tha t may have specific functions. T he following 
sections will briefly introduce these locally acting isoforms of 
IGF-1, IGF-1 receptors through which IGF acts on  target 
tissues, and the binding proteins by w hich IGF-1 is trans­
ported and whose action  may be regulated.
MUSCLE-SPECIFIC ISOFORMS OF IGF-1 AND  
M ECH ANO -G RO W TH FACTOR (M G F)
Two know n isoforms of the IGF-1 gene are expressed by 
muscle w hen it is subjected to m echanical stim ulation. These 
are derived from the IGF-1 gene by a process of alternative 
splicing. T his is a complex m echanism  by which exons are 
arranged in different com binations from pre-m RNA . It is an 
im portant and com m on process for generating protein diver­
sity and regulating gene expression in higher eukaryotes. T he 
IGF-1 gene contains two prom oters initiating at the 5' exons 
1 and 2. T ranscripts in itiating  at exon 2 are com m on in the 
liver and are highly G H  dependent, whereas transcripts in i­
tiating at exon 1 are widely expressed in extrahepatic tissues. 
A lternative splicing of the IGF-1 gene generates three dif­
ferent E peptides th a t have a com m on N -term inal sequence 
but alternative C -term inal sequences. A  schem atic represen­
tation of the exon arrangem ent o f the IGF-1 gene and its 
splice variants can be seen in Figure 1.
T he first isoform is similar to the  hepatic endocrine type of 
IGF-1. Several different abbreviations have emerged for this 
isoform: IG F-IEa (10), L.IGF-1 (14), and m.IGF-1 (8). 
Transgenic mice th a t overexpress this particular isoform in 
skeletal muscle have been shown to have pronounced muscle 
hypertrophy (8), and it seemed th a t the older animals showed
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F ig u re  1. A schem atic rep resen ta tion  of th e  IGF-1 gen e  and  its splice 
variants believed to  be  expressed in m uscle. The black box  d en o tes  the 
insert in exon 5 (49-base pair), w hich gives rise to  th e  alternatively spliced 
MGF isoform.
signs of protection  against the norm al loss of muscle mass 
associated w ith aging. It was concluded tha t the localized 
mIGF-1 transgene expression preserved muscle architecture 
and age-independent regenerative capacity of muscle.
T he  second isoform, IG F -lE b  (hum ans), is thought to be 
predom inately expressed in the liver, and its role in muscle is 
unknow n. T he  third isoform is a splice variant resulting from 
a novel splice acceptor site in the in tron preceding exon 6 
and is generated in muscle subjected to stretch and overload 
(14). T his isoform is term ed MGF, IG F-lEc (hum an), and 
IGF-Eb (rat) in the literature. Structurally, the M GF gene 
differs from its liver type counterpart because of the presence 
of a 49-base pair insert (52 base pairs in the rat). It is thought 
no t to be glycosylated, therefore it is expected to have a 
shorter half-life than  the liver IGFs. M GF is thus likely to be 
designed to act in an autocrine/paracrine, rather than  sys­
tem ic, mode of action. As a result, it binds to its own 
muscle-specific binding protein, in the interstitial tissue 
spaces.
INSULIN G RO W TH FACTOR-1 RECEPTOR (IGF-1 R)
T he cellular effects of IGF-1 are m ediated by the activa­
tion  of a specific tyrosine kinase receptor. IGF-1 binds with 
high affinity to the Type 1 dim eric receptor, which is struc­
turally and functionally homologous to the insulin receptor. 
It is composed of two ligand binding a  subunits and two 
transm em brane /3 subunits. It is know n tha t the biological 
activity of a horm one or grow th factor does no t simply reflect 
the  level of horm one or grow th factor, but also depends on 
the concen tra tion  of the  receptor and the  affinity of its 
interaction. T here is evidence th a t there is an im pairm ent of 
both IGF-1R density and signaling in aged skeletal muscle. 
However, IGF-1R num ber, binding capacity, and affinity 
were shown to increase in the soleus muscle of old mice after 
physical exercise (13), suggesting th a t old anim als retain 
plasticity for IGF-1R.
IGF-BINDING PROTEINS (IGFBP)
T he in teraction  betw een IGFs and their binding proteins 
(IGFBP) represents prereceptor regulation. Excluding an 
M G F binding protein, six IGFBPs have been characterized to 
date. T ogether, these act as m odulators of IGF-1 action. 
T heir m ain functions are to 1) stabilize and transport IGFs
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from the circulation to peripheral tissues, 2) m ain tain  a 
reservoir of IGFs in the circulation, 3) po ten tia te  or inhibit 
IGF action, and 4) mediate IG F-independent biological ef­
fects. Of the six systemic-type binding proteins, IGFBP-3 is 
primarily responsible for m aintain ing IGF-1 levels in the 
circulation in conjunction  w ith ano ther protein  called acid 
labile subunit. T here is some evidence th a t alterations in 
IGFBP expression, namely IGFBP-4 and IGFBP-5, occur in 
unloaded or overloaded soleus muscle and th a t this may play 
a role in skeletal muscle adaptation  to changes in loading (3).
MECHANICAL ACTIVITY A N D  THE EXPRESSION OF 
LOCALLY PRODUCED G RO W TH FACTORS
The expression of the two m ain muscle isoforms of IG F-1, 
namely IG F-IEa and IG F-lE c (M G F), seem to be affected in 
different ways by physical activity. A n  early study by DeVol 
etal. (5) dem onstrated th a t there was a threefold increase in 
total IGF-1 m R N A  levels in the soleus and plantaris muscle 
in 11- to 12-wk-old female rats after tenotom y-induced hy­
pertrophy. These levels were m aintained 2, 4, and 8 d after 
the experim ental procedure, thereby suggesting a relation­
ship between local stim ulation of skeletal muscle growth and 
IGF-1 gene expression.
Yang et al. (14) showed th a t M G F was markedly up- 
regulated in rabbit extensor digitorum  longus muscle, w hich 
had been subject to acute stre tch  by immobilizing the h ind 
limb in the extended position. In the same study it was shown 
that the expression of the IG F-IEa isoform was also induced 
by mechanical stim ulation.
This work was further supported in a study in which 
mRNA expression of the muscle-specific isoforms of IGF-1 
was investigated in rabbit muscle after different m echanical 
stimuli regimens (7). T h e  study showed th a t w ith in  4 d of 
stretch using plaster cast im mobilization, w ith the limb in the 
plantar flexed position, th a t a marked up-regulation of both  
IGF-IEa and M GF was apparent. Electrical stim ulation at 10 
Hz com bined w ith stretch  (overload) resulted in an even 
greater increase of both  types of IGF-1 transcript. Electrical 
stim ulation alone, w ithout stretch, resulted in no significant 
increase com pared w ith muscle from sham -operated controls. 
The expression of both  systemic and autocrine IGF-1 in 
muscle provides an interesting link betw een the m echanical 
signal and a marked increase in structural gene expression 
involved in tissue rem odeling and repair.
GROWTH H O RM O NE A N D  IGF-1 IN OLD AGE
T he G H-IGF-1 axis plays an  essential role in postnatal 
growth and developm ent. A  summary of this process is sche­
matically represented in Figure 2. C irculating  G H  and IGF-1 
are required for growth in adolescence and for the m ainte­
nance of muscle mass and strength  in adulthood. Levels of 
these horm ones reach their peak during adolescence and are 
m aintained at som ewhat lower levels during adulthood. In 
later life, there is a further decline in the production  of G H  
and IGF-1. It was suggested th a t a close relationship existed 
between the age-related decline in the G H  and IGF-1 axis
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Figure 2. A sum m ary o f th e  GH-IGF-1 axis. A. Systemic p roduction  of 
IGF-1 is governed  by GH release from  th e  an terio r p ituitary gland. Systemic 
IGF-1 exists in th e  "free" an d  "b o u n d "  s ta te  in th e  circulation. B. Recent 
w ork has em phasized  th e  im portance of a G H -independent, au tocrine/ 
paracrine form  of IGF-1 p roduced  in n o nhepatic  tissues including muscle, 
w hich is th o u g h t to  play a key role in m uscle ad ap ta tio n a l processes. ALS, 
acid labile subunit; IGFBP-3, IGF binding pro tein  3.
and a loss o f muscle mass and strength. In young adults who 
were G H  deficient, the  adm inistration  of recom binant G H  
had positive effects in terms of muscle growth. It was thus 
hypothesized th a t older individuals w ith decreased levels of 
circulating G H  and IGF-1 would benefit from such trea t­
m ent. T h e  results, however, have been disappointing, with 
rates of p rotein  synthesis being no different in older m en who 
have undergone strength train ing  with recom binant G H  
supplem entation w hen com pared with those who only-un­
derw ent strength  train ing (15). In  this regard, and in support 
of the  argum ent th a t systemic growth factors may be of 
relatively m inor im portance in hypertrophy, is one study that 
showed th a t the  response to a single in jection  of G H  in older 
m en increased plasma IGF-1 concentrations but resulted in 
no increase in the m R N A  for IGF-1 in muscle (12).
THE ROLE OF SATELLITE CELLS IN MUSCLE 
G RO W TH A N D  REPAIR
If locally produced IGF-1 plays a role in the hypertrophic 
process, how m ight it exert its action? O ne likely m echanism  
is through its influence on satellite cells. Satellite cells are 
small m ononucleate precursor cells th a t are located between 
the basal lam ina and sarcolem ma of muscle fibers (Fig. 3). 
T hese cells are believed to rem ain m itotically inactive but are 
mobilized by increased m echanical loading or damage, play­
ing a role in bo th  adaptation  and repair of muscle. It is 
believed th a t these cells proliferate and differentiate into 
myoblasts, w hich th en  fuse w ith existing fibers, providing 
new nuclei to m ain tain  the D N A  to protein  ratios of fibers 
undergoing hypertrophy. Satellite cells are im portant for 
postnatal grow th of muscle and are the primary means by
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F igure  3. A possible role for IGF-1 in satellite cell activation during 
skeletal m uscle regeneration . Satellite cells are  activated in response to  a 
m echanical signal, e.g ., injury, denervation , exercise, or s tretching. Hepa- 
tocyte g row th  factor (HGF) is also th o u g h t to  activate satellite cells 
th rough  its receptor c-M et, expressed in qu iescen t satellite cells. Activa­
tion of quiescent satellite cells results in th e  expression of th e  m yogenic 
factors MyoD and /or Myf5 and  th e  generation  of m yogenic precursor cells 
(mpcs). IGF-1 is th o u g h t to  play a role in bo th  m pc proliferation and  in the  
d ifferentiation of m pcs into m yotubes. (Reprinted from  Seale, P., and  M.A. 
Rudnicki. A new  look a t th e  origin, function , and  "stem -cell" s ta tu s  of 
muscle satellite cells. Dev. Biol. 2 1 8 :1 1 5 -1 2 4 , 2000. Copyright © 2000  
Academ ic Press. Used w ith perm ission.)
which adult muscle mass is formed. T he ir num ber decreases 
gradually after birth, and there is some recent evidence from 
studies of hum an satellite cells in culture th a t the replicative 
potential of these cells may be reduced in later life (4).
DeVol e t a l. (5) suggested tha t during muscle growth, 
locally produced IG F-1 had two d istinct functions with re­
spect to satellite cell involvem ent in th a t it stim ulated both 
proliferation and differentiation of satellite cells. T he role of 
IGF-1 in satellite cell activation  was further supported by 
experim ents in which direct infusion of IGF-1 into the tib ­
ialis anterior muscle of adult rats resulted in an increased 
total muscle protein and D N A  con ten t, dem onstrating skel­
etal muscle hypertrophy related to satellite cell activation 
(1). Further evidence for the role of these cells in hypertro­
phy is provided by an experim ental approach whereby satel­
lite cells were prevented from proliferating after treatm ent 
with y-radiation. T he subsequent overloading of the adult rat 
soleus muscle failed to evoke hypertrophy of the overloaded 
irradiated muscles (9).
Furthermore, Musaro e t a l. (8) have recently reported tha t 
IGF-1 is able to induce the calcineurin nuclear factor of 
activated T  cells. This signaling pathway leads to activation 
of G A T A -2, a transcription factor whose up-regulation is 
related to muscle fiber hypertrophy.
IG F -1 is therefore thought to play an im portant role in the 
stim ulation of both myogenic precursor cell proliferation and 
muscle hypertrophy during muscle regeneration. W hether 
IGF-1 is involved in the “d irec t” stim ulation  of satellite cell 
activation has yet to be determ ined. Effective therapeutic 
strategies aimed at the m ain tenance of skeletal muscle 
strength in aging and neurom uscular disease m ight depend 
on the developm ent of m ethods to increase the muscle sat­
ellite cell population. Expanding m ature satellite cell popu­
lations by adm inistering mIGF-1 genes may provide an ef­
fective clinical strategy for the prevention, reduction, or 
reversal of age and disease-related muscle frailty (8).
ADAPTABILITY OF AGING H U M A N  MUSCLE
Despite the po tential age-related im pairm ents in growth 
factors, a num ber of recent studies have shown tha t the 
muscles of even very frail, very elderly people (> 8 5  yrs) are 
able to adapt to m uscle-strengthening exercise (Fig. 4). T he 
observation tha t G H  seems relatively ineffective in stim ulat­
ing muscle growth, raises questions as to the role systemic 
growth factors may play in the adaptation  to exercise. Fiat- 
arone-Singh e t a l. (6) recently used an im m unohistochem ical 
technique to study IGF-1 expression in muscle biopsy sam­
ples obtained from older m en and women (aged 72-98  yrs) 
after 10 wk of strength training. T hey used a general IGF-1 
antibody and showed a -5 0 0 %  increase in the levels of IGF-1 
w ith in  the muscle fibers of these subjects after the training 
period. T he antibody used for im m unohistochem ical analysis 
was nonisoform  specific, hence-it cross-reacted w ith all three 
IGF-1 isoforms. It was therefore difficult to determ ine from 
this study exactly w hich IGF-1 isoforms had increased in the 
muscle after strength  training. In addition, in the posttrain- 
ing biopsy samples, they observed increased ultrastructural 
damage and an increase in the num ber of fibers expressing 
em bryonic myosin heavy chain  isoforms. T his would be in 
support of the hypothesis th a t muscle damage provokes the 
“in itia l” step in the rem odeling process, w hich ultimately 
leads to muscle regeneration. T h e  increase in am ount of 
weight tha t could be lifted after training was proportional to 
the significant increase in IGF-1 im m unoreactivity in muscle 
after training. However, the effect of a similar training reg­
im en on younger individuals was no t investigated in this 
study. Therefore the question as to w hether a similar or 
smaller percentage change in IGF-1 peptide levels occurs in 
older individuals rem ains to be determ ined.
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F ig u re  4. M agnetic  resonance  im aging im ages taken  at th e  mid-thigh 
region of a male subject 92 yrs of ag e  before  and  a fte r 12 wk of s trength 
training o f th e  knee ex tensor and  flexor m uscles. Q uadriceps lean cross- 
sectional a rea  increased by 4 4 %  in this individual. (Reprinted from  Har­
ridge, S.D., A. Kryger, and  A. S tensgaard . Knee ex tensor s treng th , activa­
tion, and  size in very elderly peop le  following s treng th  training. M uscle 
Nerve  2 2 :8 3 1 -8 3 9 ,1 9 9 9 . C opyright © 1999 John Wiley & Sons, Inc. Used 
w ith perm ission.)
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SUMMARY
It is clear tha t the aging process, w hich results in a loss of 
muscle mass, is associated w ith a reduction in systemic G H / 
IGF-I muscle. However, it is also clear th a t hypertrophy is 
linked to the production of local grow th factors, and the 
effects of the aging process on the local regulation of IGF-I 
and its isoforms and its coupling to satellite cell activation 
has yet to be fully determ ined. T h e  potency of IGF-1, and 
particularly MGF, may provide the  source for po ten tia l th e r­
apies for older people to increase muscle mass, particularly for 
those who may not be able to provide their muscles w ith 
appropriate physical stimuli through exercise.
The superior mass and function  of m aster strength  and 
power athletes provides evidence of the  benefits of long-term  
mechanical signals. Yet, even these highly trained athletes 
are not im mune to the effects of the aging process, albeit 
having a considerable advantage over their nonactive coun­
terparts. T he fact th a t frail, nonactive older people seem to 
retain the ability to hypertrophy their muscles in response to 
strengthening exercise suggests th a t m echanism s triggering 
the growth of muscle rem ain in place. However, it m ight be 
speculated tha t the activation  threshold of m echanical stim ­
uli for IGF-1 increases w ith age such th a t m echanical signals 
provided by tasks of daily living are no longer sufficient to 
maintain muscle mass.
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